case_id,mode,case_type,iteration,Q0_answer,Q0_reasoning,Q1_answer,Q1_reasoning,Q2_answer,Q2_reasoning,Q3_answer,Q3_reasoning,Q4_answer,Q4_reasoning,Q5_answer,Q5_reasoning,Q6_answer,Q6_reasoning,Q7_answer,Q7_reasoning,Q8_answer,Q8_reasoning,input_tokens,output_tokens,total_tokens
Case3223,rag,all_correct,iter3,BRCA1/2,Patient was referred specifically for BRCA1 and BRCA2 testing (patient info). The policy FEP 2.04.02 addresses germline BRCA1 and BRCA2 testing (policy).,Not Specified,"Policy specifies age-related criteria for affected individuals (eg, breast cancer diagnosed ≤45, etc.) but does not impose an age limit for testing an unaffected first-degree relative; the patient is an unaffected 75-year-old and no policy upper-age exclusion for unaffected relatives is specified.",Not Specified,"Policy states testing should be performed in a setting with suitably trained providers who can give pre- and post-test counseling, but it does not specify required ordering provider specialty or that a general practitioner cannot order testing; the patient was referred by a general practitioner but the policy does not define explicit ordering-provider credentials.",Yes,"Policy lists that testing of an unaffected individual is medically necessary if they have a 1st- or 2nd-degree blood relative meeting any Patients With Cancer criterion; the patient's sister (a 1st-degree relative) had epithelial ovarian carcinoma, which meets the 'personal history of epithelial ovarian carcinoma at any age' criterion.",Not Specified,"Policy strongly recommends testing an affected family member first whenever possible to aid interpretation, but it does not state that such prior testing is an absolute prerequisite for coverage of testing an unaffected relative; the patient’s documentation does not indicate whether affected-relative testing was done.",Yes,"Policy family-history criteria are central to eligibility; the patient has a first-degree relative (sister) with epithelial ovarian cancer, which is a specified qualifying family history in the policy.",No,Policy requires testing be performed in a setting that can provide appropriate pre- and post-test genetic counseling and states formal genetic counseling is recommended; there is no documentation of pre-test genetic counseling for this patient (patient info).,Not Specified,The provided policy document does not list or map specific CPT codes to BRCA1/2 testing; no CPT code is specified in the policy text.,No,"From an adjudication perspective: the patient meets the policy's medical-necessity criterion for an unaffected individual with a first-degree relative with epithelial ovarian cancer. However, the policy explicitly states testing should be performed in a setting that provides appropriate pre- and post-test genetic counseling. There is no documentation of pre-test genetic counseling in the patient information, so the policy's counseling/setting requirement is not met as documented; therefore coverage is not approved based on the available information.",18927,2477,21404
Case14226,rag,all_correct,iter3,BRCA1/2,Patient is being evaluated specifically for germline BRCA1 and BRCA2 testing per the clinical information; policy addresses BRCA analysis.,Yes,"Policy requires age 18 years or older for BRCA testing (Known familial, AJ founder, and Full Sequence analyses); patient is 55, meeting the age requirement.",No,"Policy explicitly requires pre- and post-test genetic counseling by an appropriate provider for BRCA testing. The patient has not completed pre-test genetic counseling, so ordering/provider requirements are not met.",No,"Policy defines specific medical/diagnostic indications for full BRCA sequencing (e.g., breast/ovarian/pancreatic/prostate cancers, specific age/pathology criteria, or defined family-history combinations). The patient has an unspecified primary solid tumor (not listed) and the policy does not state acceptance based solely on a 2.5% risk score from Tyrer‑Cuzick/BRCAPro/Penn II; therefore the patient does not meet the policy's listed medical indications.",Yes,"Policy requires no previous full sequencing or prior BRCA testing for full sequence analysis; patient has not undergone prior genetic testing, satisfying the 'no previous testing' requirement.",No,Policy specifies family-history criteria related to breast/ovarian/pancreatic/prostate cancers and degrees of relatives. The provided family history (mother with a hematologic/immunologic disorder) does not meet the BRCA family-history criteria in the policy.,No,"Policy requires pre- and post-test genetic counseling by an appropriate provider for BRCA testing. The patient did not complete pre-test genetic counseling, so counseling requirements are not met.",81162,"Policy billing guidance indicates that when BRCA1/2 deletion/duplication analysis is performed concurrently with BRCA1/2 sequencing, CPT 81162 ('BRCA1/2 full sequencing and duplication/deletion analysis (combined)') is likely most appropriate.",No,"From an adjudication perspective the patient fails key policy requirements: they do not meet the policy's specified clinical/diagnostic indications for BRCA testing (tumor type not among listed indications and policy does not accept the stated 2.5% risk score as a standalone criterion) and pre-test genetic counseling (required by policy) was not completed. Although age and lack of prior testing are acceptable, these deficiencies mean the request does not meet the policy's coverage criteria.",10313,2521,12834
Case10451,rag,all_correct,iter3,WES,Patient clinical note explicitly states neurologist referred the 10-year-old for whole exome sequencing (WES).,Yes,"Policy criteria list 'Moderate, severe, or profound Intellectual Disability diagnosed by 18 years of age' as an indication for WES; patient is 10 with moderate-severe ID diagnosed in childhood, meeting the age-related criterion.",Yes,"Policy requires WES be ordered by a medical geneticist, neonatologist, neurologist, or developmental pediatrician; the ordering provider is a neurologist, satisfying this requirement.",Yes,"Policy requires a clinical history strongly suggesting a genetic cause plus one or more features such as moderate/severe intellectual disability by age 18; patient has unexplained moderate-severe ID diagnosed in childhood and nonspecific neurodevelopmental presentation, meeting the medical indication.",Not Specified,"The WES coverage criteria do not mandate prior testing (CMA) as a prerequisite; although the patient had nondiagnostic CMA, the policy does not require specific prior tests before WES.",No,"Policy lists 'other first- or second-degree family member(s) with similar clinical features' or consanguinity as supportive criteria; the documented sibling event (brief resolved unexplained event) does not constitute a similar neurodevelopmental phenotype or consanguinity, so relevant family-history criteria are not met.",Not Specified,Policy states genetic counseling is 'strongly recommended' prior to WES but does not list counseling as an explicit coverage requirement; the record shows no documented counseling but counseling is not required for coverage per the policy text.,81415,"Policy applicable CPT codes list 81415 for exome (proband) sequence analysis; the requested test is WES for the proband, corresponding to 81415.",Yes,"Per the UnitedHealthcare WES policy, coverage requires (1) nonspecific presentation (no well-defined syndrome), (2) ordering by an approved specialty (neurologist), and (3) presence of qualifying features such as moderate/severe ID by age 18. The patient meets these criteria and prior CMA was nondiagnostic—WES is therefore medically necessary under the policy.",36961,1508,38469
Case4196,rag,all_correct,iter3,WES,Patient information explicitly states whole exome sequencing (WES) is being requested. (Patient fact),Yes,"Policy specifies WES may be medically necessary for children with unexplained neurodevelopmental disorders. The patient is 10 years old, which meets the policy's age/child criteria. (BCBS_FEP policy statement)",Yes,"Policy criterion 1 requires evaluation by a clinician with expertise in clinical genetics and counseling. Patient has documentation of pre-test genetic counseling and a described phenotype and family history, which satisfy the policy's provider/counseling requirement. (BCBS_FEP policy criterion 1; patient fact: pre-test genetic counseling completed, phenotype and family history provided)",No,"Policy requires ALL criteria including: (1) genetics evaluation/counseling (met), (2) evidence there is potential for change in management (not documented in the patient information), and (3) genetic etiology considered most likely despite previous genetic testing or prior testing failed to yield diagnosis / next would be invasive testing (prior testing noted was FISH nondiagnostic but the patient record does not document the required potential for a change in management). Because criterion 2 is not documented, the patient does not meet all required medical-indication criteria. (BCBS_FEP policy statement; patient facts)",No,"Policy criterion 3 expects prior genetic testing (examples: CMA and/or targeted single-gene testing) or prior testing that failed to yield a diagnosis. The patient had prior FISH testing that was nondiagnostic, but there is no documentation of standard prior testing such as chromosomal microarray (CMA) or targeted single-gene testing as described in the policy. Therefore required prior testing per policy is not documented as completed. (BCBS_FEP policy criterion 3; patient fact: FISH nondiagnostic only)",Yes,"Policy notes family history of developmental delay is relevant. Patient has a brother with moderate to severe intellectual disability in childhood, which is relevant to eligibility under the policy. (BCBS_FEP policy guidelines; patient fact)",Yes,"Policy requires genetic counseling (evaluation by clinician with genetics expertise and counseling). Patient information documents pre-test genetic counseling completed with plans for post-test follow-up, meeting the policy's counseling requirement. (BCBS_FEP policy criterion 1; patient fact)",Not Specified,The provided BCBS_FEP WES/WGS policy document does not specify CPT billing codes for WES; no CPT mapping is included in the policy text. (Policy text lacks CPT code listings),No,"Although age, counseling, and family history criteria are met, the policy requires ALL listed criteria for WES to be considered medically necessary. The patient record does not document (a) the required evidence that WES would lead to a potential change in management and (b) completion of the standard prior genetic testing described in policy (eg, CMA/targeted testing). Because all policy criteria are not met, the test is not covered per the BCBS_FEP policy. (BCBS_FEP policy statement; patient facts)",14850,2908,17758
Case18281,rag,all_correct,iter3,WGS,Patient clinical information states the cardiologist ordered whole genome sequencing (WGS).,Not Specified,"The policy includes some age-based criteria for specific indications (e.g., ID diagnosed by 18) but does not impose an overall age cut-off for WGS for multiple congenital anomalies; the patient is 6 years old, which is not excluded by the policy.",No,"Policy requires WGS be ordered by a medical geneticist, neonatologist, neurologist, or developmental pediatrician; the ordering provider is a cardiologist, so provider requirement is not met (policy: 'WGS is ordered by a medical geneticist, neonatologist, neurologist, or developmental pediatrician').",Yes,"Policy medical-necessity criteria include 'multiple congenital anomalies (must affect different organ systems)' for WGS; the patient is a child with multiple congenital anomalies that do not fit a well-delineated syndrome, so the clinical criterion is met.",Yes,"Policy WGS criteria require that 'neither CMA nor WES have been performed.' Patient had only Fragile X testing (nondiagnostic) and no CMA or WES documented, so this requirement is satisfied.",Yes,"Policy lists 'other first- or second-degree family member(s) with similar clinical features' and 'laboratory abnormalities suggestive of an IEM' among features supporting sequencing; patient has a sibling with an inborn error of metabolism, which is relevant family history.",Not Specified,"Policy states genetic counseling is 'strongly recommended prior to WES or WGS' but does not make counseling a coverage requirement; patient had no pre-test genetic counseling, but counseling is not a mandated coverage criterion in the policy.",81425,"Policy's applicable CPT codes list 81425 for genome sequence analysis ('Genome (e.g., unexplained constitutional or heritable disorder or syndrome); sequence analysis'), which corresponds to WGS.",No,"Although the clinical indication (multiple congenital anomalies) and prior-testing condition (no CMA/WES) are met and family history is supportive, the policy requires WGS to be ordered by a medical geneticist, neonatologist, neurologist, or developmental pediatrician; the ordering provider is a cardiologist, so the policy's provider requirement is not met and coverage is therefore not supported.",36944,2179,39123
Case17196,rag,all_correct,iter3,CMA,Patient clinical information states the oncologist referred the patient for chromosomal microarray (CMA) testing; the policy also discusses CMA testing.,Not Specified,"The policy describes CMA indications (developmental delay/ID, ASD, multiple congenital anomalies) but does not establish explicit age-based inclusion/exclusion criteria for CMA coverage.",Not Specified,"The policy discusses the role of genetic counseling and that testing is ordered by clinicians, but it does not specify ordering-provider specialty or other explicit ordering requirements for CMA.",No,"Policy coverage for CMA is limited to evaluation of developmental delay/intellectual disability, autism spectrum disorder, or multiple congenital anomalies; the patient has a longstanding adult neuropsychiatric presentation (bipolar/schizophrenia/OCD) and does not meet the policy-defined indications.",Not Specified,"The policy does not require completion of specific prior tests before CMA (it notes CMA may be first-line and references fragile X testing in ASD workups), so no explicit prior-test requirement is specified for this request.",Not Specified,"While the patient has a sibling with early hearing/visual impairment, the policy does not define family history or consanguinity criteria as requirements for CMA eligibility.",Not Specified,"The policy recommends formal genetic counseling in most cases and describes who should perform it, but it does not state a mandatory pre-test counseling requirement as a coverage condition for CMA.",Not Specified,The policy document does not list or map specific CPT codes to CMA testing; no CPT code is specified in the provided policy text.,No,"Per the policy, CMA is medically necessary only for developmental delay/ID, ASD, or multiple congenital anomalies. The patient's indication is an adult neuropsychiatric disorder (bipolar/schizophrenia/OCD), which is not a covered indication under this policy; therefore CMA is not covered.",15705,1641,17346
Case8288,rag,all_correct,iter3,WES,Patient statement: 'whole exome sequencing (WES) is being pursued.',Not Specified,"The policy does not impose an age limit for prenatal WES; age-related criteria in the policy apply to postnatal pediatric indications (e.g., diagnoses by age 18) but not to prenatal/fetal testing.",Not Answerable,"Policy requires prenatal WES to be ordered by or in consultation with a medical geneticist or maternal-fetal medicine specialist. Patient data do not state who ordered the WES or whether such consultation occurred, so compliance with ordering-provider requirement cannot be confirmed.",Yes,"Policy prenatal WES indication: fetus with a congenital anomaly affecting a single organ system plus family history suggesting a genetic etiology qualifies. Patient has a major fetal cardiac anomaly (single organ) and a family history of an inborn error of metabolism in a sibling, satisfying the clinical indication.",Yes,"Policy requires CMA and/or karyotype to have been performed and uninformative prior to prenatal WES. Patient had a prior chromosomal microarray (CMA) that was nondiagnostic, meeting this prior-test requirement.",Yes,"Policy lists family history as a qualifying feature for prenatal WES when a single-organ congenital anomaly plus family history suggests genetic etiology. Patient has family history of an inborn error of metabolism in an older sibling, which is relevant.",Yes,"Policy states genetic counseling is strongly recommended prior to WES/WGS. Patient/family have had multiple sessions with a genetic counselor, meeting the counseling recommendation.",81415,"CPT 81415 corresponds to 'Exome (e.g., unexplained constitutional or heritable disorder or syndrome); sequence analysis,' which matches the requested whole exome sequencing.",No,"Although patient meets the clinical indication (single-organ fetal anomaly plus relevant family history) and prior CMA was nondiagnostic, the policy requires that prenatal WES be ordered by or in consultation with a medical geneticist or maternal-fetal medicine specialist and that an appropriate fetal sample source be used. The patient record does not document that the ordering/consultation requirement or sample source are met; because the policy requires all listed criteria be satisfied for coverage, coverage cannot be confirmed and the request is not covered per the available documentation.",36980,2360,39340
Case3422,rag,all_correct,iter3,WES,Patient is being considered for whole-exome sequencing (WES) after a nondiagnostic chromosomal microarray (CMA) per the clinical information.,No,"Policy ES medical necessity criteria explicitly require the member to be <21 years of age. The patient is 34, so age-based eligibility is not met (policy: 'Member is <21 years of age').",Not Answerable,"Policy specifies pretest counseling/documentation (e.g., clinical letter, genetic/family history evaluation, counseling by medical geneticist or affiliated genetic counselor) but the record only notes the patient was 'referred by oncology' and has seen a genetic counselor multiple times; there is insufficient information about the ordering provider's specialty, whether a required clinical letter or written consent was provided, or whether the rendering lab is qualified per the Health Plan policy.",No,"Policy defines specific clinical indications (and requires member <21). The patient has isolated congenital choanal atresia as an adult; criteria for multiple congenital anomalies or neurodevelopmental indications (and the age requirement) are not met, so the defined medical indications are not satisfied.",Yes,"Policy requires prior testing documentation and that the member not have prior ES/WGS; patient had a nondiagnostic CMA and there is no indication of prior ES/WGS, satisfying the policy's prior-test requirements (policy: 'previous tests performed and results' and 'The member has not had previous exome sequencing performed, AND The member has not had previous genome sequencing performed').",No,Policy requires appropriate genetic and family history evaluation but does not list maternal breast cancer at age 50 as a relevant family-history criterion for ES for congenital anomalies; the patient's reported family history (mother with breast cancer at 50) is not a specified family-history indication for ES in this context.,Not Answerable,"Policy requires pretest counseling by a medical geneticist or affiliated genetic counselor and written documentation/consent and a clinical evaluation letter. The patient 'has seen a genetic counselor multiple times,' but there is no documentation provided here of formal written consent, a clinical letter with the required elements, or confirmation that counseling met the policy's specified content, so sufficiency cannot be determined.",81415,Policy states exome sequencing for the proband should be billed with CPT 81415 ('81415 should be billed for the proband').,No,"Despite prior CMA and counseling, the policy's medical necessity criteria for ES require the member be <21 and meet defined phenotype criteria. The patient is 34 and does not meet the age-based criterion; therefore ES is not covered per the policy.",10464,2305,12769
Case5885,rag,all_correct,iter3,WGS,Patient information explicitly states whole genome sequencing (WGS) is requested.,Yes,"Policy age-related items reference criteria diagnosed by age 18; the patient is 11 years old, which falls within the age-based thresholds cited in the WGS/WES policy (e.g., features diagnosed by 18 years).",Yes,"Policy requires WGS be ordered by a medical geneticist, neonatologist, neurologist, or developmental pediatrician; the test was requested by/through neurology per the patient information, meeting the ordering-provider requirement.",No,"Policy defines specific clinical indications for WGS (e.g., multiple congenital anomalies affecting different organ systems, moderate/severe ID by 18, global developmental delay, epileptic encephalopathy <3, or two or more listed features). The provided facts note a 'major abnormality affecting at least one organ system' but do not document any of the policy-specified qualifying features (multiple-system congenital anomalies, DD/ID, epilepsy, or two or more listed features), so the patient does not clearly meet a defined medical indication.",Yes,"Policy prerequisite for WGS includes that neither CMA nor WES have been performed. Patient has had Fragile X testing only (no CMA or WES), satisfying the policy prior-test condition for WGS.",No,"Policy lists relevant family-history criteria (e.g., first-/second-degree family members with similar clinical features or consanguinity). The patient has a maternal history of long QT syndrome, but no information links that to the patient's presenting abnormality or documents a family member with similar clinical features—so the family-history criteria are not met.",Yes,"Policy states genetic counseling is strongly recommended prior to WGS/WES. Patient information reports pre-test counseling was discussed with a genetic specialist and plans for post-test follow-up are in place, meeting the policy's counseling recommendation.",81425,"Policy's applicable CPT codes list 81425 as 'Genome (e.g., unexplained constitutional or heritable disorder or syndrome); sequence analysis', which corresponds to clinical WGS.",No,"Although ordering provider, age, and prior-test (no CMA/WES) and counseling aspects align with policy, the policy requires specific clinical features (e.g., multiple-system congenital anomalies, DD/ID, epileptic encephalopathy, or two or more listed features) that are not documented in the provided clinical information. Because the patient does not clearly meet the medical-indication criteria in the WGS coverage rationale, the WGS request is not covered per the policy.",36937,3443,40380
Case14195,rag,all_correct,iter3,BRCA1/2,The patient was referred specifically for BRCA1/2 testing (document states referral for BRCA1/2). Basis: patient clinical information.,Yes,Policy explicitly states testing minors for BRCA1/2/PALB2 is investigational; the patient is 18 (not a minor) so the age-based restriction for minors does not apply. Basis: 'Genetic testing in minors ... is considered investigational' in the policy.,No,"Policy requires testing be performed in a setting with suitably trained providers who can give appropriate pre- and post-test counseling. The patient has had no pretest genetic counseling per the clinical info, so ordering/provider requirements are not met. Basis: 'Genetic testing should be performed in a setting that has suitably trained health care providers...give appropriate pre- and post-test counseling' and genetic counseling guidance.",No,"Policy defines medical indications based on personal cancer history or family history of relevant cancers. The patient has no personal history of cancer and the only relevant family history is a maternal uncle with neurologic disease (dystonia/ataxia), not breast/ovarian/pancreatic/prostate cancer, so the patient does not meet the policy's medical criteria. Basis: policy criteria for individuals without cancer require a 1st- or 2nd-degree relative meeting listed cancer criteria or >5% probability.",Not Specified,"Policy recommends, when possible, testing an affected family member first and discusses prior limited testing scenarios, but it does not mandate specific prior tests be completed before germline BRCA1/2 testing. Basis: 'it is strongly recommended that an affected family member be tested first whenever possible' and testing strategies sections.",No,"Policy explicitly evaluates family history of breast/ovarian/pancreatic/prostate cancer in eligibility. The patient's only reported family history is a maternal uncle with dystonia/ataxia (no cancer), so the patient does not have the family history specified by the policy. Basis: policy definitions of relevant close relatives and required cancer-family criteria.",No,"Policy specifies pre- and post-test genetic counseling by experienced providers and notes counseling is recommended prior to testing. The patient has had no pretest genetic counseling, so counseling requirements are not met. Basis: 'Genetic testing should be performed in a setting ... who can give appropriate pre- and post-test counseling' and 'Genetic counseling ... recommended.'",Not Specified,The provided policy document does not list or map specific CPT codes for BRCA1/2 testing or billing; therefore the appropriate CPT code cannot be determined from the policy text. Basis: absence of CPT coding in the policy.,No,"Under the policy, germline BRCA1/2 testing is medically necessary only when personal cancer history or specified family cancer history/criteria are met or >5% prior probability; this patient is an unaffected 18-year-old without a qualifying family cancer history or documented >5% risk and lacks required pretest counseling. Therefore the requested BRCA1/2 test is not covered. Basis: policy statements on indications for individuals without cancer, testing-unaffected-individuals criteria, and counseling requirement.",18924,2226,21150
Case2847,rag,all_correct,iter3,WES,Patient information explicitly states 'whole exome sequencing (WES) is being pursued.',Yes,"Policy addresses infants/children and defines BRUE as in infants <1 year; the patient is a 5-week-old infant (<1 year), meeting the age context in the policy (policy examples specifically reference infants/children).",Not Answerable,"Policy requires documentation that the individual has been evaluated by a clinician with expertise in clinical genetics. The clinical information notes pre-test counseling by a genetic counselor but does not state whether a clinician with expertise in clinical genetics provided the required evaluation, so available information is insufficient to determine compliance with ordering provider requirements.",Yes,"Policy Guidelines list 'Infant with high risk stratification on evaluation for a Brief Resolved Unexplained Event (BRUE) ... Required cardiopulmonary resuscitation (CPR)' as a clinical feature suggesting a genetic disease. The patient had a high-risk BRUE requiring CPR, so meets a specified medical indication in the policy.",Yes,"For standard WES the policy lists prior genetic testing (eg, chromosomal microarray) as part of the evaluation when prior testing has failed to yield a diagnosis. The record states prior chromosomal microarray (CMA) testing was nondiagnostic, satisfying the prior test requirement described in the policy.",No,"The policy specifies relevant family history examples (eg, arrhythmia, BRUE in sibling, LQTS, sudden unexplained death). The patient’s family history notes the mother has a persistent immunologic/hematologic disorder, which is not among the policy's listed relevant family-history criteria, so the patient does not have the specified family history per policy.",Yes,"The policy requires genetic counseling and that individuals be counseled about risks. The clinical information documents pre-test counseling completed with a genetic counselor and plans for post-test follow-up, satisfying the counseling requirement in the policy.",Not Specified,The provided BCBS FEP policy text does not list or map specific CPT codes to whole exome sequencing; therefore a CPT code cannot be selected from the policy document alone.,Yes,"Under the FEP policy, standard WES may be considered medically necessary for children when ALL criteria are met: (1) documentation of evaluation/counseling by a genetics-expert clinician, (2) potential for change in management, and (3) prior genetic testing nondiagnostic (eg, CMA). The patient is an infant (5 weeks) with a high-risk BRUE requiring CPR (policy example of clinical feature suggesting genetic disease), prior CMA was nondiagnostic, and pre-test genetic counseling was completed. While documentation of evaluation by a clinician with genetics expertise is not explicitly stated in the record, the combination of pre-test genetic counseling, phenotype (BRUE with CPR), and nondiagnostic CMA meet the policy's clinical and prior-testing criteria supporting medical necessity for WES per the FEP policy; therefore coverage is indicated.",14852,3265,18117
Case11855,rag,all_correct,iter3,CMA,Patient information states chromosomal microarray (CMA) is being ordered to assess for copy number variants.,Not Specified,The UnitedHealthcare CMA policy does not define specific age cutoffs for postnatal CMA eligibility; age-based eligibility is not specified in the coverage rationale.,Not Specified,"The policy strongly recommends pre-test genetic counseling and genetics expertise for counseling, but it does not mandate a specific ordering provider specialty or type to order CMA.",No,"Policy coverage rationale lists specific covered indications (ASD, isolated severe congenital heart disease, multiple anomalies not specific to a well-delineated syndrome, developmental delay/intellectual disability). The chart documents a single-organ congenital anomaly without documentation of ASD, DD/ID, or isolated severe CHD, so the patient does not explicitly meet the listed medical indications.",Yes,"The AAN/model elements in the policy state targeted testing (e.g., Fragile X) should be negative if indicated prior to CMA; the patient had Fragile X testing previously performed and nondiagnostic, satisfying the prior test requirement where applicable.",Not Specified,The policy does not use family cancer history or the reported maternal-aunt breast cancer as an explicit eligibility criterion for CMA; family history criteria are not specified for CMA eligibility in the coverage rationale.,Yes,"The policy 'strongly recommends' pre-test genetic counseling; the patient had pre-test counseling with a genetic specialist and plans for post-test follow-up, meeting the counseling expectation in the policy.",81228,"Policy lists CPT 81228 for cytogenomic (genome-wide) analysis (CGH microarray) to interrogate regions for copy number variants, which aligns with the requested CMA to detect CNVs.",No,"Per the UnitedHealthcare CMA coverage rationale, coverage is limited to the listed indications (e.g., ASD, isolated severe CHD, multiple anomalies, DD/ID). The provided clinical information documents a single-organ congenital anomaly without documentation that it meets any of those explicit covered indications; therefore the test is not covered under the stated criteria.",30417,2701,33118
Case3465,rag,all_correct,iter3,WGS,Patient information states 'whole genome sequencing (WGS) has been ordered.' Coverage determination will therefore evaluate WGS. (Patient fact),Yes,"Policy age-based criteria for WES/WGS reference features diagnosed by age (e.g., intellectual disability diagnosed by 18 years; global developmental delay onset prior to 5 years). The patient is 2 years old with developmental delay/intellectual disability, meeting the policy's age-related criteria. (Policy: WGS criteria; Patient fact)",Yes,"Policy requires WGS be ordered by a medical geneticist, neonatologist, neurologist, or developmental pediatrician. The patient is being evaluated by and the test was ordered by a medical geneticist. (Policy requirement; Patient fact)",Yes,"Policy lists global developmental delay and intellectual disability (diagnosed by 18 years) as qualifying clinical indications for WGS. The patient has developmental delay and intellectual disability without a specific syndrome, which satisfies those clinical criteria. (Policy criteria; Patient fact)",Yes,"Policy for WGS requires 'Neither CMA nor WES have been performed' prior to WGS. Patient history lists prior Fragile X testing (nondiagnostic) but does not report prior CMA or WES, so the patient's prior-testing status meets the policy requirement. (Policy requirement; Patient fact)",No,"Policy lists family history of similar features or consanguinity as supportive criteria. While the patient has a paternal history of Long QT syndrome, that is not a first/second-degree family member with similar neurodevelopmental features nor consanguinity; thus the patient does not meet the policy family-history criterion. (Policy criteria; Patient fact)",Yes,"Policy states genetic counseling is 'strongly recommended prior to WES or WGS.' The patient had pre-test counseling with a genetic counselor and plans for post-test counseling, meeting the counseling recommendation in the policy. (Policy guidance; Patient fact)",81425,"Policy's Applicable Codes list maps whole genome sequence analysis to CPT code 81425 ('Genome; sequence analysis'), which corresponds to the requested WGS. (Policy Applicable Codes)",Yes,"From an adjudication perspective, all specified WGS coverage criteria in the policy are met: patient is a pediatric case with global developmental delay/intellectual disability (policy clinical indication), test ordered by a medical geneticist (policy ordering-provider requirement), patient is 2 years old (age criteria satisfied), CMA/WES have not been performed (policy prior-test requirement), and pre-test genetic counseling was completed (policy counseling recommendation). Therefore WGS is covered per the policy. (Policy criteria; Patient facts)",36943,2240,39183
Case15557,rag,all_correct,iter3,WGS,Patient information states testing being pursued with whole genome sequencing (WGS).,Not Specified,"The UHC policy does not impose a strict age limit for WGS; age-specific items in the criteria (e.g., ID diagnosed by 18 years) are feature- related rather than an absolute exclusion/inclusion based solely on age.",Yes,"Policy requires WGS be ordered by a medical geneticist, neonatologist, neurologist, or developmental pediatrician; the patient was referred by/being evaluated by neurology (neurologist), meeting the ordering-provider requirement.",Yes,"Policy requires clinical history suggesting a genetic cause plus either one major feature or two or more listed features. The patient has a congenital anomaly (present since birth) and 'other first- or second-degree family member(s) with similar clinical features' (affected sibling) — two listed features, satisfying the clinical indication for WGS.",Yes,"Policy states WGS is appropriate when 'Neither CMA nor WES have been performed.' Patient had nondiagnostic FISH but no CMA or WES reported, satisfying the prior-test requirement for WGS.",Yes,"Policy lists 'other first- or second-degree family member(s) with similar clinical features' and consanguinity as relevant criteria; the patient has a sibling with a similar congenital anomaly, which is directly relevant.",Not Specified,"The policy 'strongly recommends' genetic counseling prior to WES/WGS but does not state counseling as a formal coverage requirement. Patient has documented genetic counseling visits, but counseling is a recommendation in the policy rather than a strict coverage criterion.",81425,"Policy's Applicable Codes list maps 'Genome (e.g., unexplained constitutional or heritable disorder or syndrome); sequence analysis' to CPT code 81425, which corresponds to WGS.",Yes,"Per the UHC policy, WGS is medically necessary when (1) neither CMA nor WES have been performed (met), (2) ordered by an approved specialist (neurologist — met), and (3) clinical history suggests a genetic cause with qualifying features (patient has congenital anomaly and an affected sibling — two listed features). Therefore the request meets the policy coverage criteria for WGS.",36940,2481,39421
Case4982,rag,all_correct,iter3,WES,Patient information states the patient is being considered for whole exome sequencing (WES).,Yes,"Policy age-based criteria reference features diagnosed by age 18 for WES (e.g., ID diagnosed by 18). The patient is 11 years old, so age is within the policy-specified age window for pediatric indications.",Yes,"Policy requires WES be ordered by a medical geneticist, neonatologist, neurologist, or developmental pediatrician. The patient was referred by/being evaluated by a developmental pediatrician, meeting the ordering provider requirement.",Yes,"Policy requires clinical history strongly suggesting a genetic cause plus specific features. The patient has a congenital anomaly (Hirschsprung disease) and a first-degree relative (sibling) with early-onset epileptic encephalopathy, meeting the policy’s listed features supporting WES.",Not Specified,"The policy does not mandate specific prior testing (e.g., CMA) before outpatient WES except in the prenatal setting or when a specific syndrome/targeted test is suspected. The record notes prior nondiagnostic FISH but policy does not require additional specific prior tests for WES in this scenario.",Yes,"Policy lists relevant family history (other first- or second-degree family member(s) with similar clinical features) as a criterion. The patient has a sibling with epileptic encephalopathy before age three, which is relevant per policy.",Not Specified,"The policy 'strongly recommends' genetic counseling prior to WES/WGS but does not state counseling as a formal coverage requirement; the patient has documented pre-test genetic counseling, however counseling is not defined as a mandatory coverage criterion in the policy.",81415,Applicable CPT codes in the policy list 81415 for exome sequence analysis (proband); this best corresponds to WES requested.,Yes,"Per policy WES is medically necessary when ordered by an approved specialty and the clinical history suggests a genetic cause with qualifying features. The patient is 11, the ordering provider is a developmental pediatrician, and qualifying features (congenital anomaly and relevant first-degree family history of early-onset epileptic encephalopathy) are present; therefore coverage is supported per the policy.",36969,2799,39768
Case14371,rag,all_correct,iter3,WES,Patient record states the general pediatrician ordered whole exome sequencing (WES).,Yes,"Policy lists age-related phrasing (e.g., features diagnosed by age 18) and the member is 11 years old; the patient meets the age-related timing (under 18) for pediatric neurodevelopmental indications.",No,"UnitedHealthcare policy requires WES to be ordered by a medical geneticist, neonatologist, neurologist, or developmental pediatrician; the ordering provider is a general pediatrician and does not meet the listed provider requirement.",No,"Policy requires either (A) one of a specific single-feature list (e.g., global developmental delay, moderate/severe ID by 18) or (B) two or more features from a specified list (which includes autism). The patient has autism/complex NDD but only one qualifying feature is documented, so the specified medical indication criteria are not met per policy.",Not Specified,"The policy does not mandate specific prior testing (e.g., CMA) for postnatal WES in NDD/ASD cases except when a specific syndrome is suspected; Fragile X testing was performed but the policy does not require this as a prerequisite.",Yes,"Policy lists family history/consanguinity among qualifying considerations. The patient has a maternal aunt with a persistent severe immunologic disorder (a second-degree relative), which is relevant family history per policy.",Not Specified,"Policy states genetic counseling is ""strongly recommended"" prior to WES/WGS but does not make counseling a formal coverage requirement; the family did meet with a genetic counselor, but counseling is not required for coverage per the policy text.",81415,"Policy's applicable codes list CPT 81415 for exome (sequence analysis), which corresponds to WES.",No,"Under UnitedHealthcare policy, WES coverage requires both meeting the clinical feature criteria and being ordered by an approved specialist. Although the patient is age-eligible and has relevant family history and pre-test genetic counseling, the clinical criteria (only one documented qualifying feature: ASD) and the ordering provider requirement (general pediatrician vs required specialist) are not met; therefore the test is not covered per the policy.",36945,3311,40256
Case15202,rag,all_correct,iter3,BRCA1/2,Patient was referred for BRCA1 and BRCA2 testing to evaluate hereditary breast/ovarian cancer risk (patient statement).,No,"The policy specifies age-based criteria for BRCA testing in individuals with breast cancer (eg, diagnosed ≤45, 46–50 with additional features, ≤60 for triple-negative). The patient is 65 and does not meet any listed age-based criteria in the policy.",Yes,"Policy requires testing be performed in a setting with suitably trained providers who provide pre- and post-test counseling. The patient had pre-test counseling with a genetic specialist and plans for post-test follow-up, satisfying provider/counseling setting requirements.",No,"Policy defines specific clinical indications (personal history of breast cancer meeting age/phenotype criteria, certain family histories, other high-risk cancers). The patient has a malignant phyllodes tumor and is 65 with no reported qualifying family cancer history; these do not meet the policy's listed medical indications.",Not Specified,"The policy discusses prior/limited testing situations (eg, prior limited single-gene testing or testing affected family members first) but does not specify required prior tests for this precise scenario; no required prior test completion is documented.",No,"Policy specifies relevant family history (close blood relatives with breast/ovarian/pancreatic/prostate cancer, etc.) as qualifying criteria. The only family history reported is a sister with an immunologic/hematologic disorder (not a qualifying cancer), so patient does not have the specified family history.",Yes,"Policy recommends formal genetic counseling by experienced providers for genetic testing. The patient completed pre-test counseling with a genetic specialist and plans post-test follow-up, meeting the counseling requirement.",Not Specified,The provided policy text does not list or map CPT codes to BRCA1/BRCA2 testing; therefore a specific CPT code cannot be determined from the policy.,No,"Under the policy, BRCA1/2 testing is medically necessary only when specific personal cancer features or qualifying family histories are met. The patient (age 65 with a malignant phyllodes tumor and no qualifying family cancer history) does not meet the policy's coverage criteria, so the test is not covered per policy.",18954,2035,20989
Case8621,rag,all_correct,iter3,WES,Patient info states the child is undergoing whole exome sequencing (WES).,Yes,"Policy includes age-related feature thresholds (e.g., DD/ID diagnosed by age 18, GDD onset <5). The patient is 2 years old and therefore meets the policy's age-related feature windows for pediatric neurodevelopmental indications.",No,"Policy requires WES be ordered by a medical geneticist, neonatologist, neurologist, or developmental pediatrician. The ordering provider is the child’s oncologist, which does not meet the specified ordering-provider requirement.",No,"Policy requires either (a) clinical history strongly suggests genetic cause plus one primary feature (e.g., GDD, moderate/severe ID) or (b) clinical history strongly suggests genetic cause plus two or more listed features (autism is one). The record documents autism but does not explicitly document a second qualifying feature (e.g., global developmental delay, dysmorphic features, consanguinity, similar affected first/second‑degree relative with similar clinical features), so the specified medical-indication criteria are not clearly met.",Not Specified,"The WES coverage criteria do not mandate completion of a prior specific test (postnatal WES criteria do not require prior CMA). The patient did have CMA nondiagnostic, but the policy does not require CMA before WES for outpatient postnatal testing.",Yes,Patient reports an uncle with a congenital anomaly. The policy lists 'other first- or second-degree family member(s) with similar clinical features' and consanguinity as relevant family-history criteria; an uncle is a second-degree relative and thus constitutes family history per the policy.,Not Specified,"Policy states genetic counseling is strongly recommended prior to WES/WGS but does not list counseling as a formal coverage requirement. The patient has had pre-test genetic counseling, but counseling is not a stated mandatory coverage criterion.",81415,Policy applicable codes list 81415 for exome (sequence analysis) for a proband; this best corresponds to the requested WES.,No,"Although the patient is pediatric with autism and prior nondiagnostic CMA (factors relevant to WES), the policy explicitly requires WES be ordered by a medical geneticist, neonatologist, neurologist, or developmental pediatrician. The ordering provider is an oncologist, so the ordering-provider requirement is not met and coverage per the policy is not supported.",36950,3032,39982
Case14141,rag,all_correct,iter3,WES,Patient information states whole exome sequencing (WES) is planned to investigate an underlying genetic etiology.,Yes,Policy specifies WES may be medically necessary for evaluation of unexplained congenital or neurodevelopmental disorders in children; the patient is a 7-year-old child and thus meets the age-based (pediatric/children) criterion.,Not Answerable,"Policy requires documentation that the individual has been evaluated by a clinician with expertise in clinical genetics. The patient record notes referral by an oncologist and that pre-test genetic counseling was completed, but it does not explicitly document evaluation by a clinician with expertise in clinical genetics, so sufficiency of the ordering provider cannot be determined from the provided information.",Yes,"Policy medical-necessity criteria include children with unexplained multiple congenital anomalies after standard workup; the patient has multiple congenital anomalies and a nondiagnostic prior CMA, which satisfies the policy's clinical indication criteria.",Yes,"Policy requires prior genetic testing (eg, chromosomal microarray) to have failed to yield a diagnosis or equivalent; the patient had prior CMA testing reported as nondiagnostic, meeting the prior-test requirement.",Yes,"Policy lists family history of developmental delay as relevant; the patient has a sibling with global developmental delay, which is a relevant family history per policy.",Yes,"Policy requires genetic counseling (performed by experienced personnel). The patient had pre-test genetic counseling completed and arrangements for post-test counseling, which satisfies the policy's counseling requirement as documented.",81415,The requested test is whole exome sequencing; CPT 81415 corresponds to exome sequencing (clinical WES) and is the best match among the provided codes.,Yes,"Applying the policy: the patient is a child with multiple congenital anomalies, prior CMA was nondiagnostic, relevant family history is present, and pre-test genetic counseling has been completed—these satisfy the policy's medical-necessity criteria for standard WES. (Note: documentation of evaluation by a clinician with expertise in clinical genetics was not explicitly provided in the record; however other required elements of the policy are met.)",14836,2515,17351
Case6747,rag,all_correct,iter3,WGS,Patient information explicitly states whole genome sequencing (WGS) was ordered by the medical geneticist.,Yes,"Policy eligibility is written for children (pediatric population); the patient is 12 years old, which meets the 'children' age category referenced in the policy and related guidelines.",Yes,"Policy criterion 1 requires evaluation by a clinician with expertise in clinical genetics; the ordering provider is a medical geneticist, which satisfies this requirement.",No,"The policy defines medical necessity for standard WES for unexplained congenital/neurodevelopmental disorders and for rapid WGS/WES in critically ill infants; it states 'Whole genome sequencing is considered investigational for the diagnosis of genetic disorders in all other situations.' The patient is a non-critically ill child with multiple congenital anomalies, so WGS is investigational per the policy and does not meet a defined medical indication for WGS.",Yes,"Policy criterion 3 requires previous genetic testing (e.g., chromosomal microarray) to be nondiagnostic before WES/WGS; the patient had CMA previously performed and reported nondiagnostic, satisfying the prior-test requirement.",Yes,"Policy guidance lists family history of developmental delay as relevant; the family reports a sibling with developmental delay, which is a relevant family history per the policy.",Yes,"Policy criterion 1 requires counseling about potential risks of genetic testing by an individual experienced in genetics; the patient had pre-test counseling completed and post-test counseling planned, meeting the counseling requirement.",Not Specified,The provided policy document does not list or map CPT codes to WES or WGS; no CPT guidance is present in the text supplied.,No,"Based on the policy: standard WES may be medically necessary for a child with unexplained congenital anomalies after nondiagnostic CMA, but the policy explicitly states 'Whole genome sequencing is considered investigational for the diagnosis of genetic disorders in all other situations.' The patient is a non-critically ill child and WGS is investigational per the policy; therefore WGS is not covered.",14819,2569,17388
Case811,rag,all_correct,iter3,WES,Patient information explicitly states whole exome sequencing (WES) is being pursued to evaluate an underlying genetic etiology.,Yes,Policy specifies WES is medically necessary for children with unexplained congenital or neurodevelopmental disorders; the patient is a 7-week-old infant (child) and therefore meets age-related criteria.,Not Answerable,"Policy requires documentation that the individual has been evaluated by a clinician with expertise in clinical genetics and counseled. Patient info documents pre-test counseling by a genetic counselor and a referral by a general pediatrician but does not explicitly state evaluation by a clinician with expertise in clinical genetics, so insufficient information to confirm this requirement.",Yes,"Policy medical indication includes unexplained congenital or neurodevelopmental disorders in children; the infant has early-onset movement abnormalities (dystonia, ataxia, intermittent hemiplegic episodes) and an unexplained phenotype, meeting the clinical indication.",Yes,"Policy indicates WES is appropriate when previous genetic testing (eg, chromosomal microarray) failed to yield a diagnosis. Patient had CMA previously performed and reported as nondiagnostic.",Yes,"Policy notes relevant family history (eg, developmental delay, multiple congenital anomalies) supports testing. Patient has a positive family history in an older sibling with multiple congenital anomalies.",Yes,"Policy requires genetic counseling; patient information documents pre-test counseling completed with a genetic counselor and planned post-test follow-up, satisfying the counseling requirement.",Not Specified,"The provided policy document does not list or map specific CPT codes to WES, so a specific CPT code is not specified in the policy text.",Yes,"Based on policy, WES may be considered medically necessary for children with unexplained congenital or neurodevelopmental disorders when criteria are met. The patient is an infant with an unexplained early-onset movement disorder, prior nondiagnostic CMA, relevant family history, and documented genetic counseling, and therefore meets the policy's medical necessity criteria.",14871,2615,17486
Case7604,rag,all_correct,iter3,WGS,Patient clinical note explicitly states 'whole genome sequencing (WGS) has been ordered.' Basis: patient information.,Not Specified,"Policy does not impose a specific age cutoff for WGS; age-specific items in the policy apply to certain features (e.g., ID diagnosed by 18) but no age-based exclusion/requirement for WGS is specified. Basis: UnitedHealthcare WGS coverage rationale.",Yes,"Policy requires WGS be ordered by a medical geneticist, neonatologist, neurologist, or developmental pediatrician; the ordering provider is a neurologist, meeting the requirement. Basis: UnitedHealthcare WGS ordering-provider criterion.",Yes,"Policy medical necessity requires clinical history strongly suggesting a genetic cause plus at least one feature such as 'Multiple congenital anomalies (must affect different organ systems)'; the neonate has multiple congenital anomalies across several organ systems, meeting the indication. Basis: UnitedHealthcare WGS coverage rationale.",Yes,"Policy requires that neither CMA nor WES have been performed prior to WGS. Patient history documents only FISH (nondiagnostic) and does not indicate prior CMA or WES, so the policy condition (no prior CMA/WES) is satisfied. Basis: UnitedHealthcare WGS prerequisite 'Neither CMA nor WES have been performed.'",Yes,"Policy lists 'Other first- or second-degree family member(s) with similar clinical features' as a relevant feature for WGS; patient has an older sibling with multiple congenital anomalies, meeting the family-history criterion. Basis: UnitedHealthcare WGS coverage rationale.",Not Specified,Policy 'Genetic counseling is strongly recommended' prior to WES/WGS but does not state counseling as a strict coverage prerequisite; the patient declined counseling but policy does not make it a required condition for coverage. Basis: UnitedHealthcare policy 'Genetic counseling is strongly recommended.',81425,Requested test is whole genome sequencing; UnitedHealthcare policy lists CPT 81425 for 'Genome ... sequence analysis' corresponding to WGS. Basis: Applicable codes in policy (81425).,Yes,All coverage criteria in the policy for WGS are met: WGS ordered by an acceptable provider (neurologist); clinical indication present (multiple congenital anomalies across organ systems); neither CMA nor WES documented as previously performed; family history supportive. Genetic counseling is recommended but not mandated for coverage. Basis: UnitedHealthcare WGS coverage rationale and applicable codes.,36935,2138,39073
Case950,rag,all_correct,iter3,WES,Patient clinical info states whole exome sequencing (WES) is being pursued to evaluate unexplained epileptic encephalopathy.,Yes,"Policy age-related criterion specifically lists 'epileptic encephalopathy with onset before three years of age' as an indication for WES; patient had seizure onset before age 3, meeting that age-related criterion.",Yes,"Policy requires WES be ordered by a medical geneticist, neonatologist, neurologist, or developmental pediatrician; the patient is being evaluated by a medical geneticist who is pursuing WES.",Yes,Policy medical-necessity criteria include unexplained epileptic encephalopathy with onset before age 3 as an indication for WES; the patient has unexplained epileptic encephalopathy with onset <3 years and nonspecific presentation.,Not Specified,"Policy does not mandate specific prior tests for outpatient WES in this scenario (it notes targeted/single-gene testing if a specific syndrome is suspected and prenatal CMA/karyotype requirements for prenatal WES). The patient’s karyotype was nondiagnostic, but no explicit prior-test requirement for this non‑prenatal WES indication is stated.",No,Policy lists consanguinity or affected first/second-degree relatives with similar features as relevant family-history criteria; the patient’s family history (an uncle with prostate cancer) does not meet those specified family-history/consanguinity criteria.,Not Specified,"Policy 'strongly recommends' genetic counseling prior to WES/WGS but does not make counseling a strict coverage requirement; the patient has had genetic counseling, but the policy frames it as recommendation rather than a mandatory coverage criterion.",81415,Policy applicable CPT codes list 81415 for exome (sequence analysis) which corresponds to WES requested for this patient.,Yes,"Under UnitedHealthcare policy WES is proven and medically necessary when ordered by an appropriate specialist for nonspecific presentations and when criteria such as 'epileptic encephalopathy with onset before three years of age' are met. The patient meets these coverage criteria (medical geneticist ordering, unexplained epileptic encephalopathy with onset <3 years), so WES is covered per the policy.",36974,2093,39067
Case17822,rag,all_correct,iter3,WGS,Patient information explicitly states whole genome sequencing (WGS) has been ordered as the next-tier diagnostic test.,Yes,"Policy includes age-related provisions for some features (e.g., features diagnosed by age 18) and the patient is 13; additionally the qualifying feature (multiple congenital anomalies affecting different organ systems) has no age restriction, so the patient's age meets policy age-related criteria.",Yes,"Policy requires WGS be ordered by a medical geneticist, neonatologist, neurologist, or developmental pediatrician; the order was placed by a medical geneticist.",No,"Although the patient meets the clinical phenotype (multiple congenital anomalies affecting different organ systems) and ordering-provider requirement, the policy’s WGS criteria explicitly require that 'Neither CMA nor WES have been performed.' The patient has already had a nondiagnostic CMA, so the WGS medical-necessity criteria are not met.",No,"Policy explicitly requires for WGS that 'Neither CMA nor WES have been performed.' The patient completed a CMA (nondiagnostic), so the prior-test requirement for WGS is not satisfied.",Yes,"Policy lists 'other first- or second-degree family member(s) with similar clinical features' and 'growth abnormality (e.g., ... short stature)' among qualifying features; the patient has a sibling with short stature, a relevant family history.",Not Specified,"The policy 'strongly recommends' genetic counseling prior to WES/WGS but does not list pretest genetic counseling as an explicit coverage requirement; the patient declined counseling, but counseling is not stated as mandatory for coverage.",81425,"Policy applicable CPT codes list 81425 for 'Genome (e.g., unexplained constitutional or heritable disorder or syndrome); sequence analysis,' which corresponds to WGS.",No,"Per the UnitedHealthcare WGS coverage criteria, WGS is medically necessary only when 'Neither CMA nor WES have been performed.' The patient already underwent a CMA (nondiagnostic), therefore WGS does not meet the policy's required prior-test criterion and is not covered.",36947,2386,39333
Case9408,rag,all_correct,iter3,WES,Patient information explicitly states the 17-year-old is undergoing whole exome sequencing (WES) requested by a medical geneticist for evaluation of epileptic encephalopathy.,Yes,Policy coverage applies to 'children' with unexplained congenital or neurodevelopmental disorders; patient is 17 years old (child under the policy) so age-based eligibility is met (policy applied to pediatric patients).,Yes,"Policy requires evaluation by a clinician with expertise in clinical genetics. The test was ordered by a medical geneticist, satisfying the ordering-provider requirement in the policy.",Yes,"Policy lists unexplained neurodevelopmental disorders and persistent seizures as appropriate indications for WES. Patient has early-onset epileptic encephalopathy (onset before age 3) and prior standard workup was nondiagnostic, meeting the policy's medical indication criteria.",Yes,"Policy requires previous genetic testing (eg, chromosomal microarray) to have failed to yield a diagnosis or be considered despite prior testing. The patient had chromosomal microarray analysis (CMA) previously performed and nondiagnostic, meeting the prior-test requirement.",No,"The policy lists family-history items relevant to selection (eg, developmental delay, inborn errors) but the patient’s family history notes the mother has a severe immunologic/hematologic disorder without documentation that it is a genetic disorder described in the policy; thus a relevant genetic family history per the policy examples is not demonstrated.",Yes,"Policy requires counseling by an individual with expertise in genetic medicine. Patient information documents pre-test counseling was completed and plans for post-test follow-up with a genetic counselor, meeting the counseling requirement.",81415,"The requested test is whole exome sequencing (WES); among the provided CPT options, 81415 corresponds to exome sequencing and best matches the requested WES.",Yes,"Under the FEP policy, standard WES may be considered medically necessary for children with unexplained neurodevelopmental disorders when all criteria are met. The patient is a 17-year-old evaluated by a medical geneticist, has early-onset epileptic encephalopathy with prior nondiagnostic CMA, and has documented genetic counseling — satisfying the policy's required criteria, so the test is covered.",14851,2224,17075
Case3592,rag,all_correct,iter3,CMA,"Patient information explicitly states chromosomal microarray (CMA) testing for developmental disorders is being requested. Policy also addresses CMA (e.g., CPT 81228).",Yes,Policy criteria state testing must be performed on a living child or adult; the patient is a neonate (living child) and thus meets the policy's age-related requirement.,Not Specified,The policy requires pre- and post-test genetic counseling by an appropriate provider but does not specify ordering-provider specialty or exact ordering-provider requirements for CMA; the ordering provider requirements are therefore not specified.,No,"The policy defines specific postnatal presentations for CMA coverage (e.g., developmental delay/intellectual disability, autism spectrum disorder, major congenital cardiac anomaly, multiple congenital anomalies). The patient has neonatal-onset epileptic encephalopathy, which is not one of the explicitly listed presentations.",No,"Policy requires 'No previous CMA testing' for diagnostic postnatal CMA. Patient had a prior chromosomal microarray that was nondiagnostic, so the policy's prior-test requirement is not met.",Not Specified,The policy does not make family history of unexplained developmental regression a defined eligibility criterion for CMA (it only calls out specific exclusions such as family history of chromosome rearrangement in phenotypically normal individuals). The patient's family history is therefore not a specified criterion in the policy.,Yes,"Policy requires pre- and post-test genetic counseling by an appropriate provider. The patient had pre-test counseling with a genetic specialist and post-test follow-up is planned, satisfying the counseling requirement.",81228,The policy lists CPT 81228 as a chromosomal microarray procedure code for constitutional CMA; this best corresponds to the requested CMA.,No,"Per policy, CMA is reimbursable only if no previous CMA testing has been performed and specific clinical presentations are met. The patient had a prior CMA (nondiagnostic), violating the 'no previous CMA' requirement; additionally the patient's indication (neonatal epileptic encephalopathy) is not one of the policy's explicitly listed postnatal presentations. Therefore the test is not covered under the policy.",10103,1948,12051
Case17929,rag,all_correct,iter3,CMA,Patient information states 'tumor chromosomal microarray (CMA) testing has been requested' — the test explicitly requested is chromosomal microarray analysis (CMA).,Not Specified,"The UnitedHealthcare CMA policy defines clinical indications (e.g., DD/ID, ASD, multiple congenital anomalies) but does not impose explicit age cutoffs for these indications; no age-based exclusion is specified that would disqualify a 7-year-old.",Not Specified,The policy emphasizes pre/post-test genetic counseling and provider expertise but does not mandate a specific ordering provider specialty or restrict ordering to particular provider types.,Yes,"Policy states CMA is medically necessary for evaluation of individuals with 'multiple anomalies that are not specific to a Well-Delineated Genetic Syndrome' and for DD/ID and notes CMA when karyotype is nondiagnostic. The patient is a 7-year-old with a major abnormality affecting at least one organ system and a prior nondiagnostic karyotype, meeting the policy’s medical indications.",Not Specified,"The policy does not universally require completion of specific prior tests before CMA; CMA can be first-tier in many settings and although it notes CMA is useful when karyotype is normal, it does not mandate prior testing — patient did have a prior nondiagnostic karyotype but the policy does not require it.",Not Specified,The policy’s family-history–related criteria address evaluation of biological parents/siblings of a fetus/child with an abnormal CMA; it does not identify a family history of BRCA1/2 as relevant to CMA eligibility. The patient’s maternal BRCA1/2 pathogenic variant is not a policy-specified criterion for CMA.,Yes,"The policy 'strongly recommends' pre-test genetic counseling prior to CMA. The patient had 'multiple pretest counseling sessions with a genetic counselor' and plans post-test follow-up, satisfying the counseling expectations in the policy.",81228,The policy lists CPT 81228 ('Cytogenomic (genome-wide) analysis ... comparative genomic hybridization [CGH] microarray analysis') as a CMA code; 81228 best corresponds to the requested chromosomal microarray.,Yes,"Per the UnitedHealthcare CMA policy, CMA is medically necessary for evaluation of individuals with multiple anomalies or DD/ID and when karyotype is nondiagnostic. The patient is a 7-year-old with a major organ-system abnormality and a nondiagnostic prior karyotype, has had pretest genetic counseling, and thus meets the policy criteria for coverage.",30400,2097,32497
Case12834,rag,all_correct,iter3,CMA,Patient record states chromosomal microarray (CMA) testing has been ordered (requisition specifies a tumor-type rather than a germline assay).,Not Specified,The Cigna policy for chromosomal microarray for solid tumors (MOL.TS.344.A) does not specify any age-based eligibility criteria for the test.,Not Specified,The policy requires the rendering laboratory be a qualified provider per Health Plan policy but does not specify ordering provider specialty or other ordering-provider requirements.,No,"Policy medical necessity is limited to CMA on solid tumor tissue for individuals diagnosed with CNS cancer or soft tissue sarcoma. The patient has a neurodevelopmental disorder (no documented CNS cancer or soft tissue sarcoma), so the patient does not meet the policy's specified indications.",Not Specified,The policy does not define any required prior testing that must be completed before ordering CMA for solid tumors.,Not Specified,The policy's coverage criteria are diagnosis-based (CNS cancer or soft tissue sarcoma) and do not specify family history or consanguinity criteria; the patient’s family history (maternal uncle with movement disorder) is not addressed as a coverage criterion.,Not Specified,The policy mentions laboratories should address potential germline/secondary findings but does not specify genetic counseling as a coverage requirement for CMA on solid tumors; the record notes counseling is not documented.,81277,The policy's procedures table maps cytogenomic neoplasia microarray analysis (solid tumor CMA) to CPT code 81277.,No,"Per the Cigna policy, CMA on solid tumor tissue is medically necessary only for members diagnosed with CNS cancer or soft tissue sarcoma. The patient is a 16-year-old with a neurodevelopmental disorder and no documented diagnosis of CNS cancer or soft tissue sarcoma; therefore the requested tumor-type CMA is not covered under this policy.",6182,1258,7440
Case4604,rag,all_correct,iter3,WES,Patient information explicitly states whole exome sequencing (WES) is being requested.,Yes,"Policy applies to 'children' with unexplained neurodevelopmental disorders; the patient is a 6-year-old child, so age meets the policy's child-based eligibility.",Not Answerable,"Policy requires evaluation by a clinician with expertise in clinical genetics. Patient facts document pre-test counseling by a genetic counselor but do not explicitly state the patient was evaluated by a clinician with expertise in clinical genetics or who is the ordering provider, so insufficent information to determine if ordering/provider requirements are satisfied.",Yes,"Policy medical indication is 'unexplained congenital or neurodevelopmental disorders in children.' The patient has developmental delay/intellectual disability of unknown etiology, meeting the defined clinical indication (and prior CMA was nondiagnostic).",Yes,"Policy indicates WES is appropriate when previous genetic testing (eg, chromosomal microarray) has failed to yield a diagnosis; the patient had prior CMA testing that was nondiagnostic.",Yes,"Policy lists family history of developmental delay as relevant. The patient has an older sibling with moderate–severe intellectual disability, which is relevant to eligibility.",Yes,"Policy requires genetic counseling by an individual with experience/expertise. Patient facts state pre-test counseling was completed with a genetic counselor and post-test follow-up is planned, meeting the counseling requirement.",Not Specified,"The provided policy document does not list or specify CPT billing codes for WES, so a specific CPT code cannot be determined from the policy text.",Yes,"Per the policy, standard WES may be medically necessary for children with unexplained neurodevelopmental disorders when all criteria are met. The patient is a child with unexplained developmental delay/ID, prior CMA was nondiagnostic, family history is positive, and genetic counseling was completed—together these satisfy the policy clinical indications and prerequisites, supporting coverage as medically necessary.",14848,2800,17648
Case8661,rag,all_correct,iter3,WGS,Patient information explicitly states whole genome sequencing (WGS) is requested.,Yes,"Policy’s WGS criteria reference pediatric-onset features 'diagnosed by 18 years of age'; patient is 7 years old, which meets the policy age-related references.",Yes,"Policy requires WGS to be ordered by a medical geneticist, neonatologist, neurologist, or developmental pediatrician; the ordering provider is the child's neurologist, which meets the policy requirement.",No,"Policy requires either (A) the patient have one of the first-list features (e.g., epileptic encephalopathy onset <3 years) or (B) two or more of the second-list features (e.g., significant hearing/visual impairment plus another second-list feature). The patient has significant hearing/visual impairment (one second-list feature) and a sibling with early epileptic encephalopathy (family history) but does not have two second-list features nor the first-list feature in the proband; therefore the specified medical/clinical criteria for WGS are not met per the policy.",Yes,"Policy criterion for WGS states 'Neither CMA nor WES have been performed.' Patient history documents prior Fragile X testing only and does not report prior CMA or WES, so the policy’s prior-test condition for WGS is satisfied.",Yes,"Policy lists 'Other first- or second-degree family member(s) with similar clinical features' and 'consanguinity' as relevant features; the patient has a sibling with early-onset epileptic encephalopathy, which is relevant family history per the policy.",Not Specified,Policy states genetic counseling is 'strongly recommended' prior to WES/WGS but does not make pre-test counseling an explicit coverage requirement. Patient declined pre-test counseling and plans post-test counseling; the policy does not mandate pre-test counseling as an eligibility criterion.,81425,"Policy’s applicable CPT codes list 81425 for 'Genome (e.g., unexplained constitutional or heritable disorder or syndrome); sequence analysis' which corresponds to WGS.",No,"Although age and ordering provider meet policy requirements and no prior CMA/WES is documented, the policy requires specific clinical features (either a first-list feature in the proband or two or more second-list features). The patient only meets one second-list feature (significant hearing/visual impairment) and thus does not meet the policy’s medical necessity criteria for WGS, so the test is not covered under the provided policy.",36963,3495,40458
Case6451,rag,all_correct,iter3,WGS,The clinical information states 'whole genome sequencing (WGS) is being pursued.',Not Specified,"The UnitedHealthcare WES/WGS policy does not establish a specific age cutoff for WGS; it references age for certain diagnostic features (e.g., diagnoses by 18 years) but no age-based exclusion/requirement that would disqualify a 7‑week‑old.",Yes,"Policy requires WGS to be ordered by a medical geneticist, neonatologist, neurologist, or developmental pediatrician; the ordering provider is a developmental pediatrician, which meets the requirement.",No,"Policy requires either (A) one of the primary features (e.g., global developmental delay, multiple congenital anomalies, etc.) or (B) two or more secondary features (e.g., hypotonia in infancy plus another listed feature). The infant has hypotonia (one secondary feature) but does not have a second qualifying feature documented, so the medical indication criteria are not met.",Yes,"Policy states WGS is indicated when 'neither CMA nor WES have been performed.' The record documents a prior karyotype (nondiagnostic) and does not document prior CMA or WES, so the patient meets the policy condition regarding prior tests.",No,"The policy lists family history of similar clinical features (first/second‑degree relative) or consanguinity as relevant. The record documents the mother has a persistent severe immunologic/hematologic disorder but not 'similar clinical features' to the proband’s hypotonia; consanguinity is not reported, so the specific family‑history criterion relevant to eligibility is not met.",Not Specified,"The policy 'strongly recommends' genetic counseling prior to WES/WGS but does not state counseling as a strict coverage requirement. The chart documents pre‑test counseling was completed, but the policy does not define counseling as a mandatory coverage criterion.",81425,"Policy's applicable CPT codes list 81425 for 'Genome (e.g., unexplained constitutional or heritable disorder or syndrome); sequence analysis,' which corresponds to WGS.",No,"Although ordering provider and prior‑test conditions are met and counseling was performed, UnitedHealthcare's WGS coverage criteria require either a primary qualifying feature or two or more secondary features suggesting a genetic cause. The infant has hypotonia (one secondary feature) but lacks documentation of a second qualifying feature or a primary listed feature; therefore the medical‑necessity criteria in the policy are not satisfied and WGS is not covered per the provided policy.",36937,3698,40635
Case19255,rag,all_correct,iter3,BRCA1/2,Patient was referred for BRCA1/2 testing per the clinical info. Basis: patient notes explicitly state BRCA1/2 testing is being pursued.,Yes,Patient is 38 with history of breast cancer(s). Policy: 'BRCA1/2 gene testing is proven and medically necessary for individuals with a personal history of Breast Cancer diagnosed at age 65 or younger.' Patient meets ≤65 age criterion.,Not Specified,The policy strongly recommends pre-test genetic counseling and involvement of genetics expertise but does not mandate a specific provider specialty to order BRCA1/2 testing. (Patient did receive pre-test counseling from a genetic specialist.),Yes,"Policy lists 'Multiple primary Breast Cancers (as a prior diagnosis or as a bilateral primary cancer)' as an indication for hereditary cancer genetic testing. Patient has two separate primary breast cancers, meeting medical indication per policy.",Not Specified,"Policy does not require completion of specific prior tests before BRCA1/2 germline testing. The patient had prior nondiagnostic FISH, but the policy does not list FISH or other testing as a required prerequisite for BRCA1/2 testing.",Yes,"Policy considers metastatic prostate cancer a BRCA-related cancer and family history criteria are relevant. Patient's father has metastatic prostate cancer (first-degree relative), which is relevant per policy.",Yes,"Policy 'Pre-test genetic counseling is strongly recommended.' Patient completed pre-test counseling with a genetic specialist, satisfying the counseling recommendation in the policy.",81162,"Policy's Applicable Codes list 81162 for BRCA1/BRCA2 full sequence analysis plus duplication/deletion analysis, which corresponds to the requested BRCA1/2 testing.",Yes,"Coverage supported by policy: BRCA1/2 testing is medically necessary for individuals with personal history of breast cancer diagnosed ≤65 and for multiple primary breast cancers. Patient is 38 with two primary breast cancers, had genetic counseling, and has relevant family history; thus testing is covered per policy.",38613,1671,40284
Case2211,rag,all_correct,iter3,BRCA1/2,Patient was referred specifically for BRCA1 and BRCA2 testing per the clinical information; policy lists BRCA1/2 testing as a distinct category (policy: BRCA1/BRCA2 gene testing).,Not Specified,"Policy specifies age criteria for some BRCA indications (e.g., breast cancer diagnosed ≤65) but does not specify an age limit for single-gene or known familial-mutation BRCA testing. The patient is 21 and age is not an explicit limiting criterion for known familial mutation testing in the policy.",Not Specified,The policy strongly recommends genetic counseling and involvement of providers with genetics expertise but does not enumerate a specific required ordering provider specialty/type; the ordering provider requirement is not explicitly specified.,Yes,"Policy states 'Single gene testing and known mutation testing for familial cancer is proven and medically necessary' and lists having a blood relative with a known P/LP variant as an indication. The patient’s mother carries a known BRCA2 pathogenic variant and the patient has multiple affected relatives and a personal primary solid tumor, meeting medical indication per policy.",Not Specified,The policy does not require completion of specific prior tests before single-gene or known familial-mutation BRCA testing; no mandatory prior testing is specified in the policy for this scenario.,Yes,"Policy includes family history criteria (e.g., known P/LP variant in a blood relative; ≥2 affected relatives on same side) as qualifying indications. The patient reports a mother with a known BRCA2 pathogenic variant and at least two additional affected blood relatives on the same side.",Not Specified,"Policy 'strongly recommends' pre-test genetic counseling but does not state it as a strict coverage requirement; although the patient completed pre-test counseling with a genetic specialist, the policy does not define mandatory counseling requirements for coverage.",81162,Policy's applicable codes list 81162 for BRCA1/BRCA2 full sequence analysis and full duplication/deletion analysis. This is the CPT code that best corresponds to BRCA1/2 testing as requested.,Yes,"Per policy, single-gene and known mutation testing for familial cancer is proven and medically necessary and having a blood relative with a known pathogenic BRCA2 variant is a listed indication. The patient meets these criteria (mother with known BRCA2 PV and multiple affected relatives), so BRCA1/2 testing is covered.",38641,2902,41543
Case18882,rag,all_correct,iter3,WES,Patient information states whole exome sequencing (WES) is being requested.,Yes,"Policy age-related criteria (e.g., ID or related features diagnosed by 18 years) apply and the child is 8 years old; multiple congenital anomalies in a child meet the policy's pediatric criteria.",Yes,"Policy requires WES be ordered by a medical geneticist, neonatologist, neurologist, or developmental pediatrician; the referral/ordering clinician is a developmental pediatrician.",Yes,Policy lists 'multiple congenital anomalies (must affect different organ systems)' as an indication for WES; the patient has multiple congenital anomalies affecting several organ systems and clinical history suggests a genetic cause.,Not Specified,Policy does not mandate specific prior tests for postnatal WES in this scenario (it only advises targeted testing if a specific syndrome is suspected or prenatal CMA/karyotype in prenatal cases); prior FISH was nondiagnostic but the policy does not require CMA prior to WES for this indication.,No,"Policy includes family history/consanguinity as a relevant criterion, but the patient does not have consanguinity or a first/second-degree relative with similar clinical features (mother has long QT, not the same multisystem congenital anomalies).",Not Specified,"Policy 'strongly recommends' pre-test genetic counseling but does not make counseling a formal coverage requirement; the family declined pre-test counseling, and the policy does not explicitly require pre-test counseling for coverage.",81415,Policy lists CPT 81415 for exome (sequence analysis) corresponding to WES (primary exome procedure).,Yes,"Per the policy, WES is medically necessary when ordered by an approved specialist and the patient has nonspecific presentation with multiple congenital anomalies; the test is ordered by a developmental pediatrician, the patient meets the clinical indication (multiple congenital anomalies), and no policy-required prior testing prevents coverage.",36940,1776,38716
Case14408,rag,all_correct,iter3,BRCA1/2,Patient was referred for BRCA1/2 testing (document: 'referred ... for BRCA1/2 testing').,Yes,"Policy requires age >= 18 for BRCA testing; patient is 75, meeting the 'Age 18 years or older' requirement in the BRCA criteria.",Not Specified,The policy specifies genetic counseling and that the rendering laboratory be a qualified provider but does not specify required ordering provider specialty; the ordering provider requirement is not specified in the policy.,Yes,"Policy allows predisposition testing when the member has a first‑degree relative who meets diagnostic criteria (e.g., 'Male with breast cancer at any age'); the patient has a brother with breast cancer (first‑degree), satisfying the family-history indication for BRCA testing.",Yes,"Policy requires no previous BRCA full sequencing/known family mutation for testing; patient has no prior genetic testing, satisfying the 'no previous testing' prerequisite.",Yes,"Policy uses family history as a key criterion; patient has a first‑degree relative (brother) with breast cancer, which is relevant per the policy's family history criteria.",Yes,"Policy requires pre- and post-test genetic counseling. Patient information states pre-test counseling was completed and post-test follow-up with a genetic counselor is planned, meeting counseling requirements.",81162,"Policy lists CPT 81162 for 'BRCA1/2 full sequencing and duplication/deletion analysis (combined)' and notes 81162 is likely most appropriate if sequencing and deletion/duplication are performed concurrently; no known familial mutation exists, so comprehensive sequencing +/- del/dup (81162) is appropriate.",Yes,"Clinical criteria in the policy are met (age >=18, required pre-test counseling completed, no prior BRCA testing, and first‑degree relative [brother] with male breast cancer meeting diagnostic criteria), supporting coverage per the BRCA guideline. Note: policy also requires the rendering laboratory be a qualified provider (not specified in patient info) but clinically the patient meets the stated coverage criteria.",10244,2384,12628
Case4262,rag,all_correct,iter3,WES,Patient information explicitly states diagnostic whole exome sequencing (WES) is being ordered.,Yes,"Policy addresses WES for children and infants with congenital anomalies; the patient is a five‑week‑old infant, which meets the age scope in the policy (children/infants).",Not Answerable,"Policy criterion 1 requires evaluation by a clinician with expertise in clinical genetics. The record states the patient was referred by an oncologist and that pre‑test genetic counseling was completed, but it does not explicitly document evaluation by a clinician with expertise in clinical genetics, so adequacy of the ordering provider cannot be confirmed from the supplied information.",Yes,"Policy: WES may be medically necessary for evaluation of unexplained congenital anomalies in children. The infant has multiple congenital anomalies not fitting a well‑delineated syndrome, which matches this specific indication.",Not Specified,"The policy references prior genetic testing (eg, CMA and/or targeted single‑gene testing) as examples but does not mandate a single specific prior test universally. The patient had a nondiagnostic karyotype, but the policy does not strictly define an exhaustive list of required prior tests.",Yes,"Policy lists family history of BRUE in a sibling as a relevant family history criterion. The patient has a sibling with a BRUE‑type event, which is a specified relevant family history.",Yes,"Policy requires genetic counseling (documentation of counseling by someone with genetics expertise). The patient record states pre‑test genetic counseling has been completed and post‑test follow‑up is planned, satisfying the counseling requirement as documented.",Not Specified,"The provided policy document does not list or map CPT codes to WES or WGS, so a specific CPT code cannot be determined from the policy text.",No,"Although the patient meets the clinical indication (unexplained multiple congenital anomalies) and genetic counseling is documented, the policy requires ALL criteria: (1) documentation of evaluation by a clinician with expertise in clinical genetics (including family history and phenotype description) and counseling, and (2) documentation that there is potential for a change in management. The supplied information does not explicitly document evaluation by a clinician with genetics expertise nor explicitly document potential for change in management, so not all required policy elements are met and coverage cannot be approved based on the provided documentation.",14843,3523,18366
Case10363,rag,all_correct,iter3,WGS,Patient information states whole genome sequencing (WGS) is being pursued after nondiagnostic FISH.,Not Specified,"The policy does not impose an overall age limit for WGS; it references age in specific phenotype criteria (e.g., diagnosis of ID by 18) but no explicit age-based eligibility cutoff applies to WGS in general.",No,"Policy requires WGS to be ordered by a medical geneticist, neonatologist, neurologist, or developmental pediatrician. The patient was referred/ordered by a general practitioner, which does not meet the specified ordering-provider requirement.",No,"Policy medical-necessity criteria for WGS require either multiple congenital anomalies (different organ systems) or other specified major findings, or two or more listed features. The patient has a single congenital anomaly since birth with no additional listed features (e.g., ID, global developmental delay, multiple anomalies, consanguinity, or a first/second-degree relative with similar features), so the policy criteria are not met.",Yes,"Policy requires for WGS that neither CMA nor WES have been performed. The patient had FISH (nondiagnostic) and there is no documentation of prior CMA or WES, so the patient meets this prior-testing requirement.",No,"The policy lists family history/consanguinity (e.g., first/second-degree relative with similar features, consanguinity) as relevant criteria. The patient’s family history (maternal aunt with pancreatic cancer) is not a listed relevant family-history criterion and there is no consanguinity documented.",Not Specified,"The policy 'strongly recommends' genetic counseling prior to WES/WGS but does not state counseling as a mandatory coverage requirement. The patient has documented pre-test genetic counseling, but counseling is a recommendation rather than an explicit coverage requirement in the policy.",81425,"Policy's applicable CPT codes list 81425 for 'Genome (e.g., unexplained constitutional or heritable disorder or syndrome); sequence analysis' which corresponds to WGS; other listed CPTs (e.g., 81415) correspond to exome.",No,"Under the UnitedHealthcare policy WGS is medically necessary only when all criteria are met. Although patient has not had CMA/WES (satisfied) and has counseling, the patient does not meet the clinical/medical-indication criteria (only a single congenital anomaly without additional required features) and the ordering provider does not meet the specialty requirement; therefore WGS is not covered per the policy.",36961,2601,39562
Case9349,rag,all_correct,iter3,WES,Patient record explicitly states whole exome sequencing (WES) is being pursued.,Yes,"Policy explicitly frames WES eligibility for children with unexplained congenital or neurodevelopmental disorders; the patient is a 5-year-old child, meeting the age-based criterion.",Not Specified,The policy requires evaluation by a clinician with expertise in clinical genetics (and counseling) but does not specify a required ordering provider specialty or type for placing the order.,No,"Policy requires ALL criteria for medical necessity (documentation of genetics evaluation including family history/phenotype and counseling; potential to change management; AND either genetic etiology most likely despite prior testing such as CMA/targeted testing or prior testing failed and next step invasive). The record does not document a genetics clinician evaluation or prior appropriate genetic testing (eg, CMA or targeted testing) meeting the policy's stated conditions, so the full medical-necessity criteria are not met per policy.",No,"Policy examples indicate prior genetic testing (eg, chromosomal microarray and/or targeted single‑gene testing) is expected in the standard WES pathway; the patient only had nondiagnostic FISH reported and no CMA/targeted testing documented, so required prior testing is not shown.",Yes,Policy specifically lists sudden unexplained death in first- or second-degree relatives before age 35 as relevant family history; the patient has a paternal uncle with sudden unexplained death <35.,Yes,Policy requires counseling by an experienced genetics professional as part of eligibility; the record states pre-test counseling was completed with a genetic counselor and post-test follow-up plans are confirmed.,81415,The requested test is whole exome sequencing (WES); CPT code 81415 corresponds to clinical exome sequencing and is the best match among provided options.,No,"Although age, relevant family history, and genetic counseling are documented, the policy requires ALL listed criteria to be met for medical necessity (including documentation of evaluation by a clinical genetics expert and appropriate prior genetic testing such as CMA/targeted testing or the alternative pathway). Those required items are not documented in the provided information, so per the policy the test is not covered.",14843,2978,17821
Case1428,rag,all_correct,iter3,WGS,Patient info states 'whole genome sequencing (WGS) has been ordered.' Basis: patient clinical information.,Not Specified,"UnitedHealthcare WGS policy does not impose a general age cutoff for WGS; it references age-limited features (e.g., ID diagnosed by 18 yrs) but no rule that the proband's age must meet a specific numeric threshold. The infant is 3 weeks old and the policy does not disallow WGS by age.",Yes,"Policy requires WGS be ordered by a medical geneticist, neonatologist, neurologist, or developmental pediatrician. Patient testing was ordered by a medical geneticist (patient info), meeting the provider requirement per policy.",No,"Policy coverage for WGS requires clinical criteria be met (either one of the listed major features such as multiple congenital anomalies, moderate/severe ID by 18, global DD, or epileptic encephalopathy; or two or more of a specified list including 'congenital anomaly' and 'other first- or second-degree family member(s) with similar clinical features'). The infant has a single congenital anomaly (Hirschsprung disease) and a sibling with severe intellectual disability (family history), but the policy requires either a major listed feature in the proband or two or more listed features — the documentation does not demonstrate the required combination per the policy; therefore medical indication criteria are not met.",Yes,"Policy states WGS is indicated when 'Neither CMA nor WES have been performed.' Patient has only Fragile X testing (nondiagnostic) and there is no documentation of prior CMA or WES, so the prior-test condition for WGS in the policy is satisfied.",Yes,"The policy lists relevant family history (e.g., 'other first- or second-degree family member(s) with similar clinical features') as a criterion. Patient has a first-degree sibling with severe intellectual disability diagnosed by age 18, which is relevant family history per the policy.",Not Specified,"The policy states genetic counseling is 'strongly recommended' prior to WGS/WES but does not make pre-test genetic counseling an explicit mandatory coverage requirement. Patient information documents no pre-test genetic counseling, and the policy does not require it as a hard coverage criterion.",81425,"Policy's applicable CPT codes list 81425 as 'Genome (e.g., unexplained constitutional or heritable disorder or syndrome); sequence analysis' which corresponds to WGS ordered for this patient.",No,"Although ordering provider and prior-test conditions meet policy requirements and family history is present, UnitedHealthcare's WGS coverage requires the patient to meet the specified clinical indication criteria (major feature or two or more listed features). The infant documents only one qualifying feature (a congenital anomaly) and does not meet the policy's defined clinical indications for WGS; therefore the test is not covered under the policy.",36931,3956,40887
Case3359,rag,all_correct,iter3,WES,Patient information explicitly states 'Whole exome sequencing (WES) is being requested.',Yes,Patient is 4 years old. The policy includes age-referenced criteria such as global developmental delay onset prior to 5 years and features diagnosed by 18 years; a 4-year-old child meets the age-related thresholds referenced in the WES coverage criteria.,Yes,"Policy requires WES to be ordered by a medical geneticist, neonatologist, neurologist, or developmental pediatrician. The ordering provider is a developmental pediatrician, which meets the policy requirement.",Yes,Policy requires clinical history suggesting a genetic cause plus specific features. The patient has significant hypotonia and ongoing developmental concerns and a first-degree relative (sibling) with developmental delay — meeting at least two listed features (hypotonia and other family member with similar features) under the WES indications.,Not Specified,"The WES coverage criteria do not mandate completion of specific prior tests for postnatal WES (prenatal WES requires prior CMA/karyotype). Although CMA was previously performed and nondiagnostic for this patient, the policy does not require prior testing before WES in this context.",Yes,"Policy lists 'Other first- or second-degree family member(s) with similar clinical features' and 'consanguinity' as relevant criteria. Patient has a sibling with developmental delay (first-degree), which is a specified relevant family-history criterion.",Not Specified,"Policy states genetic counseling is 'strongly recommended' prior to WES/WGS but does not state it as a required coverage condition. The patient did receive pre-test counseling, but the policy does not make counseling a strict coverage requirement.",81415,"Policy's applicable CPT codes list 81415 for exome (e.g., unexplained constitutional or heritable disorder or syndrome) sequence analysis, which corresponds to WES.",Yes,"Under the policy, WES is proven and medically necessary when ordered by an approved specialist and the clinical history suggests a genetic cause with qualifying features. The ordering provider is a developmental pediatrician and the patient has qualifying features (hypotonia + affected sibling), so the policy criteria for coverage are met.",36955,2283,39238
Case9978,rag,all_correct,iter3,WES,Patient clinical information states the 53-year-old is undergoing whole exome sequencing (WES) ordered by the neurologist.,Yes,"Policy lists 'epileptic encephalopathy with onset before three years of age' as a specific WES indication; the patient’s seizures began before age 3, meeting the policy's age-of-onset criterion.",Yes,"Policy requires WES be ordered by a medical geneticist, neonatologist, neurologist, or developmental pediatrician; the ordering provider is a neurologist, satisfying this requirement.",Yes,"Policy defines epileptic encephalopathy with onset before age 3 as a defined medical indication for WES; the patient has that condition, so the medical indication is met.",Not Specified,The WES coverage criteria do not mandate prior testing for this indication (they note targeted single-gene/panel first only if a specific syndrome is suspected); no mandatory prior test is specified in policy for this scenario.,No,"Policy’s family-history criterion specifies 'other first- or second-degree family member(s) with similar clinical features.' The patient’s brother has an inborn error of metabolism (different phenotype), so the policy-specified family-history criterion is not met.",Not Specified,The policy states genetic counseling is 'strongly recommended' prior to WES but does not list counseling as a formal coverage requirement; thus no mandatory counseling requirement is specified for coverage determination.,81415,Policy's applicable CPT codes list 81415 for 'Exome ... sequence analysis' which corresponds to WES being ordered.,Yes,"Per the UnitedHealthcare policy, WES is medically necessary for epileptic encephalopathy with onset before age 3 when ordered by an appropriate provider; the patient had onset <3 years, the test is ordered by a neurologist, and the indication matches policy, so WES is covered.",36935,2156,39091
Case22,rag,all_correct,iter3,BRCA1/2,Patient information states he is 'undergoing BRCA1/2 testing' to evaluate hereditary predisposition; policy covers BRCA1/BRCA2 testing.,Yes,"Policy specifies testing in minors is investigational but otherwise includes prostate cancer indications 'at any age' (eg, 'Personal history of metastatic or intraductal/cribriform histology prostate cancer at any age'); patient is 18 (not a minor) and therefore meets age-related eligibility.",Not Specified,The policy requires testing be performed in a setting with suitably trained providers who can give pre- and post-test counseling but does not specify required ordering provider specialty; patient’s ordering provider (neurologist) is not disallowed by any explicit policy ordering-provider requirement.,Yes,"Policy lists 'Personal history of metastatic or intraductal/cribriform histology prostate cancer at any age' as a medically necessary indication; patient has metastatic high-risk prostate cancer with intraductal/cribriform histology, so he meets a defined clinical indication.",Not Specified,"Policy does not mandate specific prior tests (eg, CMA) before BRCA1/2 germline testing; prior CMA was nondiagnostic but the policy does not list CMA or other prior testing as a required prerequisite.",Yes,"Policy includes family-history criteria and notes relevance of relatives with metastatic or intraductal/cribriform prostate cancer; patient’s father had metastatic high-risk prostate cancer with intraductal/cribriform features, which is a relevant family history per policy.",Yes,"Policy requires testing be performed where appropriate pre- and post-test counseling is available and recommends formal genetic counseling; patient completed pre-test counseling and will have post-test follow-up with a genetic counselor, satisfying counseling requirements.",Not Specified,"The provided BCBS_FEP policy document does not specify CPT or billing codes for BRCA1/2 testing, so no CPT code can be selected from policy text.",Yes,"Per policy, germline BRCA1/BRCA2 testing is medically necessary for individuals with 'personal history of metastatic or intraductal/cribriform histology prostate cancer at any age.' The patient meets this criterion, has appropriate genetic counseling, and therefore the test is covered under the policy.",18975,2050,21025
Case5605,rag,all_correct,iter3,WGS,Patient information explicitly states the referral is for whole genome sequencing (WGS).,No,Policy's med/coverage statements allow rapid WGS/WES only for critically ill infants in NICU/PICU; the patient is an 11-year-old non‑critically ill child. The Policy Statement also explicitly states: 'Whole genome sequencing is considered investigational for the diagnosis of genetic disorders in all other situations.' Thus the patient's age/clinical setting does not meet the age/acuity-based eligibility for covered WGS.,Yes,"Policy requires documentation that the individual has been evaluated and counseled by a clinician with expertise in clinical genetics. Patient had pre-test counseling completed with a genetic specialist, satisfying the ordering/provider requirement in the policy.",No,"The policy defines medical indication for WGS only for rapid use in critically ill infants; for non‑critically ill children WGS is described as investigational. The patient (11 y/o with congenital cardiac anomaly, not critically ill) does not meet the policy's specified medical indication for WGS.",Not Specified,"The policy specifies prior testing (eg, CMA and/or targeted single‑gene testing) as part of WES coverage criteria, but does not specify mandatory prior testing requirements for non‑rapid WGS in the Policy Statement. (Patient did have a nondiagnostic CMA, but the policy does not explicitly require CMA prior to WGS in this non‑rapid, non‑critically ill context.)",No,"The policy lists specific family history items relevant to sequencing (eg, arrhythmia, BRUE, developmental delay, LQTS, sudden unexplained death <35). Patient's family history (maternal aunt with pancreatic cancer) is not among the policy-specified relevant family history criteria.",Yes,"Genetic counseling is a stated requirement in the policy ('Documentation that the individual has been evaluated by a clinician with expertise in clinical genetics... and counseled'). The patient had pre‑test counseling by a genetic specialist, meeting this requirement.",81425,The requested test is whole genome sequencing (WGS); the CPT code among provided options corresponding to whole genome sequencing is 81425.,No,"Per the Policy Statement, whole genome sequencing is considered investigational for diagnosis 'in all other situations' except for rapid WGS in critically ill infants. This patient is an 11‑year‑old non‑critically ill child; therefore WGS is not covered under the policy despite prior nondiagnostic CMA and counseling.",14822,3626,18448
Case19162,rag,all_correct,iter3,WGS,The clinical information explicitly states testing was referred for whole genome sequencing (WGS).,Not Specified,The policy applies to neonates/children but does not impose an explicit age cutoff or age-based exclusion for WGS/WES eligibility.,Yes,"Policy criterion 1 requires evaluation by a clinician with expertise in clinical genetics and counseling; the patient was referred by a medical geneticist and received pre-test counseling by a genetic counselor, satisfying ordering/provider requirements.",No,"Policy allows WGS only as rapid WGS for critically ill infants in NICU/PICU meeting specific criteria. The patient is a neonate with neurologic findings but is not documented as critically ill or in an intensive care unit, so the specific medical indications for WGS coverage are not met (policy: 'Whole genome sequencing is considered investigational for the diagnosis of genetic disorders in all other situations').",Not Specified,"The policy specifies prior testing criteria for standard WES (eg, CMA and/or targeted testing) but does not specify required prior tests for WGS in non-rapid situations; the document does not state a definitive prior-test requirement for the requested WGS.",Yes,"Policy guidelines list family history of an inborn error of metabolism as relevant. The patient has a sibling with an inborn error of metabolism, which is a relevant family history per the policy.",Yes,"Policy criterion 1 requires counseling about potential risks of genetic testing by someone with expertise; pre-test counseling was completed with a genetic counselor and post-test follow-up is planned, meeting the counseling requirement.",Not Specified,The provided policy document does not specify CPT or billing codes for WGS; therefore a best-fit CPT code is not specified in the policy text.,No,"Per the policy, whole genome sequencing is only considered medically necessary as rapid WGS for critically ill infants in NICU/PICU meeting specific criteria. The patient is not documented as critically ill or in intensive care, and the policy states 'Whole genome sequencing is considered investigational for the diagnosis of genetic disorders in all other situations,' so the requested WGS is not covered.",14852,2715,17567
Case15834,rag,all_correct,iter3,WES,"Patient information explicitly states ""whole exome sequencing (WES) has been ordered.""",Not Specified,"The policy includes age references for some diagnoses (e.g., ID diagnosed by 18 years, GDD onset <5 years) but does not impose a specific minimum/maximum age cutoff for WES in an infant with suspected ASD; no age-based exclusion applicable to this infant is specified.",Not Answerable,"Policy requires WES to be ordered by a medical geneticist, neonatologist, neurologist, or developmental pediatrician. The clinical information states WES ""has been ordered"" and that pre-test counseling was done by a ""genetic specialist,"" but it does not explicitly state the specialty of the ordering provider, so available information is insufficient to determine whether ordering-provider requirements are met.",No,"Policy coverage for WES requires (among other criteria) that clinical history strongly suggests a genetic cause and either (A) one or more specific major features (e.g., multiple congenital anomalies, moderate/severe ID, global developmental delay, early epileptic encephalopathy) or (B) two or more listed features (the list that includes autism spectrum disorder). The infant has concern for ASD but lacks other documented qualifying features (no congenital anomalies, no diagnosed GDD/ID, no epilepsy, consanguinity not present), so the documented clinical criteria in the policy are not met.",Not Specified,"The policy specifies certain prior testing for some scenarios (e.g., prenatal CMA/karyotype prior to prenatal WES; targeted single-gene or panel testing if a specific syndrome is suspected) but does not mandate a specific prior test for outpatient WES for suspected ASD; although Fragile X testing was done and nondiagnostic, the policy does not explicitly require it as a prerequisite in this situation.",Yes,"The policy lists ""other first- or second-degree family member(s) with similar clinical features"" and consanguinity as relevant features. The patient has a maternal aunt (a second-degree relative) with a congenital anomaly, which constitutes a family history that is relevant to genetic evaluation per the policy.",Yes,"The policy states genetic counseling is strongly recommended prior to WES/WGS. The patient had pre-test counseling completed with a genetic specialist, satisfying the counseling requirement as documented.",81415,"Policy list of applicable CPT codes maps exome sequence analysis to 81415 (""Exome; sequence analysis""), which corresponds to the requested WES.",No,"Under the UnitedHealthcare WES policy, WES is covered only when all required criteria are met (nonspecific presentation not fitting a targeted test, appropriate ordering provider, and qualifying clinical features). Although WES was ordered and pre-test counseling performed, the documented clinical information does not demonstrate the required medical-necessity features (patient has concern for ASD but lacks other required major features or two-or-more qualifying features per the policy) and the ordering-provider specialty is not confirmed; therefore coverage criteria are not met.",36936,3148,40084
Case13,rag,all_correct,iter3,WES,Patient summary explicitly states the newborn was referred for whole exome sequencing (WES).,Yes,"Policy coverage applies to 'children' with unexplained congenital anomalies; the patient is a newborn (a child), so age meets the policy's age-related eligibility.",No,"The policy explicitly requires documentation that the individual 'has been evaluated by a clinician with expertise in clinical genetics' and counseled. The chart states evaluation was by a general pediatrician; it does not document evaluation by a clinician with expertise in clinical genetics, so ordering/provider requirement is not met based on provided information.",Yes,"Policy lists unexplained multiple congenital anomalies as an indication for WES. The newborn has multiple congenital anomalies not fitting a defined syndrome and prior genetic testing was nondiagnostic, matching the policy's clinical indication.",Yes,"Policy requires prior genetic testing failed to yield a diagnosis (eg, CMA or targeted testing). The patient had prior karyotype testing that was nondiagnostic, satisfying the policy's requirement for prior genetic testing that failed to yield a diagnosis.",Yes,"Policy guidance lists family history of developmental delay as relevant. The patient has a sibling with unexplained developmental regression, which is a relevant family history per the policy.",Yes,"The policy requires genetic counseling; the patient record states pre-test genetic counseling was completed and post-test follow-up is planned, meeting the counseling requirement.",Not Specified,The provided BCBS FEP WES/WGS policy text does not specify or map CPT codes to WES; no CPT guidance is present in the policy document supplied.,No,"Although the patient meets the clinical indication, prior testing, family-history, age, and counseling criteria, the policy requires evaluation by a clinician with expertise in clinical genetics as an ALL criterion. The provided information documents evaluation by a general pediatrician (no genetics clinician documented), so not all policy criteria are met and coverage cannot be approved under the policy.",14829,2369,17198
Case16487,rag,all_correct,iter3,WES,Patient information states whole exome sequencing (WES) has been ordered for the newborn.,Not Specified,"The policy does not impose a strict age cutoff for WES; it lists age-related features (e.g., ID diagnosed by 18) but no absolute age exclusion that would preclude a newborn. Thus age-based eligibility is not specifically limiting in this case.",No,"Policy requirement: WES must be ordered by a medical geneticist, neonatologist, neurologist, or developmental pediatrician. The ordering provider for this case is an oncologist, which does not meet the policy-specified ordering provider requirement.",No,"Policy defines specific clinical indications (e.g., multisystem congenital anomalies, global developmental delay, persistent/severe immunologic or hematologic disorder in the proband, consanguinity, etc.). The newborn has recurrent BRUE — not listed — and no proband immunologic/hematologic disorder or other listed features. Therefore the patient does not meet a listed medical indication per the policy.",Not Specified,"Policy does not mandate specific prior tests for outpatient WES other than recommending targeted testing when a specific syndrome is suspected. The patient had nondiagnostic FISH, but the policy does not explicitly require or specify FISH or other prior tests in this scenario.",Yes,Patient has a relevant family history: a maternal aunt with a persistent severe immunologic or hematologic disorder. The policy lists family history (first- or second-degree relatives) and persistent/severe immunologic or hematologic disorder among relevant features for consideration.,Not Specified,"The policy states genetic counseling is strongly recommended prior to WES/WGS but does not state it is a strict coverage requirement. Patient information notes pre-test counseling was completed, which aligns with the policy recommendation.",81415,"Policy's applicable CPT codes list 81415 for exome (sequence analysis), which corresponds to WES ordered for this patient.",No,"Although WES is the requested test and family history/counseling are supportive, the policy requires WES be ordered by a medical geneticist, neonatologist, neurologist, or developmental pediatrician. The ordering provider is an oncologist, so the request does not meet the policy's ordering-provider requirement and therefore is not covered per the policy.",36947,2431,39378
Case3677,rag,all_correct,iter3,BRCA1/2,Patient info states she is 'undergoing BRCA1/2 testing.' Basis: patient clinical information.,Yes,"Policy: 'BRCA1/2 gene testing is proven and medically necessary for individuals with a personal history of Breast Cancer diagnosed at age 65 or younger.' Patient is 46 years old with a personal history of breast cancer, meeting the age-based criterion.",Not Specified,Policy strongly recommends pre-test genetic counseling and genetic expertise but does not mandate a specific ordering provider specialty/type as a coverage requirement. Patient was referred by a nurse practitioner and completed counseling (patient fact).,Yes,"Policy lists BRCA1/2 testing as medically necessary for individuals with a personal history of breast cancer (≤65) and/or with a personal history plus a family history that includes BRCA-related cancers or ≥2 affected relatives on same side. Patient has a personal history of breast cancer and a maternal history of pancreatic cancer plus at least two additional affected relatives on the same side, meeting the medical indication criteria.",Not Specified,"Policy does not require completion of any specific prior test before BRCA1/2 germline testing. (Patient fact: prior CMA was nondiagnostic, but CMA is not a policy prerequisite.)",Yes,"Policy includes family history criteria (e.g., first-/second-degree relative with pancreatic cancer or ≥2 affected relatives on same side). Patient has a mother with pancreatic cancer and at least two additional affected maternal relatives, which is relevant to eligibility.",Not Specified,Policy 'strongly recommends' pre-test genetic counseling but does not state it as a strict coverage requirement. Patient completed pre-test genetic counseling and plans post-test follow-up (patient fact).,81162,Policy Applicable Codes list 81162 for 'BRCA1 ... BRCA2 ... gene analysis; full sequence analysis and full duplication/deletion analysis' which corresponds to BRCA1/2 testing requested.,Yes,Based on policy coverage rationale BRCA1/2 testing is medically necessary for individuals with personal history of breast cancer diagnosed ≤65 (patient is 46) and the patient also has relevant family history (maternal pancreatic cancer and multiple affected relatives). Pre-test counseling completed. Therefore BRCA1/2 testing is covered per the provided policy.,38638,2045,40683
Case3474,rag,all_correct,iter3,WGS,Patient information explicitly states whole genome sequencing (WGS) is being ordered.,Not Specified,"The policy does not impose a general age cutoff for WGS; age-related items in the policy refer to specific diagnostic features (e.g., ID diagnosed by age 18, GDD onset <5) but no standalone age eligibility is specified for WGS in the policy.",Yes,"Policy requires WGS be ordered by a medical geneticist, neonatologist, neurologist, or developmental pediatrician; the patient was evaluated by and WGS is being ordered by a medical geneticist, meeting the provider requirement.",No,"Policy coverage for WGS requires (among other things) that the clinical history meet specified features (e.g., multiple congenital anomalies affecting different systems OR one of listed primary features OR two or more listed features). The patient has a single congenital anomaly (choanal atresia) and an affected sibling with developmental delay (not clearly 'similar clinical features'); therefore the explicit clinical/medical-indication criteria in the policy are not met.",Yes,"The WGS coverage criteria require that neither CMA nor WES have been performed. Patient had a karyotype (nondiagnostic) but no CMA or prior WES reported, so this prior-test requirement in the policy is satisfied.",No,"The policy lists family history (other first- or second-degree family members with similar clinical features) or consanguinity as an eligibility feature. The patient has an older sibling with developmental delay, but the sibling does not have clearly similar features to the proband's choanal atresia, so the policy's family-history/consanguinity criterion is not met.",Not Specified,"The policy states genetic counseling is 'strongly recommended' prior to WES/WGS but does not state counseling as a strict coverage requirement. Patient has had pre-test counseling, but counseling is not specified as a mandatory coverage criterion in the policy.",81425,"Policy applicable codes list 81425 as 'Genome (e.g., unexplained constitutional or heritable disorder or syndrome); sequence analysis,' which corresponds to WGS.",No,"Although ordering provider requirements and prior-test conditions are met (medical geneticist ordered, no prior CMA/WES), the patient does not meet the policy's defined medical-necessity clinical criteria for WGS (e.g., multiple congenital anomalies or the required combination/primary features). Therefore per the policy the test is not covered.",36944,2976,39920
Case15938,rag,all_correct,iter3,WGS,Patient information explicitly states whole-genome sequencing (WGS) is being considered.,Not Specified,The UnitedHealthcare policy does not set an explicit age cutoff for WGS eligibility; examples include neonates but no age-based exclusion or required age is specified.,Yes,"Policy requires WGS be ordered by a medical geneticist, neonatologist, neurologist, or developmental pediatrician; the ordering provider is a neonatologist, satisfying this requirement.",Yes,Policy coverage for WGS requires (among other items) a nonspecific clinical presentation and one of the feature-sets (or two+ of a secondary list). The infant has nonspecific neonatal cholestasis being evaluated for metabolic/genetic etiology (clinical presentation not fitting a well-defined syndrome) and has at least two relevant features from the policy's list: laboratory abnormality suggestive of an inborn error of metabolism (conjugated hyperbilirubinemia/cholestasis) and a first‑degree family history of unexplained developmental regression. Thus the clinical indication criteria are met.,Yes,"Policy for WGS requires that neither CMA nor WES have been performed; the record documents prior karyotype (nondiagnostic) but no CMA or WES, so the prior-test requirement for WGS is satisfied.",Yes,"Policy lists family history (other first- or second-degree family members with similar clinical features) and unexplained developmental regression among relevant features. The patient has a sibling with unexplained developmental regression, which is relevant to eligibility per the policy.",Not Specified,"The policy states genetic counseling is ""strongly recommended"" prior to WES/WGS but does not make documented pretest genetic counseling a formal coverage requirement; the record documents no pretest genetic counseling but counseling is not specified as a hard coverage criterion.",81425,Policy's Applicable Codes list CPT 81425 for genome (whole genome) sequence analysis; this corresponds to WGS being requested.,Yes,"Under the UnitedHealthcare WGS coverage rationale, requirements are met: WGS is ordered by a neonatologist; clinical presentation is nonspecific and a genetic cause is suspected; neither CMA nor WES have been performed; and the patient meets listed features (laboratory abnormality suggestive of IEM and relevant family history). Therefore WGS is medically necessary and covered per the policy.",36949,3083,40032
Case4067,rag,all_correct,iter3,WES,Patient clinical note explicitly states whole exome sequencing (WES) has been ordered.,Not Specified,"The policy does not impose a strict age cutoff for WES; it references pediatric-onset features (e.g., diagnoses by age 18, global developmental delay with onset prior to 5) but no explicit single age eligibility limit is stated for WES.",Yes,"Policy requires WES be ordered by a medical geneticist, neonatologist, neurologist, or developmental pediatrician; the test was ordered by a developmental pediatrician, meeting the policy's ordering-provider requirement.",No,"Policy coverage requires the clinical presentation to be nonspecific AND either (A) one of a specified core features (e.g., global developmental delay, moderate/severe ID, multiple congenital anomalies, epileptic encephalopathy) or (B) two or more listed features (e.g., hypotonia plus another). The record documents significant hypotonia only and no additional listed qualifying features, so the medical-indication criteria in the policy are not met.",Not Specified,"The WES coverage criteria did not mandate completion of specific prior tests for non-prenatal WES; although the patient had nondiagnostic karyotype, the policy does not list a required prior test for outpatient WES in this scenario.",No,"The policy lists family history of other first- or second-degree relatives with similar clinical features and consanguinity as qualifying family-history criteria. The patient has a paternal uncle with sudden unexplained death (not described as having similar features), which does not match the family-history criteria in the policy.",Not Specified,"The policy states genetic counseling is strongly recommended prior to WES/WGS but does not make counseling a stated coverage precondition; the patient record does not document counseling, and the policy does not define a required counseling documentation condition for coverage.",81415,"Policy's applicable codes list CPT 81415 for exome (sequence analysis), which corresponds to WES ordered for this patient.",No,"Although the ordering provider (developmental pediatrician) meets the policy requirement and WES is the requested test (CPT 81415), the patient does not meet the policy's medical-necessity criteria (patient has hypotonia but lacks the required one core feature or two qualifying features). Based on the UnitedHealthcare WES/WGS policy coverage rationale, the test is not covered.",36932,2581,39513
Case11514,rag,all_correct,iter3,WES,Patient information explicitly states whole exome sequencing (WES) was requested.,Yes,"The policy contains age‑related criteria (e.g., features diagnosed by age 18, global developmental delay onset before age 5). The patient is 10 years old, which is within the age bounds referenced in the policy (e.g., criteria tied to diagnosis by age 18), so age does not preclude eligibility per policy.",No,"UnitedHealthcare policy requires WES to be ordered by a medical geneticist, neonatologist, neurologist, or developmental pediatrician. The test was ordered by the patient’s oncologist, which does not meet the policy's specified ordering‑provider requirement.",No,"The policy requires either (A) clinical history strongly suggests a genetic cause plus one severe feature (e.g., multiple congenital anomalies, moderate/severe ID, global developmental delay, early epileptic encephalopathy) or (B) clinical history strongly suggests genetic cause plus two or more listed features (e.g., lab abnormalities suggestive of an IEM plus another feature such as a first/second‑degree relative with similar features, consanguinity, dysmorphism, etc.). This patient has a lab abnormality (conjugated hyperbilirubinemia suggestive of possible IEM) and a cousin with an IEM (cousin is not a first/ or second‑degree relative). Only one qualifying feature from the policy list is present, so the patient does not meet the policy’s defined medical indication criteria for WES.",Not Specified,"The WES coverage criteria in the policy do not mandate a specific prior test universally (they note targeted gene testing if a specific syndrome is suspected, and CMA is required in some prenatal WES scenarios). No specific required prior tests for outpatient WES are specified for this indication.",No,"The policy considers family history relevant when it involves other first‑ or second‑degree family members with similar clinical features. The patient’s affected relative is a cousin (not first/second‑degree), so the policy’s family‑history criterion is not met.",Not Specified,"The policy 'strongly recommends' pre‑test genetic counseling prior to WES/WGS but does not state genetic counseling as an explicit coverage requirement. The record notes no pre‑test counseling documentation, but counseling is not specified as a mandatory coverage criterion in the policy.",81415,"Per the policy's Applicable Codes, CPT code 81415 corresponds to exome (sequence analysis) which matches the requested WES.",No,"Under UnitedHealthcare policy the request fails key coverage criteria: the ordering provider is not one of the allowed specialties (medical geneticist, neonatologist, neurologist, developmental pediatrician) and the clinical features do not meet the policy's required medical‑indication thresholds (patient has only one qualifying feature: lab abnormality suggestive of an IEM). Therefore the WES request is not covered per the policy.",36969,2824,39793
Case11981,rag,all_correct,iter3,WGS,Patient information states 'Whole genome sequencing (WGS) is being requested' — explicitly identifies WGS.,Yes,"Policy age thresholds (e.g., features diagnosed by age 18) apply; patient is 9 years old which meets pediatric age references in the WGS coverage criteria (e.g., features diagnosed by 18 years).",Not Specified,"Policy requires WGS to be ordered by a medical geneticist, neonatologist, neurologist, or developmental pediatrician. Patient record notes referral by neurology and pre-test discussion with a genetic specialist but does not explicitly state which provider is the ordering provider.",Yes,Policy requires clinical history strongly suggesting a genetic cause plus specified features. Patient has abnormal muscle tone noted in infancy (hypotonia/hypertonia) and ongoing motor/neurologic and developmental concerns — meeting the listed neurologic/developmental features for WGS.,Yes,"Policy requires that neither CMA nor WES have been performed prior to WGS. Patient had fragile X testing only; there is no documentation of prior CMA or WES, meeting the policy requirement that CMA/WES have not been performed.",No,"Policy lists family history (first- or second-degree relatives with similar clinical features) as a qualifying feature. Patient has a maternal uncle with a severe immunologic disorder, but this is not described as a family member with similar neurodevelopmental/motor features required by the policy.",Not Specified,"Policy 'strongly recommends' genetic counseling prior to WES/WGS but does not make counseling a strict coverage precondition. Patient had pre-test discussion with a genetic specialist, but counseling is described as recommended rather than a formal stated coverage requirement.",81425,"Policy Applicable Codes list CPT 81425 as 'Genome (e.g., unexplained constitutional or heritable disorder or syndrome); sequence analysis' corresponding to whole genome sequencing.",Yes,"Under the UnitedHealthcare policy, WGS is medically necessary when (a) neither CMA nor WES have been performed (true), (b) presentation is nonspecific and no targeted gene test fits (patient has nonspecific motor/developmental phenotype and fragile X was nondiagnostic), (c) ordered by an approved specialty (patient was referred by neurology and had pre-test discussion with a genetic specialist — consistent with neurologist/geneticist involvement), and (d) the patient has qualifying features (hypotonia/abnormal tone in infancy and ongoing neurologic/developmental concerns). Based on these facts and the policy criteria, WGS is covered.",36954,3636,40590
Case7682,rag,all_correct,iter3,WES,Patient clinical information states whole exome sequencing (WES) is being requested.,Yes,"Policy age-related criteria reference features diagnosed by age 18; the patient is 9 years old (<18) and therefore meets age-based criteria where specified (e.g., features diagnosed by 18 years).",Yes,"Policy requires WES be ordered by a medical geneticist, neonatologist, neurologist, or developmental pediatrician; the request was made by a developmental pediatrician.",Yes,Coverage criteria include multiple congenital anomalies affecting different organ systems as an indication for WES; the patient has multiple congenital abnormalities affecting different organ systems.,Not Specified,"The policy does not universally mandate prior specific tests for postnatal WES (it only advises targeted testing if a specific syndrome is suspected); although the patient had a nondiagnostic karyotype, the policy does not require completion of particular prior tests before WES in this scenario.",Yes,Policy lists 'other first- or second-degree family member(s) with similar clinical features' as a relevant criterion; the patient has a sibling with developmental delay.,Not Specified,"The policy 'strongly recommends' genetic counseling prior to WES but does not state counseling as a mandatory coverage requirement; the patient did receive pre-test counseling and plans post-test follow-up, but counseling is not specified as a coverage prerequisite.",81415,"Policy applicable codes list CPT 81415 for exome (sequence analysis), which corresponds to WES.",Yes,"Per the UnitedHealthcare policy WES is proven and medically necessary when ordered by an allowed provider and when criteria are met; here WES is ordered by a developmental pediatrician and the patient meets a listed indication (multiple congenital anomalies affecting different organ systems), so the test is covered.",36935,1944,38879
Case3494,rag,all_correct,iter3,WES,Patient information states 'whole exome sequencing (WES) is being requested.',Yes,"Policy criterion: member must be <21 years of age for ES. Patient is a six‑week‑old infant, which meets the <21 years requirement.",Not Specified,"The policy lists requirements for a 'qualified' rendering laboratory and recommends pretest counseling by genetics professionals, but does not explicitly specify ordering‑provider specialty/type required for coverage (no explicit ordering provider requirement stated).",No,"Policy requires ALL listed criteria for medical necessity (e.g., detailed genetic/family history evaluation with a clinical letter, alternate etiologies considered/ruled out, specific phenotype criteria). Patient has a single noted congenital abnormality and 'concern for an evolving complex neurodevelopmental disorder' but does not meet the policy's defined phenotype thresholds (e.g., multiple congenital anomalies or TWO listed neurodevelopmental criteria), nor is the required clinical evaluation/documentation provided.",Not Specified,"The policy requires no prior ES/GS (patient has none) and that the clinical presentation not fit a syndrome for which first‑tier testing (e.g., CMA) is available, but it does not mandate specific prior tests (postnatal) to have been completed before ES; prenatal ES does require prior CMA, but this is not a prenatal case.",Not Specified,"The policy requires a family history be documented in the clinical evaluation, and prenatal ES lists family history as a specific criterion in some contexts, but for routine pediatric ES family history/consanguinity is not presented as a standalone coverage criterion. Patient has a sibling with dysmorphic features, but the policy does not make family history alone sufficient or explicitly required for coverage in this scenario.",Not Specified,"The policy cites ACMG recommendations that pretest counseling by a medical geneticist or genetic counselor (with consent) should occur, and the coverage criteria require an appropriate genetic/family history evaluation and clinical letter, but the policy's formal ES coverage criteria do not explicitly state that documented genetic counseling is a hard requirement for coverage. Patient declined counseling; the policy does not clearly state this alone disqualifies coverage.",81415,Billing section: '81415 should be billed for the proband' when analyzing the entire exome sequence (proband WES).,No,"Per policy ES is medically necessary only when ALL listed criteria are met. Although patient meets age and has no prior ES/GS, multiple required elements are missing (no documented clinical letter detailing genetic/family history and testing algorithm, alternate etiologies not documented as considered/ruled out, phenotype criteria per policy are not clearly met). Therefore coverage is not supported under the policy.",10475,2770,13245
Case7014,rag,all_correct,iter3,WGS,Patient notes explicitly state 'whole genome sequencing (WGS) is being requested' by neurology.,Not Specified,The UnitedHealthcare WGS policy does not impose an explicit age cutoff for WGS; eligibility is based on clinical features rather than patient age.,Yes,"Policy requires WGS be ordered by a medical geneticist, neonatologist, neurologist, or developmental pediatrician. The request was initiated by/through neurology, meeting that ordering-provider requirement.",Yes,"Policy medical-indication criteria include nonspecific clinical presentation not fitting a well-defined syndrome and 'multiple congenital anomalies.' The infant has nonspecific multiple congenital anomalies, which matches the listed indication.",Yes,"Policy requires that neither CMA nor WES have been performed prior to WGS. Patient had a karyotype (nondiagnostic) but there is no record of prior CMA or WES, so the patient meets the prior-test condition for WGS.",Yes,"Policy notes 'other first- or second-degree family member(s) with similar clinical features' as a supporting feature. The patient has a maternal aunt with a congenital anomaly (a second-degree relative), meeting the family-history criterion.",Not Specified,"The policy 'strongly recommends' genetic counseling prior to WES/WGS but does not state it as a strict coverage requirement. The patient did receive pre-test counseling, but the policy does not define counseling as a mandatory eligibility criterion.",81425,"Policy lists CPT 81425 for 'Genome (e.g., unexplained constitutional or heritable disorder or syndrome); sequence analysis' corresponding to WGS.",Yes,All applicable policy criteria for medically necessary WGS are met: nonspecific presentation not fitting a defined syndrome with multiple congenital anomalies; ordering provider is a neurologist; neither CMA nor WES has been performed; and pre-test genetic counseling completed. Therefore WGS is covered per the UnitedHealthcare policy.,36945,2353,39298
Case13517,rag,all_correct,iter3,WES,Patient record states 'whole exome sequencing (WES) was ordered.' Basis: patient clinical information.,Yes,"Policy age-related items (e.g., ID or sensory impairment diagnosed by age 18) apply when relevant; patient is 16 which satisfies any policy age thresholds. Basis: UnitedHealthcare WES coverage criteria referencing diagnoses by age 18.",Yes,"Policy requires WES be ordered by a medical geneticist, neonatologist, neurologist, or developmental pediatrician; the order was placed by a developmental pediatrician. Basis: UnitedHealthcare WES ordering-provider requirement.",Yes,Policy lists 'laboratory abnormalities suggestive of an inborn error of metabolism (IEM)' as an indication supporting WES; the patient has conjugated hyperbilirubinemia with a sibling having lab abnormalities suggestive of an IEM. Basis: UnitedHealthcare WES medical necessity criteria.,Not Specified,Policy does not mandate specific prior tests for a proband with laboratory abnormalities suggestive of IEM (only notes targeted single-gene/panel first if a specific syndrome is suspected). No required prior testing is specified for this scenario. Basis: UnitedHealthcare WES coverage rationale.,Yes,Policy includes 'other first- or second-degree family member(s) with similar clinical features' as a supporting feature; patient has a sibling with laboratory abnormalities suggestive of an IEM. Basis: UnitedHealthcare WES criteria listing family history as supportive.,Yes,Policy 'genetic counseling is strongly recommended prior to WES' and patient completed pre-test counseling with a genetic counselor (post-test counseling planned). Basis: UnitedHealthcare description of services and counseling recommendation.,81415,CPT 81415 = Exome; sequence analysis (proband) aligns with the ordered Whole Exome Sequencing. Basis: UnitedHealthcare 'Applicable Codes' listing 81415 for exome sequence analysis.,Yes,"All applicable policy criteria for medically necessary WES are met: (1) clinical presentation with laboratory abnormalities suggestive of an IEM, (2) ordered by an approved specialty (developmental pediatrician), (3) relevant family history (affected sibling), (4) age is within policy thresholds, and (5) pre-test genetic counseling performed. Basis: UnitedHealthcare WES coverage rationale and ordering/provider/counseling statements.",36953,1864,38817
Case14127,rag,all_correct,iter3,WES,Patient record states 'whole exome sequencing (WES) is being pursued.' (Patient information).,Yes,"Policy lists Global Developmental Delay and/or ID diagnosed by age 18 as qualifying features for WES. Patient is 17 with lifelong GDD (onset prior to 5 years), meeting the age-related clinical criteria (Policy: Coverage Rationale).",Yes,"Policy requires WES be ordered by a medical geneticist, neonatologist, neurologist, or developmental pediatrician. The patient’s testing is being coordinated and ordered by a medical geneticist (Patient information; Policy: Coverage Rationale).",Yes,Policy medical indication includes Global Developmental Delay and/or family history of early-onset epileptic encephalopathy as qualifying features. Patient has GDD and a sibling with epileptic encephalopathy onset <3 years (Patient information; Policy: Coverage Rationale).,Not Specified,"Policy does not require specific prior tests before WES in the non‑prenatal setting (it only advises targeted testing if a specific syndrome is suspected). Patient had prior FISH nondiagnostic, but policy does not mandate CMA/karyotype prior to postnatal WES (Policy: Coverage Rationale; Description).",Yes,Policy counts other first‑degree family members with similar clinical features as a qualifying feature for WES. Patient has a sibling with epileptic encephalopathy (Patient information; Policy: Coverage Rationale).,Not Specified,"Policy states genetic counseling is 'strongly recommended' prior to WES/WGS but does not list counseling as a strict coverage requirement. Patient did receive pre-test counseling and plans post-test counseling, but the policy frames counseling as recommendation rather than mandatory (Policy: Description).",81415,Policy lists CPT 81415 for exome (sequence analysis) which corresponds to WES (Policy: Applicable Codes).,Yes,"Patient meets all stated WES coverage criteria: nonspecific neurodevelopmental presentation (GDD), WES ordered by a medical geneticist, and qualifying clinical features (GDD and relevant family history including sibling with early-onset epileptic encephalopathy). Therefore WES is covered per the policy (Policy: Coverage Rationale; Patient information).",36965,1657,38622
Case15820,rag,all_correct,iter3,CMA,Patient info states chromosomal microarray (CMA) has been ordered; policy addresses CMA (procedure codes such as 81228).,Yes,"Policy requires testing be performed on a living child or adult; the patient is a 31-year-old adult, meeting the age/setting criterion.",Not Specified,"The policy specifies genetic counseling and that the rendering laboratory be qualified, but does not specify ordering provider specialty/type requirements for CMA.",Yes,"Policy lists developmental delay/intellectual disability (DD/ID) as a qualifying presentation. Patient has DD/ID, no prior CMA, testing on a living adult, and no suspected specific syndrome (so no more appropriate targeted test indicated).",Yes,"Policy requires no previous CMA testing; patient has no prior genetic testing reported, satisfying the 'no previous CMA' requirement.",No,Policy only notes family history of chromosome rearrangement as relevant/exclusion; the patient’s reported family history (mother with early breast cancer) is not the chromosome rearrangement/consanguinity criterion and no consanguinity is reported.,Yes,"Policy requires pre- and post-test genetic counseling by an appropriate provider; patient completed multiple pre-test genetic counseling sessions and plans post-test follow-up, meeting counseling requirements.",81228,Policy lists CPT 81228 as the chromosomal microarray (constitutional) procedure code; this corresponds to the ordered CMA.,Yes,"Based on policy criteria for CMA for developmental disorders (DD/ID), patient meets required clinical indications, has no prior CMA, fulfills counseling requirement, and is an adult; therefore the test is covered per the policy.",10097,1718,11815
Case13675,rag,all_correct,iter3,WGS,Patient information explicitly states whole genome sequencing (WGS) is being pursued.,Yes,"Policy age-related feature thresholds refer to findings diagnosed by age 18; the infant (8 weeks) has significant congenital hearing/visual impairment diagnosed in early infancy, meeting the policy's age-related phrasing.",Yes,"Policy requires WGS be ordered by a medical geneticist, neonatologist, neurologist, or developmental pediatrician; the ordering/referring provider is a neonatologist, which meets the requirement.",No,"Policy requires either (A) one of the primary features (e.g., multiple congenital anomalies, moderate/severe ID, global developmental delay, epileptic encephalopathy) OR (B) two or more features from the secondary list (which includes 'significant hearing or visual impairment'). Patient has only significant congenital hearing/visual impairment (single secondary feature) and does not meet the listed primary features, so medical indication per policy is not met.",Yes,"Policy requires that neither CMA nor WES have been performed prior to WGS; patient had prior FISH (nondiagnostic) and no documentation of CMA or prior WES, satisfying the policy's 'neither CMA nor WES have been performed' condition.",No,"Policy lists relevant family history (e.g., first- or second-degree relatives with similar clinical features) and consanguinity as criteria. The only family history documented is a father with long QT syndrome, which is not a similar hearing/visual phenotype per the policy criteria.",Not Specified,Policy states genetic counseling is 'strongly recommended' prior to WGS but does not make pre-test counseling a stated coverage requirement; patient lacks documented pre-test counseling but the policy does not mandate it for coverage.,81425,"Policy's applicable CPT codes list 81425 for 'Genome (e.g., unexplained constitutional or heritable disorder or syndrome); sequence analysis', which corresponds to WGS.",No,"Although ordering provider (neonatologist), age, and prior-test status satisfy policy conditions, the policy's medical necessity criteria for WGS require either a primary feature or two or more secondary features; the patient has only one qualifying secondary feature (significant hearing/visual impairment) and thus does not meet the policy's medical indication for coverage.",36956,2431,39387
Case2162,rag,all_correct,iter3,WGS,Patient information explicitly states whole genome sequencing (WGS) was referred/ordered.,Not Specified,Policy references 'children' and 'infants' but does not define specific age cutoffs for WGS/WES eligibility; no explicit age-based eligibility criteria are stated in the policy.,Not Answerable,"Policy requirement: evaluation by a clinician with expertise in clinical genetics (including family history/phenotype) and counseling. Patient data notes GP referral and pre-test counseling but does not explicitly document evaluation by a clinician with expertise in clinical genetics, so cannot confirm ordering-provider requirement is met.",Yes,"Policy lists 'multiple congenital anomalies' as a specific indication for sequencing. Patient is a 7-week infant with multiple congenital anomalies affecting multiple organ systems, meeting that clinical criterion.",Not Specified,"Policy examples mention prior testing (eg, chromosomal microarray analysis and/or targeted single-gene testing) or prior testing that failed to yield diagnosis but does not mandate a single exact prior-test list; patient had Fragile X testing nondiagnostic but no documentation of CMA — the policy does not strictly specify which exact prior tests are required, so this is not specified.",Yes,"Policy lists relevant family history items including developmental delay. Patient has an older sibling with autism spectrum disorder, which is relevant family history per the policy's family-history considerations.",Yes,"Policy requires genetic counseling performed by experienced individuals. Patient information states pre-test genetic counseling has been completed with plan for post-test follow-up, meeting the counseling requirement as documented.",Not Specified,The provided policy document does not list or map specific CPT codes to WGS/WES; therefore a corresponding CPT code is not specified in the policy text.,No,Policy statement: standard WGS is considered investigational for diagnosis in all other situations; rapid WGS/WES is medically necessary only for critically ill infants in NICU/PICU. The patient is not described as critically ill or in intensive care; therefore the requested (standard) WGS is investigational per the policy and is not covered.,14818,3790,18608
Case7376,rag,all_correct,iter3,WES,Patient record states whole exome sequencing (WES) has been ordered.,Not Specified,"The policy includes age-based criteria for specific phenotypes (e.g., ID diagnosed by age 18, early-onset epileptic encephalopathy), but there is no overall age cutoff for WES. The patient is 73 and no policy age exclusion for adult WES is stated; therefore no applicable age-based eligibility criterion in the policy explicitly applies to this patient.",Yes,"Policy requires WES be ordered by a medical geneticist, neonatologist, neurologist, or developmental pediatrician. The test was ordered by/referred by a neurologist, meeting the ordering-provider requirement per the policy.",No,"Policy coverage requires, among other things, that the clinical history strongly suggests a genetic cause with either (A) one of specified major features (e.g., multiple congenital anomalies, ID by 18, global developmental delay, early epileptic encephalopathy) or (B) two or more listed features. The clinical data here note an unexplained major abnormality in one organ system and a family history of breast cancer in a sister; the record does not document any of the policy-listed qualifying features (multiple congenital anomalies, early-onset ID/DD, early epilepsy, two or more listed features, consanguinity or relatives with similar clinical features). Thus the patient does not meet the policy-defined medical indications for WES.",Not Specified,"The policy specifies prior testing requirements for certain scenarios (e.g., prenatal CMA/karyotype prior to prenatal WES; specific targeted testing if a syndrome is suspected). For this outpatient adult case, the policy does not define a required prior test that must be completed before WES. Prior FISH was nondiagnostic, but FISH is not listed as a required prior test in the policy.",No,"The policy lists family history of other first- or second-degree members with similar clinical features as a qualifying feature for WES. The patient’s sister had triple-negative breast cancer, which is not described as the same clinical feature as the patient’s unexplained organ abnormality and oncology-family-history is addressed under oncology policies. No consanguinity or family members with similar phenotype is documented, so the family-history criteria in this policy are not met.",Yes,"The policy states genetic counseling is strongly recommended prior to WES/WGS. The patient completed pre-test counseling with a genetic specialist, which satisfies the policy's counseling recommendation.",81415,"CPT code 81415 in the policy corresponds to exome (e.g., unexplained constitutional or heritable disorder or syndrome); sequence analysis (proband), which matches the ordered whole exome sequencing.",No,"Per the UnitedHealthcare WES/WGS policy, coverage for WES requires meeting all listed criteria including a clinical history strongly suggestive of a genetic cause plus either one of the major features (e.g., multiple congenital anomalies, childhood-onset ID/DD, early epileptic encephalopathy) or two or more of the specified supporting features (congenital anomaly, IEM labs, autism, neuropsychiatric disorder, consanguinity, relatives with similar features, etc.). The patient’s record documents an unexplained single-organ abnormality and a family history of breast cancer but does not document any of the policy-specified qualifying features. Although ordering-provider and counseling criteria are met, the required medical indication criteria are not met; therefore WES is not covered under this policy for this patient.",36945,4975,41920
Case11124,rag,all_correct,iter3,WES,Patient information explicitly states whole-exome sequencing (WES) has been ordered.,Yes,"Patient is an infant with developmental delay; policy lists Global Developmental Delay (onset prior to 5 years) and pediatric presentations as qualifying features for WES, so age-related criteria are met per the policy.",No,"Policy requires WES be ordered by a medical geneticist, neonatologist, neurologist, or developmental pediatrician; the test was ordered following referral by an oncologist, which does not meet the specified ordering-provider requirement.",Yes,"Policy medical-necessity criteria include Global Developmental Delay as a qualifying clinical indication; the infant presents with developmental delay, meeting a defined criterion in the policy.",Not Specified,"Policy does not mandate completion of specific prior tests for initial WES except that targeted/single-gene testing is preferred if a specific syndrome is suspected; patient presentation is nonspecific and prior FISH was nondiagnostic, so no specific required prior test is specified in the policy.",Yes,"Policy lists family history (other first- or second-degree family members with similar clinical features) and consanguinity as qualifying considerations; the family has an older sibling with childhood hearing impairment, a relevant family history per the policy.",Not Specified,Policy states genetic counseling is 'strongly recommended' prior to WES but does not make counseling a specified coverage requirement; patient had pre-test counseling and post-test counseling planned.,81415,"Policy applicable codes list 81415 for exome (sequence analysis), which corresponds to WES ordered for this patient.",No,"Although the patient meets clinical indication and age criteria for WES (global developmental delay, relevant family history), the policy requires WES be ordered by specified provider types (medical geneticist, neonatologist, neurologist, or developmental pediatrician); the ordering provider is an oncologist, so the policy's provider requirement is not met and coverage is not supported.",36940,2362,39302
Case8051,rag,all_correct,iter3,WES,Patient info explicitly states whole exome sequencing (WES) is being ordered.,Yes,"Patient is a 5-week-old infant (a child). Policy states WES may be medically necessary for evaluation of unexplained congenital anomalies in children, so the patient's age falls within the policy's pediatric indication.",No,"Policy criterion 1 requires documentation that the individual has been evaluated by a clinician with expertise in clinical genetics. The ordering provider is a family medicine physician and the record does not explicitly document evaluation by a clinician with expertise in clinical genetics, so the ordering-provider requirement is not met based on provided information.",Yes,"Policy indicates WES is appropriate for children with unexplained congenital anomalies. The patient has a major congenital cardiac anomaly being evaluated for a genetic etiology, which meets the defined medical indication.",Yes,"Policy requires previous genetic testing to have failed or that a genetic etiology is most likely despite prior testing. The patient had prior FISH testing that was nondiagnostic, satisfying the 'previous genetic testing failed' element.",Yes,"Policy lists relevant family history as part of considerations for genetic testing. The patient has a family history concern (mother with short stature raising concern for a growth-related genetic condition), which is relevant to eligibility per the policy.",Yes,"Policy requires counseling: criterion 1 specifies counseling about risks by a clinician with genetics expertise and the Genetic Counseling section endorses formal counseling. The patient/family completed pre-test genetic counseling, meeting the counseling requirement.",Not Specified,The provided BCBS_FEP policy text does not list or map specific CPT codes to WES; no CPT code mapping is specified in the document.,No,"Although the patient meets age, medical-indication, prior-testing, family-history, and counseling elements, policy criterion 1 requires documentation that the individual was evaluated by a clinician with expertise in clinical genetics. That specific documentation/clinician evaluation is not shown in the provided information (ordering was by a family medicine physician), so not all policy requirements are met and the test is not covered per the policy.",14840,3152,17992
Case19905,rag,all_correct,iter3,WES,Patient info explicitly states the patient is being considered for whole exome sequencing (WES).,Not Specified,"Policy includes some age-referenced criteria for specific features (e.g., ID diagnosed by 18, GDD onset <5, epileptic encephalopathy onset <3) but there is no specific age cutoff for coverage of WES for multiple congenital anomalies; the patient is 3 years old and no age-based exclusion applies.",Yes,"Policy requires WES be ordered by a medical geneticist, neonatologist, neurologist, or developmental pediatrician; the ordering/referring provider is a developmental pediatrician, meeting the policy requirement.",Yes,"Policy lists 'multiple congenital anomalies (must affect different organ systems)' as an indication for WES; the patient is a 3-year-old with multiple congenital anomalies and prior nondiagnostic karyotype, meeting the clinical indication criterion.",Not Specified,"The policy does not mandate prior testing (e.g., CMA/karyotype) as a universal prerequisite for postnatal WES; although the patient had a nondiagnostic karyotype, the policy does not require any additional prior test completion for WES in this scenario.",No,"Policy cites consanguinity or first/second-degree family members with similar clinical features as relevant criteria; the patient’s family history is a mother with long QT syndrome (not described as similar congenital anomalies) and no consanguinity is reported, so relevant family-history criteria are not met.",Not Specified,"Policy states genetic counseling is 'strongly recommended' prior to WES/WGS but does not make counseling a stated coverage prerequisite; the patient has not had counseling, but counseling is not specified as a required condition for coverage.",81415,Policy's applicable CPT codes list 81415 for exome sequence analysis (proband) which corresponds to WES.,Yes,"Under the UHC policy WES is medically necessary when ordered by an approved specialist and one of the listed features is present. The patient is a 3-year-old referred by a developmental pediatrician (approved ordering provider) with multiple congenital anomalies and prior nondiagnostic karyotype, meeting the policy's indication for WES.",36917,2478,39395
Case10850,rag,all_correct,iter3,WGS,Patient clinical info states whole genome sequencing (WGS) has been ordered.,Yes,"Policy criteria reference age-limited features (e.g., Intellectual Disability diagnosed by 18 years, Global Developmental Delay). The patient is 13 years old with global developmental delay, meeting the policy's age-related feature criteria.",Yes,"Policy requires WGS be ordered by a medical geneticist, neonatologist, neurologist, or developmental pediatrician; the ordering provider is a developmental pediatrician, which satisfies the requirement.",Yes,"Policy lists Global Developmental Delay as an explicit clinical indication for WGS; the patient has global developmental delay, so meets a defined medical indication.",Yes,"Policy states WGS is appropriate when neither CMA nor WES have been performed. The patient had prior FISH (nondiagnostic) but no CMA or WES, meeting the prior-test condition.",Yes,Policy includes 'other first- or second-degree family member(s) with similar clinical features' as a qualifying feature. The patient has an aunt with dysmorphic features (a relevant second-degree relative).,Not Specified,"Policy 'strongly recommends' genetic counseling prior to WES/WGS but does not make counseling a strict coverage requirement. Patient completed pre-test counseling, but counseling is not defined as a mandatory coverage criterion in the policy.",81425,"Policy applicable CPT codes list 81425 for 'Genome (e.g., unexplained constitutional or heritable disorder or syndrome); sequence analysis' which corresponds to WGS.",Yes,"Under the UnitedHealthcare policy WGS is medically necessary when criteria are met: ordered by an approved specialist (developmental pediatrician), clinical presentation includes Global Developmental Delay, neither CMA nor WES have been performed, and relevant family history is present. These conditions are satisfied for this patient, supporting coverage.",36937,2468,39405
Case19321,rag,all_correct,iter3,WES,Patient record explicitly states whole exome sequencing (WES) is being pursued.,Yes,"Policy age-related items (e.g., developmental delay/ID diagnosed by 18 years) apply and the patient is 1 year old, which meets the policy's age-related eligibility bounds for pediatric WES.",Yes,"Policy requires WES to be ordered by a medical geneticist, neonatologist, neurologist, or developmental pediatrician; the ordering provider is a neurologist, meeting this requirement.",No,"Policy coverage requires either (A) clinical history strongly suggests genetic cause plus one of: multiple congenital anomalies, moderate-severe ID by 18, global developmental delay, or early epileptic encephalopathy; or (B) clinical history strongly suggests genetic cause plus two or more of a listed set (which includes ASD as one item). The record documents ASD-like features only (one listed feature) and does not explicitly document global developmental delay, ID, multiple congenital anomalies, epilepsy, or a second listed feature; therefore the defined coverage clinical indications are not met.",Not Specified,"The policy does not mandate prior CMA or other specific tests before WES in the general (non-prenatal) WES coverage criteria. (Patient has had CMA nondiagnostic, but that is not a required prior test per the WES coverage section.)",No,"Policy lists family history (other first- or second-degree family members with similar clinical features) as a qualifying feature. The record notes a maternal aunt with multiple congenital anomalies, but not a family member with similar neurodevelopmental features; thus the policy's family-history criterion is not met.",Not Specified,"The policy states genetic counseling is strongly recommended prior to WES/WGS but does not define it as a required coverage criterion; the patient did receive pre-test counseling, but counseling is presented as recommendation rather than a coverage requirement.",81415,Policy's applicable CPT codes list 81415 for primary exome (sequence analysis) which corresponds to WES being requested.,No,"Although age and ordering provider meet policy requirements, the patient does not meet the policy's specified medical indication thresholds (insufficient documented qualifying features per the WES criteria). Per the UnitedHealthcare WES coverage rationale, all listed clinical criteria must be met for coverage; they are not met in this record, so WES is not covered under the policy.",36944,2899,39843
Case2496,rag,all_correct,iter3,WES,Patient information explicitly states whole exome sequencing (WES) is being requested for a prenatal evaluation at 32 weeks.,Not Specified,"The UnitedHealthcare policy does not impose a gestational age limit for prenatal WES; age-specific limits in the policy apply to pediatric postnatal indications (e.g., diagnoses by 18 years) but prenatal gestational age eligibility is not specified.",No,"Policy prenatal WES coverage requires WES be ""ordered by or in consultation with a medical geneticist or maternal-fetal medicine specialist (perinatologist)."" The request was placed by a neonatologist (patient data) and no consultation with a medical geneticist or MFM is documented, so ordering provider requirement is not met.",Yes,"Regardless of other requirements, the policy lists consanguinity as a clinical feature supporting WES; the patient has parental consanguinity, meeting a listed medical indication for WES.",No,"Policy prenatal WES requires prior CMA and/or karyotyping that were uninformative. Patient had prior fluorescence in situ hybridization (FISH) testing (nondiagnostic) but no CMA or karyotype documented, so required prior testing was not completed.",Yes,"Policy explicitly lists consanguinity and relevant family history among criteria for WES/WGS; patient has parental consanguinity and a sibling with sudden unexplained death, both relevant family/consanguinity criteria.",Not Specified,"The policy states genetic counseling is ""strongly recommended"" prior to WES/WGS but does not make counseling an explicit coverage prerequisite; patient has no genetic counseling documented, but counseling is not specified as a hard coverage requirement.",81415,"Policy's applicable CPT codes list 81415 for exome sequence analysis (WES), which corresponds to the requested whole exome sequencing.",No,"Prenatal WES coverage criteria in the policy are not met: required prior CMA and/or karyotype uninformative is not documented (only FISH done), and prenatal WES must be ordered by or in consultation with a medical geneticist or maternal-fetal medicine specialist but the order is from a neonatologist. Although the patient has consanguinity (a supporting clinical feature), the policy's explicit prenatal coverage prerequisites are unmet, therefore the test is not covered per the policy.",36957,2118,39075
Case6867,rag,all_correct,iter3,BRCA1/2,Patient explicitly presents for BRCA1 and BRCA2 testing per the clinical information.,Yes,"Policy includes age-based criteria but also allows testing 'diagnosed at any age' when there is ≥1 close blood relative with metastatic or intraductal/cribriform prostate cancer. The patient is a breast cancer–affected individual with a brother with metastatic intraductal prostate cancer, so age does not preclude eligibility.",Not Specified,"Policy requires testing be performed in a setting with suitably trained providers and access to a CLIA-licensed lab and recommends genetic counseling, but it does not specify required ordering provider specialty or disallow orders from a nurse practitioner.",Yes,"Policy lists 'personal history of breast cancer and ... diagnosed at any age with ≥1 close blood relative with ... metastatic or intraductal/cribriform prostate cancer' as a medical indication. The patient has a personal history of breast cancer and a brother with metastatic intraductal prostate cancer, meeting a listed indication.",Not Specified,"Policy recommends testing an affected family member first when possible and describes testing strategies, but it does not mandate completion of specific prior tests before BRCA1/2 testing for an affected individual; no required prior testing is specified.",Yes,"Policy explicitly uses family history in eligibility criteria. Patient has a relevant family history (brother with metastatic intraductal prostate cancer and a mother with breast cancer), which is directly pertinent to coverage criteria.",Yes,"Policy requires appropriate pre- and post-test genetic counseling by experienced providers. The patient had multiple pre-test counseling visits with a genetic counselor, meeting the counseling requirement.",Not Specified,"The provided policy text does not list or map specific CPT/billing codes for BRCA1/2 testing, so a specific CPT code cannot be determined from the policy.",Yes,"Per policy, BRCA1/2 testing is medically necessary for individuals with a personal history of breast cancer who have ≥1 close blood relative with metastatic or intraductal/cribriform prostate cancer. The patient's history (personal breast cancer and a brother with metastatic intraductal prostate cancer), plus documented pre-test genetic counseling and lack of disqualifying factors, meet the coverage criteria.",18950,2104,21054
Case1130,rag,all_correct,iter3,WES,Patient record explicitly states the patient is 'undergoing whole exome sequencing (WES)'.,No,"The policy includes age-specific eligibility (e.g., intellectual disability diagnosed by 18 years, epileptic encephalopathy with onset before 3 years). The patient is 68 with no documentation of early-onset epilepsy or ID by age-based cutoffs, so age-based criteria in the policy are not met.",Not Answerable,"Policy requires WES be ordered by a medical geneticist, neonatologist, neurologist, or developmental pediatrician; the patient information only notes referral by cardiology and does not state the specialty of the ordering provider, so adequacy of the ordering provider cannot be determined from the provided data.",No,"Policy medical-necessity criteria require specific features (e.g., epileptic encephalopathy with onset <3 yrs, or combinations of listed features). The provided history lists persistent seizures without documentation of early-onset epileptic encephalopathy, developmental delay, multisystem congenital anomalies, consanguinity or other listed features; thus the patient does not meet the policy-defined clinical indications.",Not Specified,"The policy states targeted testing should precede WES if a specific syndrome is suspected but does not mandate a specific required prior test for this presentation; the patient did have nondiagnostic FISH, but no policy-required prior test for this clinical scenario is explicitly specified.",No,"Policy lists relevant family history as 'other first- or second-degree family member(s) with similar clinical features.' The patient reports a sister with ovarian/fallopian tube/peritoneal carcinoma, which is not 'similar clinical features' to the proband's neurologic seizures per the policy; thus the family history criterion is not met.",Yes,"Policy 'strongly recommends' genetic counseling prior to WES/WGS. Patient has seen a genetic counselor multiple times with plans for post-test follow-up, satisfying the counseling recommendation in the policy.",81415,Applicable CPT codes in the policy list 81415 for exome (sequence analysis); this best corresponds to WES.,No,Under the UnitedHealthcare policy WES is covered only when all specified criteria are met (including specialist ordering and defined clinical features/age-related indications). The patient lacks documentation of meeting the policy's medical-indication and age-based criteria and the ordering provider specialty is not documented; therefore per the policy the test is not covered.,36951,2458,39409
Case5303,rag,all_correct,iter3,BRCA1/2,Patient clinical note explicitly states referral for BRCA1 and BRCA2 testing.,Not Specified,"The policy gives age-based coverage for BRCA1/2 in the context of a personal history of breast cancer (e.g., diagnosed ≤65) or references ages for affected relatives, but it does not define a standalone age eligibility threshold for an unafflicted individual; the patient is 37 but has no personal history of a qualifying cancer.",Not Specified,The policy recommends genetic expertise/genetic counseling for test ordering and interpretation but does not state an explicit mandatory ordering-provider specialty requirement; the ordering provider (neurology referral) cannot be judged noncompliant from the policy text alone.,No,"Policy lists specific medical indications for BRCA1/2 testing (e.g., personal history of breast cancer, family history meeting defined BRCA-related criteria). The patient has no personal history of a primary solid tumor and the family history (brother died suddenly <35) is not described as cancer, so none of the policy's defined indications are met.",Not Specified,The policy does not require completion of any specific prior genetic tests before BRCA1/2 testing in this scenario; the patient has no prior testing but no prior-test requirement is specified.,No,"The policy specifies family-history criteria for BRCA1/2 (e.g., first-/second-degree relatives with early-onset breast, ovarian, pancreatic, male breast, etc.). The patient's reported family history (brother died suddenly before 35) does not meet any of the policy's specified family-history criteria.",Not Specified,"The policy states pre-test genetic counseling is 'strongly recommended' but does not make counseling an absolute coverage requirement; the patient did not receive pre-test counseling, but the policy does not explicitly require it as a condition of coverage.",81162,"The policy's Applicable Codes list 81162 as the CPT code for BRCA1/BRCA2 full sequence analysis plus full duplication/deletion analysis, corresponding to the requested BRCA1/2 testing.",No,"Per the UnitedHealthcare policy, BRCA1/2 testing is covered when policy-specified clinical criteria are met (e.g., personal history of breast cancer ≤65 or qualifying family-history criteria). This patient has no personal history of a qualifying primary solid tumor and no family history meeting the BRCA-related criteria in the policy, so coverage criteria are not satisfied.",38601,2207,40808
Case7447,rag,all_correct,iter3,WGS,Patient clinical information states the cardiologist has ordered whole genome sequencing (WGS).,Not Specified,"The policy's age-related eligibility and indications apply to children and critically ill neonates/infants; the policy explicitly states it does not address prenatal (fetal) testing, so age-based criteria for this fetal request are not specified in the policy.",No,"The policy requires evaluation by a clinician with expertise in clinical genetics (including family history/phenotype) and counseling before WES/WGS; the order was placed by a cardiologist and there is no documentation of evaluation by a genetics clinician or pre-test genetic counseling, so ordering/provider requirements are not met per policy.",Not Specified,The policy defines medical indications for children and critically ill infants but explicitly states it does not address prenatal (fetal) testing; therefore the policy does not specify clinical indications for fetal WGS.,No,"For standard WES/WGS the policy expects prior standard workup (eg, chromosomal microarray analysis and/or targeted single-gene testing) or failure of prior testing; the patient only had nondiagnostic fragile X testing and no documentation of CMA or other recommended prior testing, so required prior tests per policy have not been completed.",No,"The policy lists specific family-history items relevant to testing (eg, arrhythmia, developmental delay, inborn error of metabolism, sudden unexplained death) but does not list an aunt with triple-negative breast cancer as a qualifying family history; the provided family history does not meet the policy's specified family-history criteria.",No,"The policy requires formal genetic counseling by an experienced provider before WES/WGS evaluation; there is no documentation of pre-test genetic counseling in the patient information, so counseling requirements are not met per policy.",Not Specified,"The provided FEP policy document does not list or map specific CPT codes to WES or WGS, so a CPT code cannot be determined from the policy text.",No,"The policy explicitly does not address prenatal (fetal) WES/WGS and indicates whole genome sequencing is considered investigational for diagnosis in other situations; the Benefit Application excludes experimental/investigational procedures. Additionally, required genetics evaluation and counseling and prior testing criteria were not met. Based on the policy as the sole authority, the requested prenatal WGS is not covered.",14825,2632,17457
Case16126,rag,all_correct,iter3,BRCA1/2,Patient info states BRCA1 and BRCA2 testing has been ordered; policy pertains to germline BRCA1/BRCA2/PALB2 testing.,No,"Policy explicitly states genetic testing in minors for BRCA1/BRCA2/PALB2 is considered investigational; the patient is a 6-week-old infant, so age-based criteria are not met.",Not Specified,"Policy requires testing be performed in a setting with suitably trained providers and genetic counseling, but it does not specify required ordering provider specialty; therefore provider-type requirements are not specified.",No,"Policy defines medical indications (personal/family history of cancer or meeting specific criteria); the infant has no personal or qualifying family cancer history and testing in minors is considered investigational, so the patient does not meet medical indication criteria.",Not Specified,"Policy discusses recommended testing strategies (eg, test affected relatives first) but does not mandate specific prior tests for this scenario; available patient info (FISH nondiagnostic) is not defined as required prior testing in the policy.",No,Policy specifies family-history criteria for BRCA testing. Patient information reports parental consanguinity but no family history of BRCA-related cancers; consanguinity is not cited in the policy as qualifying for BRCA testing.,Yes,"Policy requires appropriate pre- and post-test genetic counseling by experienced providers. Patient info states pre-test counseling was completed and post-test follow-up with a genetic counselor is planned, satisfying counseling requirements.",Not Specified,The policy document does not list CPT codes for BRCA1/2 testing and the provided CPT options do not include the standard BRCA sequencing codes; therefore a best-fit CPT from the supplied list is not specified in the policy.,No,"Per the policy, genetic testing for BRCA1/BRCA2 in minors is considered investigational; the patient is a 6-week-old infant, so the requested BRCA1/2 testing is not covered.",18931,2304,21235
Case4512,rag,all_correct,iter3,WGS,Patient clinical information explicitly states whole genome sequencing (WGS) is being pursued.,No,The policy's medically necessary indications for sequencing are framed for children/critically ill infants; the patient is a 21‑year‑old adult and therefore does not meet the age-based criteria in the policy.,Not Specified,"The policy specifies ordering/evaluation requirements (eg, evaluation by a clinician with expertise in clinical genetics) for WES in children and for rapid testing in critically ill infants, but it does not specify ordering‑provider requirements for WGS in this adult outpatient scenario.",No,Policy defines specific indications for WES (children with unexplained congenital or neurodevelopmental disorders) and narrowly for rapid WGS/WES in critically ill infants; WGS for diagnosis in other situations is stated investigational. The 21‑year‑old adult with a congenital cardiac anomaly does not meet those defined indications.,No,"Policy criterion for medically necessary sequencing requires prior standard genetic workup (eg, chromosomal microarray and/or targeted single‑gene testing) or failed prior testing. The patient has had no prior genetic testing.",Yes,"The policy lists family history items relevant to sequencing (including 'BRUE in sibling'); the patient has a sibling with a BRUE, which the policy identifies as relevant family history.",Yes,"The policy requires/encourages formal genetic counseling (and for WES criterion #1 requires counseling). The patient had pre‑test counseling with a genetic counselor and a post‑test visit is planned, meeting the counseling requirement described in the policy.",Not Specified,"The provided policy document does not list or map CPT codes to WGS/WES, so a specific CPT code is not specified in the policy text.",No,"Under the policy, whole genome sequencing for diagnosis is considered investigational in all other situations (outside the narrow rapid‑testing exceptions for critically ill infants). The patient is a non‑infant adult and does not meet the policy's medically necessary criteria for genomic sequencing, so WGS is not covered.",14859,2705,17564
Case1778,rag,all_correct,iter3,WES,Patient clinical information states whole exome sequencing (WES) has been requested for diagnostic clarification.,Yes,"Policy criteria require the member to be <21 years of age for ES; the patient is 14, meeting the age criterion (Policy: 'Member is <21 years of age').",Not Specified,The policy requires an 'appropriate genetic and family history evaluation' and a clinical letter but does not specify a mandatory ordering provider specialty or explicit ordering-provider credential in the criteria; the patient was referred by a primary care physician but provider-type requirements are not explicitly defined in the policy.,No,"Policy requires that a genetic etiology is the most likely explanation based on specific clinical criteria (e.g., multiple congenital anomalies affecting different organ systems OR TWO listed criteria such as a major abnormality plus another criterion). The patient has a single ocular coloboma (one organ/system affected) with no additional listed neurodevelopmental criteria documented, so the defined medical-indication criteria for ES are not met.",No,"Policy requires prior elements including: no prior ES/WGS (met), and an 'appropriate genetic and family history evaluation' with a clinical letter detailing prior tests and results. Only prior nondiagnostic FISH is documented; there is no documentation of the required genetic evaluation/clinical letter or other prior testing per the policy, so required prior evaluation/documentation is not complete.",Not Specified,"Policy requires appropriate genetic and family history evaluation, but the patient record provided does not include any family history or consanguinity information; thus relevant family-history criteria cannot be assessed from the provided information.",No,"Policy and cited guidelines recommend pretest counseling by a medical geneticist or affiliated genetic counselor and written documentation/consent. The patient information does not document any pretest genetic counseling or consent, so the counseling requirement is not shown to be met.",81415,Policy states CPT 81415 should be billed for the proband when analyzing the entire exome sequence (Policy: '81415 should be billed for the proband... analyzing the entire exome sequence').,No,"Although age and proband-level CPT alignment are met, the policy requires (among other items) an appropriate genetic/family history evaluation with clinical documentation and that the phenotype meet defined clinical criteria (e.g., multiple congenital anomalies or two qualifying criteria). The record only documents a single ocular coloboma and a nondiagnostic FISH; required clinical documentation and specified medical-indication criteria are not met per the policy, so ES is not covered.",10435,2477,12912
Case14155,rag,all_correct,iter3,WGS,Patient clinical information explicitly states whole genome sequencing (WGS) has been requested.,Yes,"Policy requires member <21 years for genome sequencing; the patient is 7 years old, meeting the age criterion (MOL.TS.306.C).",No,The guideline requires an appropriate genetic and family history evaluation and a clinical letter detailing that evaluation be provided. The record only states neurology referral and no clinical evaluation letter is provided; therefore ordering/provider documentation requirements are not satisfied (MOL.TS.306.C criteria).,No,"Medical necessity requires that a genetic etiology is the most likely explanation and fulfillment of phenotype-specific criteria (e.g., global developmental delay under age 5, moderate/severe ID, multiple congenital anomalies, OR TWO of listed criteria). The patient has a formal concern for autism but no second qualifying feature is documented, so the policy's phenotype-based medical indication is not met (MOL.TS.306.C).",Yes,"Policy requires that the member has not had previous exome or genome sequencing; the patient has had no prior genetic testing, so the policy's prior-test requirement (absence of prior ES/GS) is satisfied (MOL.TS.306.C).",Not Specified,"While the patient has a family history (maternal uncle with severe immunologic disorder), the standard GS coverage criteria do not list family history/consanguinity as a standalone required eligibility criterion (family history is required to be evaluated but is not specified as a discrete qualifying criterion for standard GS in the policy).",Not Specified,The guideline requires an appropriate genetic and family history evaluation and documentation but does not explicitly mandate pre-test genetic counseling by a genetic counselor as a condition of coverage in the criteria section; ACMG counseling recommendations are referenced but not listed as an explicit coverage requirement in the policy criteria.,81425,Policy states 81425 should be billed for the proband when analyzing the entire genome sequence (Genome sequence/proband = 81425).,No,"Under the Cigna genome sequencing guideline the request fails coverage requirements: the patient does not meet the policy's phenotype-based medical necessity criteria (only autism documented without a second qualifying feature), and required documentation of an appropriate genetic/family history evaluation and clinical letter is not provided. Therefore WGS is not covered per MOL.TS.306.C.",9161,2444,11605
Case13406,rag,all_correct,iter3,WGS,Patient info states Whole Genome Sequencing (WGS) has been ordered by a medical geneticist.,Yes,"Policy lists Global Developmental Delay (GDD) as an indication and defines GDD onset prior to 5 years; the infant is 6 weeks old, meeting the age-related definition in the policy.",Yes,"Policy requires WGS to be ordered by a medical geneticist, neonatologist, neurologist, or developmental pediatrician; the test was ordered by a medical geneticist.",Yes,"Policy specifies WGS indications include nonspecific presentation with features such as Global Developmental Delay; the patient is being evaluated for global developmental delay, meeting a defined clinical indication.",No,"Policy WGS criteria state 'Neither CMA nor WES have been performed' as a prerequisite; the patient previously had CMA which was nondiagnostic, so the prior-test criterion for WGS is not met.",No,"Policy lists consanguinity or other first-/second-degree family members with similar clinical features as relevant criteria; the record notes a sibling with a brief resolved unexplained event (not the same clinical features) and no consanguinity, so the patient does not meet the policy's family/consanguinity criteria.",Yes,"Policy states genetic counseling is strongly recommended prior to WGS; the patient had pre-test counseling completed and will follow up after results, satisfying the counseling expectation in the policy.",81425,"Policy's applicable CPT mapping lists 81425 as 'Genome (e.g., unexplained constitutional or heritable disorder or syndrome); sequence analysis' corresponding to whole genome sequencing.",No,"Although patient meets clinical indication, ordering provider, age, and counseling expectations, the policy requires that neither CMA nor WES have been performed for initial WGS. The patient already had CMA (nondiagnostic), so WGS does not meet the policy's coverage prerequisites.",36966,2155,39121
Case3581,rag,all_correct,iter3,BRCA1/2,Patient information states BRCA1 and BRCA2 testing has been ordered. Policy specifically addresses BRCA analysis (BRCA1/2).,Yes,"Policy states Age 18 years or older is required for BRCA testing (Known familial, founder, and full sequence analyses). Patient is 69, which meets the age requirement per the policy.",Not Specified,"Policy requires pre- and post-test genetic counseling and that the rendering laboratory be qualified, but the guideline does not specify required ordering provider specialty or that a cardiologist cannot order testing. No ordering-provider specialty requirement is specified in the policy.",No,"Policy medical necessity criteria for BRCA testing are cancer- and family-history–based (breast, ovarian, pancreatic, prostate, Ashkenazi founder, known familial mutation, etc.). The patient has hearing/visual impairment and a sibling with a BRUE event but no personal or family history of the BRCA-related cancers or a known familial BRCA mutation; thus the patient does not meet the policy's defined medical indications.",Not Answerable,"The policy includes prior-testing requirements (e.g., no previous full sequencing for full sequence analysis, testing affected relatives first in many predisposition situations). The patient record does not state whether prior BRCA sequencing or deletion/duplication testing was previously performed, so it cannot be confirmed whether required prior testing conditions are met.",No,"Policy specifies family history criteria (first/second/third-degree relatives with BRCA-related cancers or known familial BRCA mutation). Patient's family history notes a sibling with a brief resolved unexplained event (non-cancer); there is no family history of BRCA-related cancers or known BRCA mutation documented, so family-history criteria are not met.",No,"The policy requires pre- and post-test genetic counseling by an appropriate provider for BRCA testing. The patient record explicitly states no pre-test genetic counseling has been conducted, so counseling requirements are not met.",81162,Policy lists CPT 81162 as BRCA1/2 full sequencing and duplication/deletion analysis (combined) and notes 81162 is likely most appropriate when sequencing and del/dup are performed concurrently. The requested BRCA1/2 testing corresponds best to this combined code per the guideline.,No,"Adjudication per the policy: although age criterion is met, the patient does not meet the policy's defined medical indications (cancer- or family-history based) for BRCA testing, and required pre-test genetic counseling has not been performed. Based on the BRCA Analysis policy criteria, the test is not covered.",10276,2301,12577
Case10529,rag,all_correct,iter3,WES,Patient information explicitly states 'whole exome sequencing (WES) is being pursued.',Yes,"Policy lists 'Moderate, severe, or profound Intellectual Disability diagnosed by 18 years of age' and the patient is 6 years old, meeting the age-based criterion in the WES coverage rationale.",Yes,"Policy requires WES be ordered by a medical geneticist, neonatologist, neurologist, or developmental pediatrician. The patient was referred by neurology and WES is being pursued via neurology, satisfying ordering-provider requirement.",Yes,"Policy medical-indication criteria include Global Developmental Delay and Intellectual Disability (onset <18 years) as qualifying features. The patient has nonsyndromic developmental delay and intellectual disability, meeting these clinical indications.",Not Specified,"The WES coverage criteria do not universally require prior tests (except when a specific syndrome is suspected or for prenatal WES where CMA/karyotype must be uninformative). The patient had Fragile X testing (nondiagnostic), but the policy does not mandate additional specific prior testing for outpatient WES in this scenario.",Yes,"Policy counts 'other first- or second-degree family member(s) with similar clinical features' as a relevant feature. The patient has a maternal uncle with neurologic disease (dystonia and ataxia), a relevant second-degree family history.",Not Specified,"Policy states genetic counseling is 'strongly recommended' prior to WES/WGS but does not state it as a strict coverage requirement. The patient has completed pre-test genetic counseling and plans post-test follow-up, but the policy language is recommendation rather than a mandatory condition.",81415,"Applicable CPT codes in the policy list 81415 for 'Exome; sequence analysis,' which corresponds to WES.",Yes,"Based on the policy, WES is proven and medically necessary when (a) presentation is nonspecific and not fitting a defined syndrome, (b) ordered by an authorized provider (neurologist), and (c) one of the qualifying features is present (the patient has developmental delay/intellectual disability and relevant family history). Fragile X was nondiagnostic and pre-test genetic counseling completed. These facts meet the policy's coverage rationale for WES.",36949,2360,39309
Case18821,rag,all_correct,iter3,WES,Patient info states the obstetrician requests fetal whole exome sequencing (WES) at 22 weeks gestation.,No,Policy age-based eligibility is specified for children/critically ill infants and the policy explicitly states it does not address prenatal (fetal) testing; the patient is a fetus (22 weeks) and therefore does not meet the policy's age-related criteria.,No,Policy requires evaluation by a clinician with expertise in clinical genetics and counseling prior to WES; the ordering clinician is an obstetrician and there is no documentation the patient was evaluated by a genetics clinician or received pre-test genetic counseling.,No,"Although the fetus has multiple congenital anomalies, the policy's defined medical indications apply to children or critically ill neonates/infants; the policy explicitly excludes prenatal (fetal) testing from its scope, so the patient's presentation does not meet the policy's clinical indications.",No,"Policy criteria for standard WES refer to previous genetic testing (eg, chromosomal microarray and/or targeted single-gene testing) or prior testing failing to yield a diagnosis; the patient has no prior genetic testing documented.",Not Specified,"The policy discusses family history as part of a genetics evaluation and gives examples (eg, developmental delay, inborn errors), but it does not specify that a report of an aunt with dysmorphic features meets an eligibility criterion for WES; thus family-history eligibility in this prenatal context is not specified.",No,Policy requires that the individual be counseled about risks of genetic testing by someone with genetics expertise; there is no documentation of pre-test genetic counseling for this patient.,81415,"The requested test is whole exome sequencing (WES); among the provided CPT options, 81415 corresponds to exome sequencing.",No,"Per the BCBS FEP policy the use of WES/WGS for prenatal (fetal) testing is not addressed and the policy's medical-necessity statements apply to postnatal children/critically ill infants. Age/setting exclusions, lack of required genetics evaluation/counseling, and absence of prior testing mean the request does not meet the policy's coverage criteria.",14844,2151,16995
Case5230,rag,all_correct,iter3,WES,Patient record explicitly states the neurology referral is for whole exome sequencing (WES).,Yes,"Policy lists age-related items (e.g., features diagnosed by age 18) for WES eligibility and the patient is 15. The patient’s age meets the policy age-related thresholds (e.g., criteria that reference diagnosis by 18 years).",Yes,"Policy requires WES be ordered by a medical geneticist, neonatologist, neurologist, or developmental pediatrician. The referral/order is from neurology, which satisfies the provider requirement per the policy.",No,"Policy coverage requires either (a) clinical history strongly suggesting a genetic cause plus one of a specific list (e.g., multiple congenital anomalies) or (b) clinical history strongly suggesting a genetic cause plus two or more listed features (e.g., congenital anomaly plus additional features). The patient has a single congenital anomaly and a sibling with an inborn error of metabolism, but the documentation does not show the required combination (multiple congenital anomalies or two or more listed features) explicitly required by the policy, so medical indication criteria are not met.",Not Specified,"The policy does not mandate a specific prior test before outpatient postnatal WES (except that targeted single-gene/panel testing should be done if a specific syndrome is suspected). The patient has already had a nondiagnostic CMA, but the policy does not require CMA prior to WES in this setting.",Yes,"Policy lists family history (other first- or second-degree family members with similar clinical features) and consanguinity as relevant features. The patient has a sibling with an inborn error of metabolism, which is a relevant family history per the policy.",Not Specified,The policy states genetic counseling is 'strongly recommended' prior to WES/WGS but does not make counseling a required coverage criterion. The patient declined counseling; counseling is recommended but not a stated coverage requirement in the policy.,81415,Policy's applicable CPT codes list 81415 for exome (sequence analysis) which corresponds to clinical WES.,No,"Although the patient’s age and ordering provider meet policy requirements and the patient has a relevant family history and prior nondiagnostic CMA, UnitedHealthcare’s WES coverage criteria require either multiple congenital anomalies (different organ systems) or the presence of two or more listed features (or other listed single-feature criteria). The clinical information documents a single congenital anomaly and a sibling with an IEM but does not document the required combination of features in the policy; therefore the request does not meet the policy’s defined medical necessity criteria for coverage.",36915,3326,40241
Case6478,rag,all_correct,iter3,BRCA1/2,Patient specifically was referred for germline BRCA1 and BRCA2 testing per the clinical information.,Not Specified,"The policy specifies age-based BRCA testing criteria for breast cancer (e.g., ≤65) but does not specify an age cutoff for BRCA1/2 testing in individuals with metastatic prostate cancer; the patient's age (52) is not addressed by an explicit age restriction in the policy for this indication.",Not Specified,The policy strongly recommends genetic counseling and involvement of providers with genetics expertise but does not mandate a specific ordering provider specialty or restrict which provider may order BRCA1/2 testing for coverage.,Yes,Policy lists metastatic prostate cancer as an indication for germline testing (Prostate Cancer section and Coverage Rationale: 'Metastatic prostate cancer') and includes BRCA1/2 among prostate cancer susceptibility genes; the patient has metastatic prostate cancer and a BRCA-related family history (father with pancreatic cancer).,Not Specified,"The policy does not require completion of specific prior tests (e.g., tumor testing or other genetic tests) as a prerequisite for germline BRCA1/2 testing in a patient with metastatic prostate cancer.",Yes,"Policy family-history criteria recognize pancreatic cancer as a BRCA-related cancer; the patient has a first-degree relative (father) with pancreatic cancer, which is relevant to BRCA testing eligibility.",Not Specified,"The policy states pre-test genetic counseling is 'strongly recommended' but does not make pre-test counseling a mandatory coverage requirement; the patient did not have pre-test counseling, but the policy does not require it as a condition of coverage.",81162,"Applicable codes list 81162 for BRCA1/BRCA2 full sequence analysis plus duplication/deletion analysis, which best corresponds to comprehensive germline BRCA1/2 testing requested.",Yes,"Based on policy Coverage Rationale and Prostate Cancer criteria, germline BRCA1/2 testing (and/or multigene testing including BRCA1/2) is medically necessary for individuals with metastatic prostate cancer and is further supported by the patient's family history of pancreatic cancer (a BRCA-related cancer). Pre-test counseling is recommended but not required for coverage per the policy.",38617,2101,40718
Case13613,rag,all_correct,iter3,WES,Patient clinical information states whole exome sequencing (WES) was requested for fetal evaluation at 22 weeks; policy differentiates WES/WGS and includes prenatal WES criteria.,Not Specified,"The policy does not impose an age cutoff for prenatal WES; age-based criteria in the policy apply to postnatal indications (e.g., diagnosis by 18 years) but prenatal testing has no age requirement specified.",Yes,Policy requires prenatal WES be ordered by or in consultation with a medical geneticist or maternal-fetal medicine specialist. The record documents a pre-test discussion with a genetic specialist (meets the consultation requirement).,Yes,"Policy lists as an indication for prenatal WES: fetus with one or more findings including multiple congenital anomalies (must affect different organ systems). The patient has fetal imaging identifying multiple structural anomalies, which meets this clinical criterion.",No,Policy requires that chromosome microarray analysis (CMA) and/or karyotyping have been performed and were uninformative prior to prenatal WES. Patient data documents only Fragile X testing (nondiagnostic) and does not state CMA/karyotype were done.,Yes,Policy recognizes family history (other first- or second-degree family members with similar features) as a relevant criterion. Patient has a maternal aunt with dysmorphic features (relevant second-degree family history).,Not Specified,"Policy 'strongly recommends' genetic counseling prior to WES/WGS but does not state counseling as an explicit mandatory coverage criterion for prenatal WES; patient did have pre-test discussion with a genetic specialist, but counseling is not defined as required for coverage in the policy.",81415,Applicable CPT codes in the policy list 81415 for exome (sequence analysis) which corresponds to WES; 81415 is the primary exome sequencing code.,No,"Although clinical indication (multiple fetal structural anomalies) and consultation with a genetic specialist are met, the policy explicitly requires prior CMA and/or karyotyping to have been performed and uninformative for prenatal WES coverage; those prior test results are not documented, so policy criteria for coverage are not fully met.",36940,1956,38896
Case5380,rag,all_correct,iter3,WGS,Patient information explicitly states whole genome sequencing (WGS) is requested.,Yes,"Policy lists age-related clinical features (e.g., epileptic encephalopathy with onset before 3 years); the patient is an 8-week-old infant with early-onset seizure-like episodes, meeting the age-related feature.",Yes,"Policy requires WGS be ordered by a medical geneticist, neonatologist, neurologist, or developmental pediatrician; the patient was referred by neurology (a neurologist), satisfying the ordering-provider requirement.",Yes,"Ignoring other requirements, the policy defines neurologic features/early-onset epilepsy (epileptic encephalopathy before age 3) as a qualifying medical indication; the infant has recurrent seizure-like episodes consistent with that clinical criterion.",No,"Policy prerequisite for WGS states 'Neither CMA nor WES have been performed.' The patient has already had CMA (nondiagnostic), so the required prior-test condition for WGS is not met.",No,"The policy specifies family-history criteria (e.g., consanguinity or first/second-degree relatives with similar features). The record notes maternal short stature but no family members with similar seizure/neuro features or consanguinity, so relevant family-history criteria are not met.",Not Specified,"The policy 'strongly recommends' genetic counseling prior to WES/WGS but does not state counseling as a strict coverage requirement; the family declined pre-test counseling, but counseling is not defined as a mandatory coverage criterion in the policy.",81425,"Policy's applicable codes list maps whole genome sequence analysis to CPT 81425 ('Genome ... sequence analysis'), which corresponds to WGS.",No,"Although the infant meets clinical and ordering-provider criteria (early-onset seizures, neurologist ordering), the policy requires that 'Neither CMA nor WES have been performed' before WGS; prior CMA was performed (nondiagnostic), therefore WGS does not meet the policy's coverage criteria.",36943,2685,39628
Case15570,rag,all_correct,iter3,BRCA1/2,Patient clinical information states the clinician requested BRCA1 and BRCA2 testing.,No,The policy explicitly states genetic testing in minors for BRCA1/BRCA2/PALB2 is considered investigational; the patient is 15 years old and therefore does not meet the age-related policy criterion.,No,"Policy requires testing be performed in a setting with suitably trained providers who can give appropriate pre- and post-test counseling. The order was placed by a general pediatrician with no documentation of pre-test genetic counseling, so provider/setting requirements are not met.",No,"Policy medical indication requires personal or family history suggesting HBOC or other listed high‑risk cancers. The patient is unaffected, has no documented family history of cancer, and is a minor (testing in minors considered investigational), so no policy-defined medical indication is met.",Not Specified,"The policy recommends testing an affected family member first when testing an unaffected individual, but it does not state a single universally required prior test in all cases. The patient has no affected family member documented; the policy guidance is recommendatory rather than a strict universal prior‑test requirement.",No,"Policy’s family-history criteria are relevant for BRCA testing. The patient’s family history documents only a mother with bipolar disorder and no cancers, so the patient does not have the policy-specified family history indications.",No,"Policy states genetic testing should be performed where appropriate pre- and post-test genetic counseling is available and recommends formal genetic counseling. There is no documentation of pre-test genetic counseling for this patient, so counseling requirements are not met.",Not Specified,The provided policy document does not list or map specific CPT codes for BRCA1/BRCA2 testing; CPT coding is not specified in the policy text supplied.,No,Based on policy: (1) testing minors for BRCA1/BRCA2 is considered investigational; (2) the patient lacks a personal or family cancer history meeting the policy criteria; and (3) required counseling/setting requirements are not documented. Therefore the test is not covered under the cited policy.,18943,2140,21083
Case5834,rag,all_correct,iter3,CMA,Patient clinical information explicitly states referral for chromosomal microarray (CMA) testing to evaluate a genomic etiology for developmental disorder.,Not Specified,The BCBS FEP policy defines clinical indications for CMA but does not specify age-based eligibility limits for CMA; therefore age criteria are not specified in the policy.,Not Specified,The policy discusses genetic counseling expertise but does not specify ordering-provider specialty or other formal ordering-provider requirements for CMA.,Yes,"Policy Statement: 'Chromosomal microarray analysis may be considered medically necessary as first-line testing in the initial evaluation of individuals with... apparently nonsyndromic developmental delay/intellectual disability.' The patient has lifelong severe intellectual disability, meeting this clinical indication.",Not Specified,"The policy allows CMA as first-line testing and does not require completion of prior genetic tests before CMA. Although guidelines referenced recommend fragile X plus CMA as first-tier, the policy does not mandate prior tests as prerequisites; the patient has had no prior genetic testing.",Not Specified,The policy's CMA coverage criteria are based on the patient's clinical presentation (developmental delay/ID/ASD/multiple congenital anomalies) and do not specify family history or consanguinity requirements; the patient's maternal history of ovarian cancer is not cited as relevant in the policy.,Yes,"Policy notes that genetic counseling is recommended and should be performed by experienced personnel. The patient had pre-test counseling with a genetic counselor on multiple occasions and plans for post-test follow-up, meeting the counseling expectation in the policy.",Not Specified,The provided BCBS FEP policy document does not list or map CPT codes to CMA; no CPT code is specified in the policy text supplied.,Yes,"Per the policy statement, CMA 'may be considered medically necessary as first-line testing' for apparent nonsyndromic intellectual disability. The patient has severe intellectual disability consistent with that indication, no prior testing is required, and genetic counseling was performed; therefore the CMA is covered under the policy.",15715,1855,17570
Case1501,rag,all_correct,iter3,WES,Patient information explicitly states 'Whole exome sequencing (WES) is being ordered.' Decision based solely on provided patient data.,Yes,"Policy criteria reference pediatric age windows (e.g., features diagnosed by 18 years, global developmental delay onset <5 years). Patient is 2 years old, which meets the age-related windows referenced in the WES coverage criteria.",Yes,"Policy requires WES to be ordered by a medical geneticist, neonatologist, neurologist, or developmental pediatrician. The ordering/referring provider is a developmental pediatrician, meeting the policy requirement.",Yes,"Policy lists multiple congenital anomalies and developmental delay/global developmental delay as qualifying clinical features for WES. The patient has multiple congenital anomalies and ongoing developmental concerns, and prior karyotype was nondiagnostic, meeting the medical indication criteria in the policy.",Not Specified,"The policy does not require a specific prior test (e.g., CMA/karyotype) for postnatal WES in all cases; it only states targeted testing is preferred if a specific syndrome is suspected and prenatal WES requires prior CMA/karyotype. Although the patient had a nondiagnostic karyotype, the policy does not specify mandatory prior testing for this postnatal WES scenario.",No,"The policy identifies consanguinity or other first-/second-degree family members with similar clinical features as relevant criteria. The patient has a maternal history of Long QT syndrome, which is not the same clinical features as the proband's congenital anomalies/developmental concerns, so the specific family-history eligibility criteria are not met.",Not Specified,"The policy 'strongly recommends' genetic counseling prior to WES/WGS but does not list counseling as a mandatory coverage criterion. Patient documentation notes pre-test genetic counseling was completed, but the policy does not make counseling a required coverage condition.",81415,"Policy's applicable CPT codes list 81415 for exome (sequence analysis) for a proband, which corresponds to WES.",Yes,"Under the UnitedHealthcare WES coverage rationale, WES is medically necessary when ordered by a qualifying provider and when features such as multiple congenital anomalies or global developmental delay are present. The patient is a 2-year-old with multiple congenital anomalies and developmental concerns, WES ordered by a developmental pediatrician, and prior karyotype was nondiagnostic — collectively meeting the policy's coverage criteria.",36937,2514,39451
Case10427,rag,all_correct,iter3,WGS,Patient information explicitly states whole genome sequencing (WGS) is being requested.,Yes,"Policy includes hypotonia in infancy as an eligible feature for WGS and several criteria reference age (e.g., features diagnosed by 18 years); the patient is an 8‑week‑old infant with hypotonia, meeting the age-related context in the policy.",Yes,"Policy requires WGS be ordered by a medical geneticist, neonatologist, neurologist, or developmental pediatrician; the test was ordered by a neurologist, satisfying provider requirement.",Yes,"Policy requires clinical history suggesting a genetic cause plus specific features. The patient has hypotonia in infancy (listed) and a family history of an older sibling with unexplained developmental regression (a listed relevant family/neurologic feature), meeting the policy's feature-based medical indication for WGS.",Yes,"Policy states WGS is appropriate when neither CMA nor WES have been performed. The record documents only prior FISH (nondiagnostic) and does not report prior CMA or WES, satisfying the policy prior-test condition.",Yes,"Policy lists family history/consanguinity as qualifying criteria (e.g., other first‑ or second‑degree family member(s) with similar clinical features and/or unexplained developmental regression). The patient has an older sibling with unexplained developmental regression, which is relevant per the policy.",Not Specified,Policy states genetic counseling is strongly recommended prior to WGS but does not make counseling a strict mandatory coverage requirement; note patient did receive pre‑test counseling per the record.,81425,Policy's applicable codes list CPT 81425 for genome (whole genome) sequence analysis; this best corresponds to the requested WGS.,Yes,"Per the UnitedHealthcare policy, WGS is medically necessary when ordered by an allowed specialist, clinical presentation is nonspecific with features suggesting genetic etiology, neither CMA nor WES have been performed, and listed features are present. The patient (8‑week‑old infant) has hypotonia, a relevant family history of unexplained developmental regression, no prior CMA/WES, and the test is ordered by a neurologist; therefore coverage criteria are met.",36955,2857,39812
Case8485,rag,all_correct,iter3,WES,Patient information explicitly states whole exome sequencing (WES) has been ordered.,Yes,"Policy requires member be <21 years of age for ES; patient is 8 years old, meeting the age requirement (policy: 'Member is <21 years of age').",No,The policy requires an 'appropriate genetic and family history evaluation' and a clinical letter with specific elements be provided for ES. The patient is being evaluated by a general pediatrician and there is no documentation presented of the required clinical evaluation/letter or pre-test counseling; therefore ordering requirements in the policy are not met.,No,"Policy defines explicit phenotype criteria for medical necessity (e.g., global developmental delay in children <5, moderate/severe ID, multiple congenital anomalies, OR meeting TWO listed neurodevelopmental criteria). The patient has hypotonia and motor delay (consistent with neuromuscular symptoms) but does not meet any single listed criterion or TWO of the listed criteria documented in the file; thus the clinical indication in policy is not met.",No,"Policy requires prior testing documentation and that prior ES/WGS not have been performed and that alternate etiologies and first-tier testing be considered and documented. While prior Fragile X testing was nondiagnostic and no prior ES/WGS reported, there is no documentation of the complete required prior evaluation/clinical letter or rule-out of alternate etiologies per policy; therefore required prior evaluation/testing is not documented as completed.",Not Specified,"The policy requires inclusion of family history in the clinical evaluation/letter but does not define a specific family-history or consanguinity criterion that alone makes ES eligible. The patient has a sibling with autism, but the policy does not explicitly list this family history as an independent coverage eligibility criterion.",No,"The policy and cited ACMG guidance require pretest genetic counseling (by a medical geneticist or affiliated genetic counselor) and written informed consent for ES. The patient record states pre-test genetic counseling was not performed, so counseling requirements in the policy are not met.",81415,Policy specifies CPT 81415 for proband exome sequencing (WES) when analyzing the entire exome; the ordered test is WES for the proband.,No,"Per the Cigna exome sequencing guideline all listed criteria must be met for ES coverage (including required clinical evaluation/letter, phenotype-based medical indication, documentation of prior testing where applicable, and pretest counseling). Although age (8 years) and prior Fragile X testing are noted, required documentation of the comprehensive genetic/family history evaluation and pretest genetic counseling is absent and the clinical phenotype does not meet the policy's defined indications; therefore the test is not covered under the policy.",10471,2383,12854
Case11795,rag,all_correct,iter3,WES,Patient information states whole exome sequencing (WES) is being ordered after nondiagnostic CMA to evaluate for an underlying genetic cause.,Not Specified,"Policy refers to 'children' and gives special guidance for infants (eg, BRUE) but does not provide a specific numeric age cutoff; the infant is a child, but the policy does not explicitly define an age-based eligibility threshold.",Not Answerable,"Policy requires documentation that the individual 'has been evaluated by a clinician with expertise in clinical genetics' and counseled. Patient data state pre-test genetic counseling was completed but do not explicitly document who the ordering provider is or whether the required genetics evaluation documentation exists, so this cannot be confirmed from the provided information.",Yes,"Policy lists 'Infant with high risk stratification on evaluation for a Brief Resolved Unexplained Event (BRUE) ... Significantly abnormal electrocardiogram (ECG), including ... possible channelopathies, arrhythmias, cardiomyopathies' as clinical features suggesting a genetic disease. The patient is a three-week-old infant with a high-risk BRUE and a markedly abnormal ECG, matching policy indications.",Yes,"Policy requires prior testing (eg, chromosomal microarray) to have failed to yield a diagnosis. The patient had CMA previously performed and nondiagnostic, meeting this prior-testing requirement.",Yes,"Policy lists family history of developmental delay/intellectual disability as relevant. The patient has a sibling with moderate to severe intellectual disability, which aligns with the policy's family-history criteria.",Yes,"Policy requires counseling by an individual with experience in genetic medicine. Patient information states pre-test genetic counseling has been completed with plans for post-test follow-up, satisfying the counseling requirement in the policy.",81415,The requested test is whole exome sequencing (WES). CPT 81415 corresponds to exome sequencing (interpretation and report) and is the best match among the provided CPT options for WES.,Yes,"Under the policy, WES may be considered medically necessary for children when all criteria are met: (1) evaluation and counseling by genetics (patient had pre-test genetic counseling and family/phenotype info documented), (2) potential to change management (abnormal ECG/channelopathy concerns are actionable), and (3) prior testing nondiagnostic (CMA nondiagnostic). These conditions are satisfied in the provided information, supporting coverage.",14874,2771,17645
Case2007,rag,all_correct,iter3,BRCA1/2,Patient was referred specifically for BRCA1 and BRCA2 testing (patient clinical information states BRCA1 and BRCA2 testing).,Yes,"Policy specifies testing in minors is investigational; the patient is 18 (an adult). The policy contains age-related criteria but does not exclude adults aged 18, so the patient's age satisfies the policy age requirements.",Not Specified,"The policy requires testing be performed in a setting with suitably trained providers and that genetic counseling be provided, but it does not specify a required ordering provider specialty/type; the ordering provider is a family medicine physician (patient info).",Yes,"Under Individuals With Cancer, the policy lists 'Diagnosed at any age with ≥1 close blood relative with breast cancer diagnosed at age ≤50 years' as a criterion. Patient has metastatic breast cancer and a mother with breast cancer ≤50, so criterion is met.",Not Specified,"The policy does not mandate prior specific tests before BRCA1/2 testing (it discusses prior limited testing scenarios and recommends testing an affected relative when available), and CMA (performed and nondiagnostic) is not identified as a required prior test.",Yes,"Family history criteria are specified in the policy (eg, ≥1 close blood relative with breast cancer diagnosed ≤50). Patient's mother had breast cancer at age 50 or younger, meeting the specified family-history criterion.",Yes,"Policy requires pre- and post-test genetic counseling by qualified personnel. Patient completed pre-test counseling and will return for post-test counseling, satisfying the counseling requirement in the policy.",Not Specified,The provided policy document does not list or map specific CPT codes for BRCA1/2 testing; no CPT guidance is given in the text provided.,Yes,Patient meets medical necessity criteria in the policy (personal history of breast cancer plus a close blood relative with breast cancer diagnosed ≤50). Pre-test counseling completed. Therefore germline BRCA1/2 testing is considered medically necessary and covered per the policy.,18944,2245,21189
Case7297,rag,all_correct,iter3,WES,Patient clinical information explicitly states whole exome sequencing (WES) is being pursued to identify an underlying genetic etiology.,Yes,"Policy allows WES for individuals with multiple congenital anomalies (must affect different organ systems); there is no minimum age exclusion for this indication and the patient is 3 years old, so the patient’s age does not preclude eligibility (policy lists some age-based thresholds for other features but multiple congenital anomalies have no prohibitive age requirement).",No,"Policy requires WES be ordered by a medical geneticist, neonatologist, neurologist, or developmental pediatrician. The information states referral by a family medicine physician and does not state that one of the required specialties ordered the test; therefore ordering provider requirements are not met per policy.",Yes,"Policy lists 'multiple congenital anomalies (must affect different organ systems)' as a qualifying clinical feature for WES; the patient has multiple congenital anomalies affecting different organ systems, meeting the medical indication.",Not Specified,"The WES coverage criteria do not mandate specific prior tests for postnatal cases with multiple congenital anomalies (prenatal WES requires prior CMA/karyotype), so no specific required prior testing is defined for this indication in the policy. The patient did have prior nondiagnostic karyotype, which is documented.",No,Policy lists consanguinity or other first- or second-degree family member(s) with similar clinical features as qualifying family-history criteria. The patient has a maternal aunt with ovarian cancer (a second-degree relative) but not 'similar clinical features' to the proband’s congenital anomalies; therefore the family-history criterion relevant to WES eligibility is not met.,Yes,"Policy states genetic counseling is strongly recommended prior to WES; the patient’s record documents pre-test counseling completed with a genetic specialist and plans for post-test follow-up, satisfying the counseling expectation in the policy.",81415,Policy applicable CPT codes list 81415 for exome sequence analysis (proband); this best corresponds to the requested WES.,No,"Although the patient meets clinical indication (multiple congenital anomalies), age, counseling, and appropriate CPT mapping (81415), the policy explicitly requires WES be ordered by a medical geneticist, neonatologist, neurologist, or developmental pediatrician. The provided information indicates referral by a family medicine physician and does not document that an eligible ordering provider placed the WES order; therefore coverage criteria are not fully met per the policy.",36959,2719,39678
Case2666,rag,all_correct,iter3,BRCA1/2,"Patient information states she is undergoing BRCA1/2 testing; policy provided is the BRCA1/BRCA2/PALB2 germline testing policy, so the test requested is BRCA1/2.",Yes,The policy specifically states genetic testing in minors is considered investigational; the patient is 21 (an adult). Thus the age-based policy restriction (minors) does not apply and her age is compatible with testing.,Yes,"Policy requires testing be performed in a setting with suitably trained providers and that genetic counseling be available. Patient had pre-test counseling with a genetic specialist and plans for post-test follow-up, satisfying provider/counseling setting requirements in the policy.",Yes,"Policy allows testing in unaffected individuals who have a 1st- or 2nd-degree blood relative meeting any criterion for Patients With Cancer. The patient’s father (1st-degree) has metastatic prostate cancer, which is listed in the policy as a qualifying cancer, so the patient meets a medical indication.",Not Specified,The policy recommends testing an affected family member first when possible but does not mandate prior diagnostic testing before testing an unaffected 1st-degree relative who otherwise meets criteria. The policy does not specify any required prior tests that the patient must have completed.,Yes,"Policy family-history criteria are relevant; the patient reports a 1st-degree relative (father) with metastatic prostate cancer, which is explicitly a qualifying family history in the policy.",Yes,"Policy states genetic counseling should be performed by someone experienced in genetic medicine. The patient completed pre-test counseling with a genetic specialist and has plans for post-test follow-up, meeting the counseling requirement described in the policy.",Not Specified,The policy document does not provide or map specific CPT codes to BRCA1/2 testing. No CPT code is specified in the provided policy text.,Yes,"Under the policy, genetic testing for BRCA1/BRCA2 may be considered medically necessary for an unaffected individual who has a 1st-degree relative meeting criteria for Patients With Cancer; the patient’s father has metastatic prostate cancer, a listed qualifying cancer, and counseling requirements are met, so the test is covered per the policy.",18944,2479,21423
Case13983,rag,all_correct,iter3,WGS,Patient information states whole genome sequencing (WGS) is being pursued at the request of the ordering gynecologist.,Yes,"Policy addresses infants/children (including neonates) and lists BRUE/abnormal ECG in infants as a clinical feature; the patient is a 7-week-old infant, which meets the policy's age-related pediatric/infant scope.",No,"Policy requires documentation that the individual has been evaluated by a clinician with expertise in clinical genetics (Policy Statement #1). The ordering provider is a gynecologist and there is no documentation that a clinician with genetics expertise evaluated the infant, so ordering-provider requirements are not met.",Yes,"Policy Guidelines explicitly list 'Infant with high risk stratification on evaluation for a Brief Resolved Unexplained Event (BRUE) ...' and 'Significantly abnormal electrocardiogram (ECG) including ... possible channelopathies' as clinical features suggesting a genetic disease. The patient has a high-risk BRUE and significantly abnormal ECG, meeting that clinical criterion.",No,"For standard WES/WGS the policy requires prior genetic testing (eg, chromosomal microarray analysis and/or targeted single‑gene testing) unless rapid testing for a critically ill infant in NICU/PICU is indicated. The patient had prior nondiagnostic FISH but no documentation of CMA or targeted single‑gene testing and is not documented as being critically ill in NICU/PICU, so required prior tests were not completed per policy.",Yes,"Policy lists family history items (eg, developmental delay, arrhythmia, BRUE in sibling) as relevant. The patient has a maternal uncle with unexplained developmental regression, which is a relevant family history per the policy.",Yes,"Policy states genetic counseling should be performed by someone with expertise. The patient had pre-test counseling with a genetic counselor and plans for post-test follow-up, satisfying the counseling requirement in the policy.",81425,The requested test is whole genome sequencing; CPT 81425 corresponds to whole genome sequence analysis/interpretation and is the best match for WGS.,No,"Although the patient meets a listed clinical criterion (high‑risk BRUE with significantly abnormal ECG) and is within the pediatric age range and has documented genetic counseling, the policy requires either (a) rapid WGS/WES for critically ill infants in NICU/PICU or (b) prior evaluation by a clinician with genetics expertise and prior appropriate genetic testing (eg, CMA or targeted single‑gene testing) for non‑rapid testing. There is no documentation the infant is critically ill/in NICU, no documentation of evaluation by a genetics clinician, and prior CMA/targeted testing was not documented. Additionally, the policy states WGS is investigational in other situations. Therefore WGS is not covered per the policy.",14898,2475,17373
Case15458,rag,all_correct,iter3,BRCA1/2,Patient is being evaluated specifically for BRCA1 and BRCA2 testing (patient summary: 'being evaluated for BRCA1 and BRCA2 testing').,Yes,"Policy lists 'Personal history of breast cancer and ... Diagnosed at age ≤45 years' as medically necessary indication. The patient is 19 with a personal history of breast cancer, meeting the age-based criterion.",Not Specified,Policy requires testing be performed in a setting with 'suitably trained health care providers' and recommends genetic counseling but does not specify required ordering provider type or specialty; the patient’s order by a nurse practitioner is not addressed explicitly in the policy.,Yes,"Policy lists personal history of breast cancer diagnosed ≤45 and personal history with a close relative with ovarian or metastatic prostate cancer as indications. Patient has personal breast cancer and family history of ovarian cancer (maternal aunt) and metastatic prostate cancer in a close relative, meeting medical indication criteria.",Not Specified,Policy discusses prior limited testing in some contexts but does not require a specific prior test (and does not require FISH prior to BRCA testing); the patient's prior nondiagnostic FISH is not defined as a required precondition in the policy.,Yes,"Policy defines 'close relatives' and lists family history (ovarian carcinoma; metastatic prostate cancer) as criteria. The patient has a maternal aunt with ovarian cancer (a close relative) and a close relative with metastatic prostate cancer, which are relevant family-history indications.",Yes,"Policy requires appropriate pre- and post-test genetic counseling and that testing occur in a setting with suitably trained providers. The patient completed pre-test genetic counseling with plans for post-test follow-up, meeting the counseling requirement described in the policy.",Not Specified,"The provided policy document does not specify CPT or billing code mappings for BRCA1/BRCA2 testing, so a specific CPT code cannot be determined from the policy text.",Yes,"Based on policy: patient has a personal history of breast cancer diagnosed ≤45 and relevant family history (ovarian carcinoma and metastatic prostate cancer), and received pre-test genetic counseling; these meet the policy's medical necessity and counseling requirements for BRCA1/2 germline testing.",18955,1838,20793
Case18868,rag,all_correct,iter3,WGS,Patient information explicitly states whole genome sequencing (WGS) has been ordered to assess for an underlying hereditary cancer predisposition.,No,"Cigna Genome Sequencing criteria explicitly require the member to be <21 years of age. The patient is 41 years old, so age-based eligibility is not met.",Not Specified,"The policy requires an 'appropriate genetic and family history evaluation' and documentation (clinical letter) but does not specify a required ordering provider specialty/type. The patient was evaluated by a medical geneticist, but the guideline does not mandate a specific ordering provider role, so explicit provider-type requirements are not specified in the policy.",No,"The policy defines specific clinical indications for genome sequencing (largely pediatric: <21 years with neurodevelopmental/congenital indications). Although the patient has suspected hereditary cancer, the policy's defined medical indications (including the mandatory age <21) are not met by this 41-year-old.",Yes,"Policy requires that the member has not had prior exome or genome sequencing. The record indicates prior karyotype was nondiagnostic and does not document prior exome or genome testing, satisfying the policy requirement of no prior ES/WGS.",Yes,"The policy considers family history as part of the genetic/family history evaluation (and family history can be relevant for eligibility in certain contexts). The patient reports a mother with a persistent severe hematologic disorder, which is relevant to hereditary risk.",No,The policy (and cited ACMG guidance within it) requires appropriate genetic evaluation and pretest counseling (by a medical geneticist or genetic counselor) and written documentation. The materials provided state there was no documented record of pre-test genetic counseling.,81425,Cigna's guideline maps whole genome sequencing (proband genome sequence analysis) to CPT code 81425; the policy directs 81425 should be billed for the proband for WGS.,No,"Per the policy, genome sequencing is considered medically necessary only when ALL listed criteria are met, including member age <21. The patient is 41 and therefore fails a mandatory criterion; consequently the test is not covered under the provided guideline.",9161,2464,11625
Case10917,rag,all_correct,iter3,WES,"Patient clinical information states ""whole exome sequencing (WES) has been ordered.""",Not Specified,"The UnitedHealthcare WES policy does not impose a strict age cutoff for postnatal WES eligibility; age-specific items in the policy reference ages for particular phenotypes (e.g., features diagnosed by 18 years, prenatal criteria) but no exclusion based on an 8-week infant age is specified.",Yes,"Policy requires WES be ordered by a medical geneticist, neonatologist, neurologist, or developmental pediatrician; the patient was evaluated by a medical geneticist who ordered WES, meeting the provider requirement.",Yes,"Policy requires clinical history suggesting a genetic cause plus one or more features (e.g., laboratory abnormalities suggestive of an inborn error of metabolism, or a first-degree family member with similar features). The infant has persistent conjugated hyperbilirubinemia (a lab abnormality consistent with possible IEM/cholestatic genetic disorders) and an older sibling with multiple congenital anomalies, meeting the medical indication criteria.",Not Specified,"The policy does not mandate specific prior tests (e.g., CMA) before postnatal WES; it only states targeted/single-gene testing should be done first when a specific syndrome is suspected. No required prior testing is documented for this clinical scenario.",Yes,"Policy lists 'other first- or second-degree family member(s) with similar clinical features' as an indication; the patient has an older sibling with multiple congenital anomalies, which is relevant family history per the policy.",Yes,"Policy states genetic counseling is strongly recommended prior to WES; the record indicates pre-test counseling was completed with a genetic specialist, satisfying the counseling expectation.",81415,Policy applicable CPT codes list 81415 for Exome (sequence analysis) corresponding to WES (proband) testing.,Yes,"Based on the policy coverage rationale: WES is medically necessary when ordered by an appropriate specialist and clinical history suggests a genetic cause with supporting features. The patient is an infant with persistent conjugated hyperbilirubinemia (lab abnormality suggestive of IEM) and a sibling with multiple congenital anomalies, WES was ordered by a medical geneticist, and pre-test genetic counseling was completed. These facts meet the policy's stated indications for coverage.",36946,1990,38936
Case12792,rag,all_correct,iter3,BRCA1/2,"The patient information states the referral is specifically for ""BRCA1/2 testing.""",No,"The policy explicitly states ""Genetic testing in minors for BRCA1, BRCA2, and PALB2 variants ... is considered investigational."" The patient is 12 years old, so age-based guidance in the policy indicates testing in a minor is not appropriate/eligible.",Not Specified,"The policy requires testing be performed in a setting with ""suitably trained health care providers"" and that genetic counseling be provided, but it does not specify a required ordering provider specialty or that only certain provider types may order testing. The case notes pre-test counseling was completed, but the policy does not define explicit ordering-provider credential requirements.",No,"Policy defines medical indications (personal history of relevant cancers or specific family history/criteria). The patient is an unaffected 12-year-old with congenital choanal atresia and a maternal growth abnormality (no described personal or family history of BRCA-related cancers or known familial BRCA/PALB2 variant), so she does not meet the listed medical indications.",Not Specified,"The policy recommends testing an affected family member first when possible and describes testing strategies, but it does not state a mandatory prior-test requirement that must be completed in this exact scenario. The provided patient data do note prior nondiagnostic FISH, but the policy does not require that specific prior testing prior to BRCA1/2 testing.",No,"The policy specifies family-history criteria (close blood relatives with early-onset breast, ovarian, pancreatic, prostate cancer, known BRCA/PALB2 pathogenic variant, etc.). The patient’s information does not describe any such cancer family history or known familial BRCA/PALB2 variant, so relevant family-history criteria are not met.",Yes,"The policy requires pre- and post-test genetic counseling in an appropriately trained setting. The patient record states pre-test genetic counseling has been completed and post-test follow-up is planned, which satisfies the policy's counseling requirement.",Not Specified,"The policy discusses recommended testing strategies (targeted familial variant testing vs comprehensive sequencing and large rearrangement analysis) but does not specify CPT codes. The provided policy text does not map tests to any of the listed CPT codes, so a specific CPT code cannot be determined from the policy alone.",No,Based on the policy: (1) BRCA1/2 testing in minors is considered investigational; and (2) the patient does not meet the policy's medical/family-history criteria for BRCA1/2 testing. Therefore the requested BRCA1/2 test is not covered under the policy for this patient.,18927,2318,21245
Case8710,rag,all_correct,iter3,WES,Patient clinical information explicitly states whole exome sequencing (WES) has been requested.,Yes,"Policy includes age-based statements (e.g., features diagnosed by 18 years). The patient is 12 years old, which meets the policy's age-related thresholds (under 18) for pediatric indications described in the WES coverage rationale.",Yes,"Policy requires WES be ordered by a medical geneticist, neonatologist, neurologist, or developmental pediatrician. The ordering/referring provider is a developmental pediatrician, which satisfies the requirement.",Yes,"Under the policy WES is medically necessary when clinical history suggests a genetic cause and listed features are present. The patient has autism spectrum disorder (a listed feature) plus at least one additional abnormality affecting another organ system (constituting multisystem involvement/two features), and presentation is nonspecific — meeting the policy's clinical indication for WES.",Not Specified,The policy does not require prior CMA/karyotype for outpatient/postnatal WES in the described indications; it only specifies targeted testing first if a specific syndrome is suspected. The patient had a nondiagnostic karyotype (documented) but the policy does not mandate additional specific prior testing in this scenario.,Yes,"Policy lists family history (other first- or second-degree family member(s) with similar clinical features) and consanguinity as relevant features. The patient has a paternal uncle (a second-degree relative) with neurologic disease (dystonia and ataxia), which is a relevant family history per the policy.",Not Specified,"The policy states genetic counseling is strongly recommended prior to WES/WGS but does not state that documented pre-test genetic counseling is an explicit coverage requirement. The patient has no documented pre-test counseling, but the policy treats counseling as recommended rather than a strict coverage criterion.",81415,"Applicable CPT codes in the policy list 81415 for 'Exome; sequence analysis', which corresponds to WES requested for this patient.",Yes,"Per the UnitedHealthcare WES coverage rationale: WES is covered when (1) presentation is nonspecific and not a well-defined syndrome, (2) ordered by an allowed specialty (developmental pediatrician), and (3) listed clinical features are met. The patient is a 12-year-old with ASD plus an additional abnormality affecting another organ system, prior karyotype nondiagnostic, and the ordering provider is a developmental pediatrician — collectively meeting the policy's coverage criteria for WES.",36953,3819,40772
Case16246,rag,all_correct,iter3,BRCA1/2,Patient is being referred for BRCA1 and BRCA2 testing per the clinical information; the request explicitly names BRCA1/2.,Yes,"Policy states BRCA1/2 testing is medically necessary for individuals with a personal history of breast cancer diagnosed at age 65 or younger; patient is 35, so she meets the age criterion (Policy: Coverage Rationale).",Not Specified,"Policy recommends genetic expertise and counseling and notes clinicians familiar with hereditary cancer should perform evaluation, but it does not state a specific required ordering provider specialty/type for BRCA1/2 testing.",Yes,"Policy lists personal history of breast cancer diagnosed ≤65 as a specific indication for BRCA1/2 testing; patient has breast cancer diagnosed before age 50, so she meets a defined medical indication (Policy: Coverage Rationale).",Not Specified,Policy does not require completion of any specific prior genetic tests before BRCA1/2 testing for an affected individual; no mandatory prior testing is listed in the BRCA1/2 coverage criteria.,Yes,"Policy specifies family history criteria and identifies pancreatic cancer as a BRCA-related cancer; patient has an uncle (a second-degree relative) with pancreatic cancer, which is a relevant family history per the policy definitions.",Not Specified,"Policy states pre-test genetic counseling is 'strongly recommended' but does not make counseling a stated coverage requirement; the patient has not had pre-test counseling, but counseling is not mandated as a condition of coverage in the policy.",81162,"Policy lists CPT 81162 for BRCA1/2 full sequence analysis plus duplication/deletion analysis, which corresponds to comprehensive BRCA1/2 testing requested.",Yes,Per the policy BRCA1/2 testing is proven and medically necessary for individuals with a personal history of breast cancer diagnosed at age 65 or younger; the 35-year-old patient with breast cancer meets the coverage criteria. Pre-test counseling is recommended but not required for coverage.,38615,1797,40412
Case14017,rag,all_correct,iter3,WES,Patient info explicitly states whole exome sequencing (WES) has been ordered.,Yes,"Policy applies to children/infants; patient is a 7-week-old infant and policy guidelines explicitly discuss infants with BRUE and infants <1 year, so the patient's age meets the pediatric/infant eligibility described in the policy.",No,"Policy criterion #1 requires documentation that the individual has been evaluated by a clinician with expertise in clinical genetics; available patient information documents evaluation by a general pediatrician and pre-test counseling but does not document evaluation by a clinician with genetics expertise, so ordering/provider requirement is not met per policy.",Yes,"Policy guidelines list 'Infant with high risk stratification on evaluation for a Brief Resolved Unexplained Event (BRUE) … with recurrent witnessed seizure like events' as a clinical feature suggesting a genetic disease appropriate for WES/rWES; the patient has a high-risk BRUE with recurrent witnessed seizure‑like events, so the clinical indication matches the policy.",Yes,"Policy criterion #3 permits WES when previous genetic testing has failed to yield a diagnosis; patient had prior karyotype testing that was nondiagnostic, which qualifies as prior genetic testing that failed to yield a diagnosis per the policy language.",Yes,"Policy guidelines list relevant family history examples and endorse consideration when family history suggests genetic disease; the patient has a maternal uncle with a neurologic movement disorder (dystonia/ataxia), which is relevant family history for possible inherited neurologic etiology under the policy.",Yes,"Policy requires genetic counseling by someone with experience in genetic medicine and documentation of counseling; patient information states pre-test genetic counseling was completed with plans for post-test follow-up, meeting the policy's counseling requirement.",Not Specified,The provided FEP WES/WGS policy document does not list or map specific CPT codes for WES; therefore a specific CPT code is not specified in the policy text.,No,"Although the patient meets clinical indication (high‑risk BRUE with recurrent witnessed seizure‑like events), prior testing, age, family history, and counseling, the policy's medical-necessity criteria for standard WES require documentation of evaluation by a clinician with expertise in clinical genetics (policy criterion #1), which is not documented in the patient information; because all required criteria must be met for coverage, the test is not covered per the policy.",14857,2514,17371
Case5674,rag,all_correct,iter3,WES,Patient information states the team plans whole exome sequencing (WES) to investigate a possible genetic epilepsy syndrome.,Yes,"Policy criteria apply to 'children' for standard WES. The patient is a 9-year-old child, which meets the age-related (child) criterion in the policy.",Yes,"Policy requires evaluation by a clinician with expertise in clinical genetics and counseling. Patient has had multiple visits with a genetic counselor and arrangements for genetics follow-up, satisfying the policy's provider/counseling requirement.",Yes,"Policy lists 'persistent seizures' among clinical features suggesting a genetic disease and states WES is medically necessary when prior testing is nondiagnostic. The patient has persistent seizures and a nondiagnostic CMA, meeting the medical indication criteria.",Yes,"Policy requires prior genetic testing (eg, chromosomal microarray and/or targeted single-gene testing) to be nondiagnostic or that a genetic etiology is still considered likely despite prior testing. The patient had a prior CMA that was nondiagnostic.",Yes,"Policy lists family history of sudden unexplained death in first- or second-degree relatives before age 35 as relevant. The patient has an uncle (second-degree relative) with sudden unexplained death before age 35, meeting the family-history criterion.",Yes,"Policy requires genetic counseling by an individual with experience/expertise. The patient has had multiple visits with a genetic counselor and planned post-test genetics follow-up, satisfying counseling requirements.",Not Specified,The provided BCBS_FEP WES/WGS policy text does not specify CPT or billing codes for WES; no CPT code mapping is given in the policy document.,Yes,"Under the policy, standard WES may be considered medically necessary for children when all criteria are met: evaluation/counseling by genetics expertise (met), potential to change management (implied by clinical evaluation for genetic epilepsy), and prior genetic testing nondiagnostic (CMA nondiagnostic). Patient facts satisfy these policy requirements; therefore WES is covered.",14831,1922,16753
Case9773,rag,all_correct,iter3,CMA,Patient information explicitly states a chromosomal microarray (CMA) was ordered to assess genomic copy number changes.,Not Specified,The FEP policy endorses CMA as first-line in postnatal evaluation of infants/children with developmental delay/intellectual disability but does not specify discrete age limits; patient is a 2-year-old which is within the postnatal/child scope but no explicit age criterion is given in the policy.,Not Specified,The policy does not impose explicit ordering-provider specialty or credentialing requirements for CMA; it does recommend genetic counseling by experienced personnel but does not restrict which provider may order the test.,Yes,"Policy statement: 'Chromosomal microarray analysis may be considered medically necessary as first-line testing in the initial evaluation of individuals with apparent nonsyndromic developmental delay/intellectual disability.' The patient is a 2-year-old with severe intellectual disability, meeting this indication.",Not Specified,The policy allows CMA as a first-line test in the initial evaluation and does not require completion of other specific prior tests before CMA in this context; patient has no prior testing which does not conflict with policy.,Not Specified,"The policy's coverage criteria are based on the patient’s developmental delay/ID and do not require family history or consanguinity as an eligibility criterion; although a maternal aunt with an immunologic disorder is reported, family-history criteria are not specified for CMA eligibility in the policy.",Yes,"The policy states experts recommend formal genetic counseling for cases when genetic testing is considered; the family completed pre-test genetic counseling and plans post-test counseling, meeting the policy's counseling recommendation.",Not Specified,The provided FEP policy discusses CMA testing but does not specify or map CPT codes for CMA; no CPT code is given in the policy text.,Yes,"Per the FEP policy, chromosomal microarray analysis 'may be considered medically necessary as first-line testing' for individuals with developmental delay/intellectual disability. The patient is a 2-year-old with severe intellectual disability, no prior conflicting testing, and has had pre-test counseling, meeting the policy criteria for coverage.",15707,1627,17334
Case18257,rag,all_correct,iter3,BRCA1/2,Patient is being evaluated for BRCA1/2 testing to assess hereditary breast and ovarian cancer risk; policy addresses BRCA analysis (BRCA1/2).,Yes,"Policy age requirement for BRCA testing (Known familial, Ashkenazi founder, Full Sequence) is >=18 years; patient is 64 so meets age criterion.",No,"Policy requires pre- and post-test genetic counseling by an appropriate provider as a prerequisite for BRCA testing; the test was ordered by the GP and there is no documentation of genetic counseling, so ordering-provider/counseling requirements are not satisfied.",Yes,"Policy Full Sequence Analysis diagnostic criteria include 'female with breast cancer diagnosis 50 years of age or younger'; patient had breast cancer diagnosed at age 50 or younger, meeting a defined medical indication.",Yes,"Policy requires no previous BRCA full sequencing (and no prior BRCA deletion/duplication for deletion testing); patient had prior CMA (nondiagnostic) but no prior BRCA testing, so prior-test requirements are satisfied.",No,"Policy defines family-history–based criteria for some BRCA pathways, but the patient's family history (a sibling with short stature) does not meet the policy's specified relevant family-history criteria for BRCA testing.",No,"Policy explicitly requires pre- and post-test genetic counseling by an appropriate provider for BRCA testing; there is no documentation that genetic counseling was provided, so counseling requirements are not met.",81162,"Policy procedure table lists BRCA1/2 sequencing and deletion/duplication combined as CPT 81162 and states 'If BRCA1/2 deletion/duplication analysis will be performed concurrently with BRCA1/2 gene sequencing, CPT code 81162 is likely most appropriate.' The patient meets criteria for full sequencing and has no prior BRCA deletion/duplication testing, so combined code 81162 is the best correspondence.",No,"Although the patient meets age and medical-indication and prior-test criteria, the policy requires documented pre- and post-test genetic counseling (and appropriate rendering lab/provider); there is no documentation of genetic counseling, therefore the BRCA test is not covered per the policy's stated prerequisites.",10263,2029,12292
Case10075,rag,all_correct,iter3,CMA,Patient information states consideration of chromosomal microarray (CMA) testing; prior CMA was nondiagnostic and CMA will be pursued. Basis: patient facts.,Not Specified,The FEP policy discusses CMA as a postnatal/first‑line test for certain indications but does not specify explicit age limits or numeric age criteria. Patient is a 4‑week‑old infant (postnatal) but no age restriction is stated in the policy. Basis: policy text (no age criteria).,Not Specified,The policy recommends genetic counseling be performed by someone with expertise but does not state specific ordering‑provider (specialty/type) requirements for CMA. Patient did receive pre‑test counseling from a genetic specialist (patient fact). Basis: policy text (no explicit ordering provider requirement).,No,"Policy lists CMA as medically necessary as first‑line for (1) apparent nonsyndromic developmental delay/ID, (2) ASD, or (3) multiple congenital anomalies not specific to a well‑delineated syndrome. The infant has meconium ileus (a single neonatal finding) and a family history of an inborn error of metabolism; there is no documentation of developmental delay/ID, ASD, or multiple congenital anomalies. Prior CMA was already nondiagnostic. Therefore the patient does not meet the policy's specified medical indications for CMA. Basis: policy statement and patient facts.",Not Specified,The policy does not define required prior tests that must be completed before performing CMA as a coverage condition (it notes CMA as first‑line and references guideline sequencing such as fragile X in ASD evaluation but does not mandate prior testing as a coverage prerequisite). Patient has had a prior nondiagnostic CMA (patient fact). Basis: policy text (no explicit prior‑test requirement).,Not Specified,"The policy does not set family history or consanguinity as an explicit coverage eligibility criterion for CMA. Patient has a family history of an inborn error of metabolism (patient fact), but the policy does not use family history as a stated coverage criterion. Basis: policy text (family history not specified as coverage criterion).",Not Specified,"The policy strongly recommends formal genetic counseling by an experienced provider and describes its importance, but it does not state counseling as an explicit coverage requirement for CMA. Patient completed pre‑test counseling with a genetic specialist and arranged post‑test follow‑up (patient fact). Basis: policy text (counseling recommended but not defined as coverage requirement).",Not Specified,The provided policy document does not list or map CPT codes to CMA testing. No CPT code correspondence for chromosomal microarray is specified in the policy text. Basis: policy text (no CPTs provided).,No,"Coverage per the FEP policy is limited to CMA when medically necessary for specific indications (nonsyndromic developmental delay/ID, ASD, or multiple congenital anomalies). This infant has a single neonatal presentation (meconium ileus), no documented developmental delay/ID or ASD, and a prior CMA was nondiagnostic. The policy also states CMA is investigational for other conditions. Therefore, under the policy the requested CMA is not covered. Basis: policy statement and patient facts (single anomaly and prior nondiagnostic CMA).",15704,2694,18398
